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1.
C H A P T E R  I 
INTRODUCTION
Species of the genus Rauwolfia (family Apocynaceae) are indigenous to 
the subtropical zones of Asia, Africa and South America, and the natives 
of these regions have employed the roots of the plant for treating a 
variety of illnesses. The genus was named in the honour of Leonhard 
Ranwolf, a Gorman physician and botanist who travelled to India in search 
of plants of medicinal interest and in 1582 published a book on medicinal 
plants. The use of Rauwolfia serpentina, so named because of the snake­
like appearance of the root, goes back in native Indian medicine to most 
ancient times. It is only, however, within the past decade that the 
plant has gained a place in orthodox therapeutics. In accounts of the 
early use of Rauwolfia in India, its sedative properties were most 
prominently mentioned as being beneficial in the treatment of excited 
and maniacal individuals.
In more recent times, Roy (1931) found that large doses of 
R. serpentina induced sleep, caused a dulling of the sensations and a 
diminution of the reflexes. In the same year, Sen and Bose (1931) 
studied the pharmacological effects of R. serpentina on the cat and 
other animal species. They reported a small drop in the blood pressure 
level and stimulation of respiration. Fatal doses caused death from 
respiratory failure; the heart continuing to beat for some time after 
respiration /
R=CH30 ,  Reserpine
CHp
H3COOC -OCOCHCH 
OCH3 
Rescinnamine
R a u w o lfia  A lk a lo id s
respiration had ceased* The characteristic hypotensive effect of 
R. serpentina was oonfirmed by Chopra, Bose, Gupta and Chopra (1942) 
who observed, following the administration of an extract of R. serpentina, 
a fall in the blood pressure level of animals with experimental hyper­
tension. In 19491 Vakil reported upon the clinical value of 
R* serpentina in human hypertension. A systematic chemical investi­
gation of the alkaloids of R. serpentina had already been made by 
Siddiqui and Siddiqui in 1931* but none of the substances isolated, 
which included ajmaline and serpentine, had shown the characteristic 
hypotensive and sedative activity of the whole root* The ultimate 
isolation of the substance responsible for the sedative actions noted by 
earlier workers was achieved by Muller, Sohlittler and Bein (1952). 
Subsequent pharmacological investigations by Bein (1933) indicated that 
this substance, which wa3 given the name of reserpine, exerted typical 
antihypertensive and tranquillizing actions in experimental animals 
including dogs, cats, monkeys and mice. These characteristic effects 
were found to be slow in onset but prolonged in duration*
Two alkaloids subsequently obtained from R. serpentina have also 
shown typical reserpine-like activity# These are rescinnamine,
(Fig. 1 page 2 ) identified by Klohs, Draper and Keller (1934) end 
deserpidine (ll-desmethoxyreserpine) (Fig. 2, page 4 ) first isolated 
by Schlittler, Ulshafer, Pandow, Hunt and Dorfman (1953)# Re sc inn amine
is the trimethoxycinnamate of methylreserpate, and deserpidine differs 
from /
4.
■'DoO
ooc
c h3o o c OCH3
10- methoxydeserpidine
CH3OOC
OOC
OCH:
/ / -  desm eth  o xyreserp /n e  
(ctes z rp id in  e )
Fig. 2
from reserpine by the absence of the methoxy group in position 11 of 
Ting A.
Pharmacological and clinical investigations carried out by a number 
of workers have indicated that the general pharmacological actions of 
reserpine are also manifested by deserpidine (Schneider, Plummer, Earl, 
Barrett, Rinehart and Dibble, 1955 and Achor and Hanson, 1956).
The pharmacological actions of reserpine were studied intensively 
by Bein (1953); Tripod and Meier (1954); Trapold, Plummer, and Tankman 
(1954); Vakil (1955); Lewis (1956); Bein (1956) and Kohli and 
Mukerji (1961). During the past decade, it has been widely employed in
the treatment of hypertension and certain psychiatric disorders.
Reserpine has enjoyed a world wide popularity, but its usefulness in the 
treatment of arterial hypertension has become limited due to its side- 
effects, the most important of which include mental depression, drowsiness, 
nasal congestion and diarrhoea. The incidence of these unpleasant 
reactions in relatively large numbers of patients has led to a search 
for compounds with reserpine-like antihypertensive actions but with 
fewer side-effects.
In 1958, Velluz and his associates synthesised an isomer of 
reserpine known as 10-methoxydeserpidine (methoserpidine) (Fig. 2 , 
page 4 ) and reported the separation of the antihypertensive actions 
from the central nervous system depressant effects of reserpine. The
drug was reported to produce none of the side-effects associated with
reserpine /
6.
CH30'
c h3o o c '^ y /  ^ohOCH:
M ethyl JZeserp&te
H O O C \ ^  OH 
OCH3 
Peserp ic A cid
Fig. 3.
reserpine therapy*
Little information is available upon the actions of 10-methoxy- 
deserpidine on isolated tissues and organs* Investigations were carried 
out upon the effects of 10-methoxydeserpidine on the cardiovascular 
system of the noraotensive, anaesthetised cat and rat* The central 
nervous system depressant effects were investigated using intact mice 
and rats*
In order to investigate the possible mechanism or mechanisms by 
which 10-methoxydeserpidine exerted its antihypertensive actions, studies 
upon the effects of this drug on tissue respiration, anaerobio glycolysis 
and the adenosine-triphosphatase activity of the rat brain, liver and 
skeletal muscle were performed.
To compare the effects of 10-methoxydeserpidine with a drug which 
exhibits reserpine-like antihypertensive and central nervous system 
depressant effects, the pharmacological properties of 10-methoxydeser­
pidine were compared with those of deserpidine which has consequently 
also been investigated*
During the isolation of reserpine in 19%-, Schlittler and his 
associates obtained reserpic acid and methylreserpate* These products 
are obtained on hydrolysing reserpine. Reserpic acid (Fig* 3, page 6 ) 
yhen esterified with diasomethane yielded a methyl ester known as methyl­
reserpate (Fig* 3 9 page 6 )• Reserpic acid is reported to possess 
none of the hypotensive or sedative actions of reserpine whereas methyl­
reserpate /
methylreserpate is known to possess about one third of the potency of 
reserpine (Rubin and Burke, 1954 and Plummer, Barrett and Rutledge,
1954)# Plummer and his associates concluded that esterification was 
necessary for the production of the characteristic central nervous system 
depressant effects of reserpine.
To compare the pharmacological aotions of reserpio acid and methyl­
reserpate with those of 10-methoxydeserpidine, studies were performed 
upon isolated tissues and organs and intact animals.
10-Methoxydeserpidine
Chemistry - 10-methoxydeserpidine is a structural isomer of 
reserpine (Fig. 2, page 4 ), the methoxy group in ring A being on 
carbon atom 10, instead of on carbon atom 11 (Velluz, 1959)*
Pharmacological Properties of 10-Methoxydeserpidine -
Effects on the Cardiovascular System. 10-methoxydeserpidine 
produces a moderate fall in the arterial blood pressure of the normo- 
tensive, anaesthetised oat and rabbit (Velluz, Peterfalvi and Jequier, 
1958). This antihypertensive response was found to be more significant 
in rats, made experimentally hypertensive by the administration of saline 
and implantation of desoxycorticosterone-aoetate pellets. 10-methoxy­
deserpidine, like reserpine, is characterised by the slowness in onset of 
its pharmacological aotions and their prolonged duration. Peterfalvi 
and Jequier (i960) observed that whatever the dosage used, the route of 
administration /
administration, or the animal species, there was no sedative action#
The carotid sinus pressor reflex in the anaesthetised cat was markedly 
reduced or abolished following the administration of 10-methoxydeser­
pidine (Peterfalvi and Jequier, i960 and La Barre, i960). The hyper­
tensive response to the intravenous injection of adrenaline in the 
anaesthetised oat was potentiated, whereas the response of the nicti­
tating membrane to adrenaline was unaltered. As with reserpine, (Bein, 
1953 and Plummer, Earl, Schneider, Trapold and Barrett, 1954) the fall 
in blood pressure level is acoompanied by a distinct bradycardia which 
is more marked in the dog and less so in the cat (Peterfalvi and Jequier,
i960). Clinical investigations of the antihypertensive actions of 10- 
methoxydeserpidine were first carried out by Meriel, Galinier, Sue and 
Bounhoure (l959)who reported it to be a safe antihypertensive agent of 
low toxicity and with no side-effects. In the subsequent clinical 
reports of Gross, Peterfalvi and Jequier (1959)* it was indicated that 
at adequate therapeutic dose levels, 10-methoxydeserpidine produced a 
fall in the blood pressure level in all types of hypertension with few 
or no side-effects. Holt (1961) revealed that two-thirds of her 
ambulant patients treated with 10-methoxydeserpidine showed a good 
hypotensive response with an absence of reserpine-like side-effects.
B u m  and Rand (1958) demonstrated that reserpine depleted the 
thoracic aorta of the rabbit of its stores of noradrenaline. 10- 
Methoxydeserpidine when given to mice at dose levels of 25 mg. per kg. 
intraperit one ally /
intrap erit one ally did not alter the catecholamine content of the heart 
and brain (Leroy and Schaepdryver, 1961)*
Effects on the Central Nervous System. Unlike reserpine, 
10-methO3Qrdeserpidine has been reported to possess no sedative or 
tranquillizing aotions (Velluz, Peterfalvi and Jequier, 1958; Gross, 
Peterfalvi and Jequier, 1959; Peterfalvi and Jequier, I960; and Holt,
1961)* When given to mice, in dose levels of 20 to 900 mg. per kg. 
intrap erit one ally and 2 g. per kg. orally, 10-methoxydeserpidine did not 
produce reseipine-like sedative effects or toxic actions. The sub­
cutaneous administration to rats of 1 mg. per kg. of 10-methoxydeserpidine 
daily for a period of two months and in dogs for three months did not 
cause loss in weight, retardation of growth or mortality (Peterfalvi 
and Jequier, i960). On the other hand, La Barre (i960) has demonstrated 
that intraperitoneal administration of 10-methoxydeserpidine (4 to 6 mg. 
per kg.) to rats, produced a reduction in motility. This effect lasted 
for a period of two days after the administration of the drugs and was 
said to be due to a sedative action.
Although 10-methoxydeserpidine is olaimed to be devoid of side-effects, 
sleepiness and mental depression were demonstrated in a proportion of 
oases following prolonged treatment with this drug (Holt, 19^1; Read,
1961; and Beilis and his associates, 1981). It has also been reported 
by Holt (1961) that 11 of her patients who had shown symptoms of anxie'ty 
were relieved of these following the use of 10-methoxydeserpidine as an 
antihypertensive /
antihypertensive agent,
Side-effects following 10-metho^rdeserpidine have been reoorded by 
other investigators and those most frequently observed clinically were 
nasal congestion, nausea, lethargy and a gain in weight, (Gross, Peter­
falvi and Jequier, 1959; aucL Read, 1961), La Barre (i960) has 
demonstrated that 10-methoxydeserpidine has less tendency than reserpine 
to produce gastric ulceration and vomiting.
The median lethal dose (LD 50) of 10-methoxydeserpidine in mice has 
been estimated by Peterfalvi and Jequier (i960) to be 2 g. per kg. intra- 
peritoneally whereas that of reserpine is 8.0 mg. per kg.
Deserpidine
Deserpidine has been studied by a number of workers who have 
reported on its effects upon intact animals. It has been shown to 
possess reserpine-like hypotensive and sedative actions and in all other 
respects appears to have the typical pharmacological properties of 
reserpine, indicating that the removal of the 11-methoxy group causes no 
qualitatively important effects (Schlittler, TJlshafer, Pandow, Hunt and 
Dorfman, 1955; Slater, Rathbun, Henderson and Neuss, 1955; Schneider, 
Plummer, Earl, Barrett, Rinehart and Dibble, 1955; Harris son, Packman, 
Smith, Hosansfey and Salkin, 1955; &nd Packman, Abbott and Harris son,
1956).
Hiarmacological Properties of Deserpidine. Deserpidine produces a 
fall /
fall in the blood pressure of the normotensive, anaesthetised cat end dog. 
Like reserpine, its antihypertensive and sedative actions are delayed in 
onset and prolonged in duration. When given intravenously to the 
anaesthetised cat or dog, a latent period of from one to three hours 
elapses before a significant reduction in the blood pressure level is 
noticed. The pressor response elicited by faradization of the central 
end of the vagus in dogs (Cronheim, Orcutt and Toekes, 1955) and cats 
(Slater, Rathbun, Henderson andNeuss, 1955) is completely abolished 
following the administration of deserpidine. When given intravenously 
to the oat and dog, deserpidine depresses the pressor responses to 
bilateral occlusion of the common carotid arteries (Schneider, Plummer, 
Earl, Barrett, Rinehart and Dibble, 1955* and Slater, Rathbun, Henderson 
and Neuss, 1955)* Tbe pressor effect of intravenous administration of 
adrenaline is enhanced following injection of deserpidine, whereas the 
depressor responses to injections of histamine and carbachol are not 
modified. The responses of the nictitating membrane to preganglionic 
stimulation of cervical sympathetic and to injection of adrenaline are 
not reduced following the administration of deserpidine (Slater, Rathbun, 
Henderson andNeuss, 1955)*
Cronheim, Orcutt and Toekes (1955) observed bradycardia associated 
with a fall in the blood pressure after deserpidine was administered to 
dogs. In the perfused, innervated but otherwise isolated hindquarters 
of the rat, in which the vasomotor tone was increased by infusion of 
noradrenaline /
noradrenaline. vasopressin or barium chloride, both deserpidine and 
reserpine exerted a direct vasodilator effect (McQueen and Blackman,
1955).
A clinical study by Ford, Borreson, Bindley and Meyer, (1957) has 
indicated that deserpidine has antihypertensive actions qualitatively 
similar to those of reserpine.
Innes, Krayer and Wand (1956) in their investigations on the heart 
rate and on the functional refractory period of atrio-ventricular 
transmission in the heart-lung preparation of the dog, observed that 
the oardio-aocelerator effects of deserpidine resembled those of 
reserpine. In the early period of their action, reserpine and deser­
pidine increased the heart rate and decreased the functional refractory 
period and atrio-ventricular propagation time. After a period of from 
90 to 150 minutes, using a dose equivalent in effect to 3 &£* of 
reserpine, deserpidine caused a decrease in the heart rate while the 
functional refractory period and the atrio-ventricular propagation time 
returned towards their original duration. Deserpidine and reserpine 
lacked this cardio-accelerator action in experiments where the heart- 
lung preparation was depleted of intrinsic catechol amines by previous 
treatment with reserpine. The transient cardio-acceleration and 
facilitation of atrio-ventrioular transmission following the use of 
reserpine and deserpidine can be explained by the release from the heart 
of catechol^amines, especially noradrenaline which is known to cause 
these /
these effects. The depressant action is concealed until the release 
of the amines is no longer sufficient to antagonise it. A number of 
workers have shown that reserpine causes a reduction in the catechol 
amine content of brain, peripheral sympathetic nervous tissues, the 
adrenal medulla, heart and artezy walls (Holzbauer and Vogt, 1956* 
Muscholl and Vogt, 1958; Carls son and Hillarp, 1956; Krayer and 
Paasonen, 1957; Paasonen and Krayer, 1958; and B u m  and Rand, 1958). 
Deserpidine was also shown to cause a decrease in the noradrenaline 
content of the rat heart. The adrenaline content was not markedly 
affected (Paasonen and Krayer, 1959) • It has also been shown to 
oause depletion of the noradrenaline content of the adrenal medulla 
of the rat (Greenberg, Toman and Jeff ay, 1959) and mouse(^cSohaep- 
dzyver and Preziosi, 1959)#
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C H A P T E R  II
A. MATERIALS
The drags used in the investigation which is described in this
section of the thesis, together with their shortened names, are &s
follows
1* Acetylcholine chloride is described as acetylcholine .
2. Sodium pentobarbitone (Veterinazy Nembutal, Abbott) is described
as pentobarbitone.
3* Histamine acid phosphate is described as histamine.
4. 5-Hydroxytryptamine creatinine sulphate is described as
5-hy droxy t iypt amin e.
5. (-)-Adrenaline bitartrate is described as adrenaline.
6. (-)-Noradrenaline bitartrate is described as noradrenaline.
7# Decamethonium iodide is described as decamethonium.
8. Nicotine hydrogen tartrate is described as nicotine.
9. Atropine sulphate is described as atropine.
10. (+)-Tubocurarine chloride is described as tubocurarine.
The following drugs were also used in the investigations presented 
in this part of the thesis.
10-Methoxydeserpidine (Roussel).
Deserpidine (Ciba).
Reserpic /
Reseipio aoid (Riker).
Methyl reserpate (Riker).
The compositions and methods of preparation of all physiological 
saline solutions used in this investigation are to he found in 
Appendix I, page 452*
Solutions of 10-methoxydeserpidine, deserpidine, methyl reserpate 
end reserpio acid were made by dissolving the solid in the minimal 
amount of glacial acetic acid and adjusting the volume with distilled 
water. The pH of the final solutions was from 3*4 to 3*6* Control 
solutions prepared in the same way and at the same pH were used 
throughout for purposes of comparison. The statistical method 
employed to calculate the experimental observations is described in 
Appendix I, page 453-
B. EXPERIMENTAL 
10-Methoxydeserpidine is a structural isomer of reserpine, the 
methoxy group being on carbon atom 10 instead of carbon atom 11 in ring 
A. In deserpidine the 11-methoxy group present in reserpine is absent.
In order to investigate the effects of this change in chemical 
structure upon pharmacological aotivity, five *tyPes experiments 
were carried out. These were:-
1. Experiments on the blood pressure level and vasomotor reflexes 
of normotensive anaesthetised oats and rats.
2. Experiments on the responses of isolated tissue preparations 
taken /
taken from organs containing smooth or skeletal muscle.
(a) Isolated strips of guinea pig ileum.
(b) Isolated strips of rabbit duodenum.
(c) Isolated strips of horse carotid arteiy.
(d) Blood vessels of the isolated, perfused rat hindquarters 
in situ.
(e) Isolated frog rectus abdominis muscle.
(f) Experiments were also carried out on isolated cardiac 
muscle, including isolated guinea pig auricles and the 
isolated perfused rabbit heart.
3* Experiments on the ganglion blocking activity.
4* Experiments on the tranquillizing and central nervous system 
depressant effects. For example, the induction of ptosis, 
miosis and the prolongation of pentobarbitone-induced sleep.
5. The determination of aoute toxicity in mice.
1. Experiments on the blood pressure level and vasomotor reflexes
of normotensive anaesthetised oats and rats.
(a) Experiments on the blood pressure of the anaesthetised oat. 
Method:
Cats of either sex, weighing from 2.0 to 4*0 kg. were used. 
Anaesthesia was induced by means of the intraperitoneal injection of 
40 to 60 mg. per kg. sodium pentobarbitone. The cat was left from 
20 to 40 minutes after the injection for surgical anaesthesia to 
develop. /
27.
develop* When anaesthetised,the cat was laid on its hack upon an 
operating table; the legs were secured to the table by means of 
strings and the head extended by passing a strong thread through the 
skin at the apex of the lower jaw* The skin covering the neck was 
cut away from the sternum to the apex of the mandible* The fascia 
covering the trachea was divided at the midline and the blunt point of 
an aneuiysm needle passed between the muscles of the neck and thence 
around, the trachea* A strong linen thread was now passed around the
trachea and a transverse incision made in the latter by means of a 
scalpel* The cut edge of the partly severed trachea was held firmly 
in a pair of blunt ended forceps and a trachea cannula inserted and 
tied into place* This was done as a precautionary measure in case it 
became necessary (due to drug-induced respiratory depression or failure) 
to keep the animal alive by means of artificial respiration* The
amounts of air entering and leaving the cannula could be controlled by
means of an adjustable sleeve or side tube* When experiments 
involving the leg muscles were performed, the external jugular vein, 
usually of the left side, was cannulated* In the other experiments 
the left femoral vein was cannulated and used for Intravenous 
injections. To cannulate the external jugular vein the skin of the 
left antero-lateral part of the neck was removed and the left external
jugular vein exposed* The fascia covering the vein was carefully
removed, a thread tied around the cephalad end and a bulldog clip put 
on /
on to the vein at the cardiac aspect. A small transverse out was 
made in the dilated vein by means of a pair of sharp-pointed iris 
scissors* A vein cannula filled with a solution of heparin in 
saline was then inserted into the incision with the pointed end 
towards the heart. Taking care that no air bubbles were left in the 
system, the cannula was connected by means of rubber tubing to a 
50 ml. burette containing normal physiological saline. The observ­
ation that the saline in the burette ran freely into the vein indi­
cated that the cannula had been correctly inserted. Having completed 
the cannulation of trachea and vein one of the carotid arteries was 
then cannulated. The arteiy was first tied off at a point as near to 
the head as possible. A bulldog clip was then placed on the arteiy 
about 3 o®* below the ligature and a thread passed under the vessel 
midway between the ligature and the bulldog clip. A small transverse 
out was made in the artery by means of a pair of sharp-pointed iris 
scissors. An arteiy cannula filled with a solution of heparin was 
inserted into the incision with the pointed end towards the heart. The 
cannula was connected by means of polythene tubing to a mercury mano­
meter and the tube filled with normal physiological saline containing 
1 unit per ml. of heparin as an anticoagulant. Air having been dis­
placed from the cannula and the pressure in the manometer set at about 
120 mm. of mercury, the artery clip was removed. A flag on one arm of 
the mercury manometer recorded the blood pressure on a moving, smoked 
paper /
paper surface.
Drug solutions were injected into the rubber connection between 
the vein cannula and the burette. Each injection was washed in 
slowly by the infusion of 3 nil. of saline from the burette. The 
blood pressure was recorded from the cannulated common carotid artery 
but when a reflex pressor response was elicited by means of bilateral 
occlusion of the common carotid arteries the blood pressure level was 
recorded from a cannulated femoral artery.
In a number of experiments upon cats the blood pressure level was 
raised by the continuous infusion of solutions of adrenaline or nor­
adrenaline , and the drugs were injected when the elevated blood pressure 
level had become steady. The adrenaline and noradrenaline solutions 
contained from 0.05 to 0.1 mg. per ml; the rate of infusion was 1 ml. 
per minute using a Palmer* s constant rate slow infusion apparatus. 
Respiratory movements were recorded by means of the apparatus shown in 
Fig. 4, page 30 . To record the respiratory volume of the anaesthetised 
oat the trachea cannula was connected to the side limb of a Palmer*s 
respiratory valve (modified from Gaddum, 1941) by means of a small 
piece of rubber tubing. The expired air was passed into a 1 litre 
capacity Buchner flask which was connected by means of rubber tubing 
from its side arm to a tambour. Changes in the volume of gas entering 
the flask are transmitted to the tambour by the rubber tubing and 
recorded on a moving, smoked paper surface using a gimbal lever.
When /
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Diagram of the apparatus used for recording the 
respiration of the anaesthetised cat*
When administered intravenously 10-methoxydeserpidine and 
deserpidine both produced a significant fall in the systolic and 
diastolic arterial blood pressure levels* In order to analyse as far 
as possible the cause and nature of the fall in blood pressure, experi­
ments were carried out on certain vasopressor reflexes. The effects 
of the drugs were studied by comparing the nature and magnitude of the 
reflex responses observed before and after their administration* At
least two or three responses were elicited before the drug injection* 
Control solvent solutions of the same volume were Injected and the 
effects on the same reflex responses observed.
Vasomotor reflexes
Certain vasopressor reflexes in which the central reflex pathways 
are in the medulla, hypothalamus and cerebrum have been investigated* 
Afferent nerve impulses are constantly impinging upon the vaso­
motor centre in the medulla from all the regions of the body but by far 
the most important of these appear to be those from the carotid sinuses, 
carotid bodies and aortic arch. Efferent impulses are thus initiated 
in the vasomotor centre and appropriate adjustments then made in the 
blood pressure according to the needs of the organism. The afferent 
nerves from the pressor receptor and chemoreoeptor endings in the 
oarotid sinuses and carotid bodies are very important in the reflex 
control of blood pressure, heart rate and respiration. Pressor 
responses can also apparently be elicited when any afferent nerve is
stimulated.
Investigations /
Investigations were carried out on the following pressor 
responses:-
(b) Carotid sinus pressor reflex
The carotid sinus is a dilatation normally present at the bifur­
cation of the common carotid artery. In the wall of the carotid 
sinus are characteristic sensory nerve endings which have the typical 
histological structure of stretch receptors and resemble those found 
in the aortic arch. Thpse receptors in the carotid sinus respond to 
the alterations in the blood pressure. The afferents from the car­
otid sinus pass mainly in the glossopharyngeal nerve to the vasomotor 
centre in the medulla. When the pressure in the sinuses is lowered 
artificially there is a reflex rise in the blood pressure, vasocon­
striction, cardiac acceleration and an increase in the rate and depth 
of respiration. These effects are due to the secretion of adrenaline 
and noradrenaline by the adrenal mednllae and vasoconstriction is due 
to an increase in the tone of the vasomotor centre. Reserpine has 
been shown to reduce markedly the pressor responses elicited by 
bilateral carotid occlusion (Bein, 1953)*
Method
The common carotid arteries were carefully separated from the 
sheath carrying the vago-sympathetic trunk and a loop of thread tied 
around each of them below the level of the carotid sinus. Pressor 
responses were elicited by bilateral occlusion of the common carotid 
arteries /
33.
arteries either "by placing bulldog clips on the arteries or by raising 
the threads looped loosely around them.
(o) Occlusion of the abdominal aorta
The abdominal cavity was opened by a midline incision. The 
rectus abdominis muscle and the fascia were retracted, the viscera 
pushed to the right and the abdominal aorta carefully dissected free 
from the fascia at a point a little below the diaphragm. A thread 
was then passed loosely around the aorta by means of an aneuiysm needle 
at a point just above the ooeliao artery. The abdominal aorta was 
occluded for a period of from fifteen to twenty seconds by raising 
the looped threads. The effects of drugs injected intravenously on 
these reflexes were followed for three to four hours after drug 
injection.
(d) Stimulation of the greater splanchnic nerve
The splanchnic nerves supply the major part of the abdominal 
viscera and are visceral sympathetic nerves. The greater splanchnic 
nerve emerges from the fifth to eighth thoracic segments of the spinal 
cord and passes through the segmental ganglia of the lateral sympa­
thetic chain to relay synapses in the ooeliac, superior mesenteric and 
renal ganglia. The preganglionic or grey fibres travel in the muscle 
coats of the larger vessels to the arterioles and thus reach the viscera 
these blood vessels supply. The afferent nerves from the viscera end 
in cell bodies lying in the dorsal root ganglion acre connected to 
the /
34
the cells of efferent nerves with their central axons and to the other 
segments of the spinal cord by means of interouncial neurons# The 
sympathetic nerve supply of the viscera is controlled by the vasomotor 
centre and posterior part of the hypothalamus.
When the central end of the splanchnic nerve is stimulated a 
reflex rise in blood pressure results due to the increase in tone of 
the vasomotor centre which causes vasoconstriction of the splanchnic 
area.
Reserpine does not cause inhibition of the response elicited by 
electrical stimulation of the cut central end of the splanchnic nerve 
(Bedn, 1953) • To investigate and compare the effects of 10-methoxy- 
deserpidine and deserpidine on this reflex the following experiment 
was carried out.
Method
The coeliao ganglion in theabdomen was exposed and dissected free, 
the greater splanchnic nerve traoed upwards and carefully cleared of 
connective and fatty tissue. The nerve was divided close to the 
ganglion and the out central end was placed on a pair of shielded 
platinum electrodes which were left in place and the abdomen closed.
The nerve was stimulated with 15 to 20 seoond bursts of impulses by 
means of a Bobbie Mclnnes square wave stimulator at a frequency of 
800 to 1,400 per minute, at 5 to 10 volts with a pulse width of 1.0 
to 1.5 msec. The experiment was performed for three to four hours 
and /
and responses elicited at intervals of 10 minutes*
(e) Stimulation of the cut oentral end of the cervical vagus 
Method
The right vago-sympathetio trunk was carefully dissected free from 
its fascia and separated from adjacent tissues* The vagus was freed 
from the cervical sympathetic trunk with which it runs* It was 
divided by means of scissors at as low a point in the neck as possible* 
The central end was placed on a pair of platinum electrodes which were 
connected to the output of a Dobbie Mclnnes stimulator* The nerve was 
stimulated by means of square wave impulses at a frequency of 800 to 
1,000 per minute, at 8 to 12 volts and with a pulse width of 0*5 to 
1*0 msec. Stimulation was continued for periods of 15 to 20 seconds 
at intervals of 5 minutes.
(f) Experiments on the blood pressure of the anaesthetised rat
Experiments were performed on the blood pressure of the anaes­
thetised rat in order to study the effects of drugs on (a) the blood 
pressure and (b) on the pressor or depressor responses elicited by 
intravenous administration of adrenaline and noradrenaline *
Method
The method adopted for recording the blood pressure of the 
anaesthetised rat was that described by Dekanski (1952) using Condon’s 
(1953) manometer (Fig.5, page 38 ).
Male albino rats weighing from 275 to 300 g* were used* The rat 
was injected subcutaneously with urethane, 175 P®r 100 g* of body 
weight /
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weight and left for one hour to attain surgical anaesthesia* After 
one hour the rat was laid on its back on the operating table, the hind 
legs were secured to the table with strings and the head was fixed on 
the table by passing a cotton thread through the skin of the lower jaw* 
The skin covering the front of the neck from the sternum to the apex 
of the mandible was removed and the fascia covering the trachea divided 
at the mid-line and the trachea exposed* A linen thread was passed 
around the trachea with the help of a blunt aneuxysm needle and a 
transverse incision made in the latter by means of a fine scalpel* A 
polythene cannula of 2*5 turn* external diameter was inserted into the 
trachea and tied into place. The skin over the inguinal region of 
the thigh was removed and the femoral vein exposed and separated from 
the femoral artery. Another deep branch reaching the femoral vein 
was tied off and the superficial pudendal vein retracted to one side. 
The femoral vein was clamped on the cardiac end and a ligature made
- i
at the peripheral end. A small transverse cut was made by means of  ^
iris scissors in the dilated piece of vein and a polythene cannula 
filled with heparin was inserted into the incision with the pointed *
end towards the heart. Taking care that no air bubbles were left in 
the system the cannula was connected by means of a short piece of fine 
rubber tubing to a 1 ml. burette containing normal physiological saline. 
Heparin, 200 units per 100 g. body weight was injected into the vein 
cannula using a 1 ml. tuberculin syringe and washed in with 0.2 ml* 
of /
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of physiological saline.
Having completed the cannulation of the trachea and vein one of 
the carotid arteries was then cannulated. The artery was first tied 
off at a point as near to the head as possible. A bulldog clip was 
then plaoed on the arteiy about 1 cm. below the ligature and a thread 
passed under the vessel midway between the ligature and the bulldog 
clip. A small transverse out was made in the arteiy by means of 
sharp-pointed iris scissors. A polythene cannula filled with a 
solution of heparin was inserted into the incision with the pointed end 
towards the heart and tied into place. The cannula was connected by 
means of polythene tubing to the Condon’s mercury manometer, the tube 
being filled with normal physiological saline containing 1 unit per 
ml. of heparin as an anticoagulant. Air having been displaoed from 
the system and the pressure in the manometer set at about 80 mm.Hg., 
the arteiy clip was removed. The flag on one arm of the mercury 
manometer recorded the blood pressure on a moving smoked paper surface.
Drug solutions were injected into the rubber connection between 
the vein cannula and the burette. Each injection was washed in 
slowly with 0.1 ml. of saline. Drug solutions were never injected in 
quantities of more than 0.2 ml.
Responses to the intravenous injection of adrenaline (l jag.) and 
noradrenaline (1 ;ug.) were taken and the effect of the drugs under 
investigation studied on these responses at intervals for a period of 
from /
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Fig. 5.
Diagram of the manometer used for recording the 
arterial blood pressure of the anaesthetised rat.
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from two to three hours.
Urethane (25 g«) was dissolved in 100 ml* of distilled water,
0.7 ml. per 100 g. body weight was used for subcutaneous injection.
2. Experiments on the responses of isolated tissue preparations 
taken from organs containing smooth or skeletal muscle.
(a) Experiments on the isolated guinea pig ileum.
The method adopted for recording the contractions of isolated 
guinea pig ileum was essentially the same as that used by G-uggenheim and 
Loffler (1916). Experiments were performed on the isolated guinea pig 
ileum to investigate the effects of drugs (a) on the smooth muscle of 
the gut and (b) on the responses of the gut to certain stimulant drugs. 
Method
Guinea pigs of either sex weighing from 300 to 500 g., and which 
had been fasted overnight, were killed by a blow on the head and the 
throats cut in order to drain out the blood. The abdominal cavity was 
opened and a piece of ileum about 3 cm. long removed from the region 
about 3 to 5 cm. proximaL to the ileocaecal junction. The contents 
of the ileum were washed out by inserting a pipette into one end of 
the gut and perfusing the gut with Tyrode*s solution (Appendix I, 
page 452). Threads were tied to both ends of the segment which 
was then set up in a 2 ml. organ bath (Pig. 6, page 40) containing 
oxygenated Tyrode*s solution. One thread was attached to a modi­
fied frontal point writing lever and the other end to a hook fixed
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Diagram of the organ bath used for experiments 
upon isolated strips of guinea pig ileum or 
strips of horse carotid arteiy
at the base of the bath, the temperature being maintained thermo­
statically at 36 - 0.5°C. Solutions containing the stimulant drugs 
were added and washed out by the overflow method. The inlet tube at 
the lower end of the bath was connected via heating coils to reservoirs 
which contained Tyrode’s solution. The dose of the stimulant drug to 
be used was determined at the start of each experiment by adding it to 
the bath by hand with a 1 ml. tuberculin syringe. Reproducible sub- 
maximal contractions were obtained at three minute intervals to an 
appropriate dose of the spasmogen which was allowed to remain in the 
bath for from 20 to 30 seconds. The drug solution was added to the 
bath one minute before the next addition of the spasmogen (acetyl­
choline, 5-bydroxytiyptamine, histamine or barium chloride). The 
length of the tissue was allowed to return to its resting level before 
the next addition of the drug.
(b) Experiments on the isolated rabbit duodenum 
Method
Rabbits of either sex weighing from 2 to 2.5 kg. were killed by a 
blow on the head* The throat was cut and the blood allowed to drain 
out, the abdominal cavity opened and a piece of duodenum about 2*. cm. 
long removed. This was freed from fatty and other tissues. Threads 
were tied to both ends of the segment and this was set up in a 10 ml. 
organ bath containing oxygenated Locke’s solution (Appendix I, 
page 452) at 36^ 0.5°C. The thread at one end of the duodenum was 
fixed /
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fixed to the lower end of the glass tube supplying oxygen to the bath 
and the thread at the other end was attached to a modified frontal 
point writing lever giving a magnification of eight times. Adrenaline 
or acetylcholine was added to the bath by means of a 1 ml. tuberculin 
syringe and^at 5 minute intervals, the effect was observed for a 
period of 2*j0 to 60 seconds. At the end of each addition of the 
drug the fluid in the bath was changed by running in fresh Looked 
solution. The solution of the drug under investigation was added 
to the bath 2 minutes before the next addition of acetylcholine or 
adrenaline and the effects were observed. The tissue was allowed 
to regain its original length and the responses to adrenaline or 
acetylcholine to return to control levels before the next addition 
of the drug. The effects of the drug on the rhythmic movements of 
the duodenal segment were also observed. The drag was added to the 
bath and allowed to remain there for 3 minutes. The bath was washed 
out by the overflow method at 10 minute intervals until the tissue 
had regained its normal rhythmic activity.
(c) Experiments on strips of horse carotid artery.
Experiments were performed on isolated strips of horse carotid 
arteiy to investigate the effect of drugs (a) directly on arterial 
smooth muscle and (b) on the responses of the arterial strips to 
stimulant drugs.
Method
The /
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The method adopted was the same as described by Kirpeker and Lewis 
(1958)* Lengths of carotid arteiy were removed from a freshly killed 
horse at the slaughter house. Arteries from young horses gave better 
results than those from older animals* The former were more sensitive 
to stimulant drugs and quicker to recover from their effects.
A portion of the artery was freed from the fascia and a strip 
about 4 cm. in length and 2 mm. wide made by cutting it into a spiral, 
using a pair of iris scissors. Threads were tied to both ends of the 
strip and it was set up in a 10 ml. organ bath containing oxygenated 
Tyrode's solution at 36 - 0*5°C* The thread at one end of the artery 
strip was fixed to the lower end of a glass tube supplying oxygen to 
the bath, the thread at the other end was attached to a modified 
frontal point writing lever giving a magnification of about 10 times. 
The strip was stretched by means of a 10 g. weight for about one hour. 
Before the experiment was started the additional weight was removed and 
the lever readjusted. Contractions were induced by addition to the 
bath of 1.0 to 2.0 pg. per ml. of adrenaline, noradrenaline, 5-bydroxy- 
tryptamine 1.0 to 2 1ig. per ml., acetylcholine 0.01 to 0.05 pg*p©r ml., 
histamine 0.1 to 0.2 pg. per ml. and barium chloride 50 to 100 pg. per 
ml. These were added to the bath as solutions in Tyrode’s solution 
by means of a 1 ml. tuberculin syringe.
Two types of experiments were performed. Stimulant drugs were 
added to the bath, standard submaximal contractions were recorded for
^ /
4 to 5 minutes and the effect of the drugs under investigation was 
studied on the magnitude of these contractions. Deserpidine and 
10-methoxydeserpidine were added 20 minutes before the next addition 
of the stimulant drug. The time interval between the two responses 
was 20 to 30 minutes.
In the second group of experiments, a sustained contraction was 
elicited by adding the stimulant drugs in the same dose range. The 
drugs under investigation were added to the bath to see whether the 
contraction was influenced. The preparation was very sensitive to 
acetylcholine even when stored for four days at 4°C. but did not show 
the same response to other stimulant drugs. Larger doses of adrenaline 
or noradrenaline were at times required to induce the desired con­
tractions in the stored arterial tissue.
(d) Experiments on the isolated perfused hindquarters of the rat
Experiments on the isolated perfused hindquarters of the rat were
carried out to study the effect of drugs on the tone of isolated blood 
vessels. The method adopted was essentially the same as that described 
by B u m  (1952) and the outflow was recorded with a Thorpe’s drop 
recorder.
Method
Rats of either sex weighing from 200 to 300 g* were killed by a
blow on the head. The throats were cut and the blood allowed to
drain out. The abdominal cavity was opened by means of a longitudinal 
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Diagram of the apparatus used for perfusion 
of the isolated rat hindquarters.
inoision extending from the sternum downwards. The rectum, the 
oesophagus and the inferior and superior mesenteric arteries were 
divided between ligatures and the abdominal viscera removed. The 
abdominal aorta was cleaned carefully and separated from the inferior 
vena cava, a loop of thread was made around the aorta, a small incision 
made with sharp-pointed iris scissors and a small polythene oaimula 
inserted and tied into place. To avoid intravascular clotting of the 
blood, heparin (10 units in 1 ml. of saline) was injected into the 
vessels through the cannula using a 1 ml. tuberculin syringe. The 
body wall and vertebral column were transected above the point of 
cannulation and the cannula attached to the perfusion system by means 
of fine rubber tubing. The perfused hindquarters were set up in the 
apparatus shown in Fig. 7, page 45# The reservoir containing the 
perfusion fluid was connected to the bubble trap and injection cannula 
by means of rubber tubing. The rate of flow of fluid from 131© bubble 
trap to the injection cannula was controlled by means of a screw clip 
and could be adjusted to a suitable rate at the beginning of each 
experiment. The hindquarters preparation was placed on a muslin rest 
lying in a filter funnel. The outflow was led via the filter funnel 
over the contacts of a Thorpe*s drop recording assembly.
After setting up the preparation, a uniform outflow record was 
obtained for at least 15 minutes before the drugs were injected into 
the injection cannula. Responses to the injection of adrenaline 
(0.1 /
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(0,1 to 1 pg.), noradrenaline (0.1 to 1 pg.), barium chloride ($0 to 
100 pg.) and acetylcholine (l to 5 pg.) were elicited. The quantity 
of fluid injected into the injection cannula was never more than 
0.1 to 0.2 ml. The effects of drugs on the constrictor or dilator 
responses of the blood vessels were recorded for two or three hours. 
Some control experiments were also carried out without injecting any 
drug.
(e) Experiments using the isolated frog rectus abdominis muscle.
The experiments were carried out on the isolated frog rectus 
abdominis muscle in order to investigate the effect of drugs 
(a) directly upon the skeletal muscle and (b) on the responses of 
the skeletal muscle to stimulant drugs.
Method
The procedure adopted for recording the contractions of the 
isolated frog rectus abdominis muscle was essentially the same as 
that described by De Jalon (1947)* Progs weighing from 25 to 50 g* 
were used. An adult frog was stunned by means of a blow on the 
head, decapitated and pithed. The frog was laid on its back on a 
disseoting board to which it was pinned. The rectus muscle was 
exposed by cutting away the skin of the abdomen and then dissected 
from its origin in the cartilage of the pectoral girdle to insertion 
in the pelvic girdle. The muscle was freed from the underlying 
connective tissues, removed from the frog and then suspended in 
an /
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Fig. 8.
Diagram of the apparatus used for experiments 
upon the isolated frog rectus abdominis muscle.
an organ bath (Fig. 8, page 48 ) of 10 ml* capacity by means of threads 
tied to each end of the muscle. A loop was made in the thread at one
end in order to fix the muscle to the bent wire in the base of the bath. 
The long thread on the other end was tied to a modified frontal point 
writing lever which gave a magnification of from 8 to 10 times.
The bath contained 10 ml. of Ringer's solution (Appendix I, 
page 452 ) at room temperature, bubbled continuously with 95$ oxygen andsi
5$ carbon dioxide. Acetylcholine, decamethonium or nicotine dissolved 
in frog Ringer's solution to give the required concentration were added 
to the bath by means ofv a 1 ml. tuberculin syringe. Uniform submaximal 
contractions to the same dose of spasmogen were obtained before the 
effects of the drugs were studied. The time interval between each
dose of spasmogen was six minutes. The resulting contractions were
recorded for 90 seconds. With nicotine and decamethonium the time 
interval between doses was about 15 to 20 minutes. The resulting con­
tractions were recorded for 2 minutes. The effects of drugs on the 
antagonism of atropine and tubocurarine to acetylcholine were also 
observed.
(f) Experiments on the isolated auricles of the guinea pig.
These experiments were carried out in order to study the action 
of the drugs on isolated cardiac muscle.
Method
The procedure adopted was the same as that described by Burn 
(1952). /
(1952). Adult guinea pigs of either sex were killed by a blow on the 
head. The throat was cut and blood allowed to drain out. The heart 
was then removed as rapidly as possible and immersed in well oxygenated 
Locke*s solution. Using a pair of fine scissors the ventricles were 
carefully removed and the auricles placed in a petri dish upon a piece 
of cotton wool soaked in Locke*s solution. A H  the extraneous tissue 
was dissected away until the horse-shoe shaped auricles alone remained. 
These were then suspended in a 10 ml. organ bath by means of two 
entomological pins to which fine cotton threads were tied. One thread 
was tied to the oxygen delivery tube at the base of the bath, the other 
to a Starling's heart lever set up so as to record the contractions of 
the auricles on a moving smoked surface. After about 30 minutes the 
beat of the auricles had usually become regular and the experiment was 
commenced. All drugs were added to the bath in the form of solutions 
in Locke's solution and by means of a 1 ml. tuberculin syringe. The 
effects of adrenaline, noradrenaline and acetylcholine were recorded 
for a period of 60 seconds after which the auricles were washed by 
replacing and draining the bath fluid three times. Sufficient time was 
allowed for the auricles to regain a normal regular rhythm and amplitude 
of beat before the next addition of the drug. 10-methoxydeserpidine 
and other drugs were added 3 to 5 minutes before each of the stimulant 
or depressant drugs tested. The bath temperature was maintained at 
29 ± 0.5°c.
(g) Experiments /
(g) Experiments on the isolated perfused rabbit heart.
In order to study the effect of the drugs under investigation 
upon (a) myocardial tone, amplitude, rate and outflow and (b) responses 
of the heart due to stimulant and depressant drugs, experiments were 
carried out on the isolated perfused rabbit heart.
Method
The isolated rabbit heart was perfused according to the method of 
Langendorff (1895) as described by B u m  (1952). This method involves 
perfusion of the coronary vessels through the aorta. Wegria (1951) 
in his review on the pharmacology of the coronary circulation quotes 
several published criticisms of this method. It is pointed out that 
the recorded outflow will give a true picture of the state of tonus of 
the coronaiy vessels only if the aortic valves are competent. This is 
not always so. In the event of aortic incompetence some perfusion 
fluid will leak past the valves into the left ventricle and so into the 
left atrium and thence to the exterior. The increased outflow may 
therefore exceed the true coronaiy outflow by the amount of fluid which 
has passed into the left ventricle. The volume of fluid draining into 
the right atrium via the ventricle is not constant and, in addition, 
cannot be measured satisfactorily. It was also pointed out that the 
volume of the coronaiy perfusate may be increased by a purely mechan­
ical massaging which cardiac muscle - stimulated by a cardiotonic 
drug - has upon the coronaiy vessels. Under these circumstances an 
increase /
increase in outflow might be taken to indicate a coronary dilatation 
which in fact was not present. Por these reasons it was decided that 
the fluid draining from the heart should be described simply as the 
ttcardiac outflow”. In spite of the objections raised to the use of 
this method, it was felt that the Langendorff preparation would still 
give some useful information about the effects of drugs on cardiac 
function in vitro. By oarefully observing the heart rate, the ampli­
tude of the contractions and at the same time measuring the outflow, 
an estimate of alterations of cardiac function as well as of the tonus 
of the coronary vessels can be obtained.
Method
Rabbits used were within the weight range of 2 to 2.5 kg* The 
animal was killed by a blow on the head, the throat cut and the blood 
allowed to drain out. The animal was then placed on its back on a 
dissecting board and the thoracic cavity exposed, care being taken not 
to damage the heart with scissors or other instruments. The lungs 
were removed and a thread was tied loosely around the aortic arch 
proximal to the origin of the innominate artery. The venae cavae and 
aorta were then severed and after removing the pericardium the heart 
was lifted out of the thorax and placed in a dish of warm oxygenated 
Locke's solution (Appendix I, page 452) at a temperature of about 57°C. 
and containing a little heparin to prevent the blood inside the heart 
from clotting. A stream of Locke's solution was allowed to run through 
the superior /
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Fig. 9.
Diagram of the apparatus used for 
recording contractions of the 
isolated rabbit or guinea pig heart*
superior vena cava from a pipette and the heart was squeezed gently. 
After washing, a cannula was tied into the aorta, taking care that its 
tip was distal to the coronary arteiy ostia. The preparation was then 
set up by connecting the cannula to the perfusion apparatus. Perfusion 
of oxygenated Locke*s solution containing double the normal concentra­
tion of glucose was started at a constant rate of flow and at a 
pressure of 35 of mercury, care being taken that no air bubbles 
entered the aorta. Any blood remaining in the preparation was rapidly 
washed away and the heart usually started to beat immediately. After 
about 30 minutes, when the beat had become regular, a supporting thread 
was tied by means of a fine needle through the tip of the left ventricle. 
A bent entomological pin was inserted into the wall of the right ven­
tricle and connected to a Starling’s heart lever which recorded the 
contractions of the heart on the surface of a smoked drum. Doubling 
the normal concentration of glucose in the perfusion fluid gave a more 
active preparation and one which was fatigued less easily. . The Locke's 
solution from the reservoir flowed through heating coils situated in a 
water bath (Fig. 9, page 53) maintained at 37°C. The glass coil was 
connected to the aortic cannula by a short length of tubing. This 
length of rubber tubing was kept short so as to avoid a drop in the 
temperature of fluid flowing from the bath through the coil into the 
aorta. The temperature drop between the water bath and the cannula was 
never more than 0.5°C. 10—Methoxydeserpidine and other drugs were 
injected by /
by means of a 1 ml. tuberculin syringe into the rubber tubing attached 
to the aortic cannula. The heart rate was counted by direct observ­
ation of the movements and the outflow measured by means of a Thorpe's 
drop recorder.
3* Experiments on the ganglion-blocking activity.
Experiments on the nictitating membrane of the anaesthetised cat. 
Method
In these experiments cats of either sex weighing between 2.0 and 
3.0 kg. were used. The cat was anaesthetised by means of an intra- 
peritoneal injection of 60 mg. per kg. of pentobarbitone sodium end 
trachea and vein cannulae inserted as described previously on page 
The head was fixed rigidly by passing a brass rod between the jaws and 
then tying the jaws firmly together with string. The ends of the rod 
were then gripped firmly in clamps and these were supported on uprights 
fixed to the side of the operating table. By means of a fine needle a 
silk thread was passed through the mid-point of the margin of the 
nictitating membrane of the right eye and tied firmly into place. The 
thread was pulled forward and then to one side, thus making an angle of 
about 30° to the long axis of the cat and then led around pulleys and 
attached to a frontal point writing lever.
The right cervical sympathetic chain was now dissected out and a 
fine cotton thread tied tightly around it at as low a point as possible 
in the neck. The chain was severed above the ligature and low in the 
neck. /
neck* The cut preganglionic cervical sympathetic chain was then 
placed on a pair of platinum electrodes and kept moist with normal 
saline* Contractions of the nictitating membrane were elicited by 
stimulation of the cervical sympathetic by means of square impulses at 
a frequency of 800 to 1,200 per minute, 8 to 15 volts, the pulse width 
being 0*5 to 1.0 msec. In any one eaqjeriment frequency of stimulation, 
voltage and pulse width were constant* The contractions of the 
nictitating membrane were recorded on a smoked surface* The nerve was 
stimulated at 3 minute intervals for 10 to 15 seconds* Having obtained 
standard reproduce able responses of the nictitating membrane by stimu­
lating the nerve trunk, solutions of drugs were injected into the 
femoral vein or the internal jugular vein one minute before the next 
period of stimulation* With deserpidine and 10-methoxydeserpidine, the 
contractions were recorded from 2 to 4 hours after the injeotion to see 
if there were any delayed effects* Contractions of the nictitating 
membrane were also obtained in response to the intravenous adminis­
tration of adrenaline or noradrenaline (15 to 20 pg* per kg*) and the 
effeots of the drugs were studied on these responses*
4* Determination of the tranquillizing and central
nervous system depressant effects*
To investigate the effects of drugs on the central nervous system 
and upon the general behaviour, two types of experiments were carried out*
(a) Experiments on rats and mice for ptosis, sedation
and gastro-intestinal activity*
Reserpine /
Reserpine is reported to have characteristic central nervous 
system depressant effects on animals as well as on human beings. It 
has also been shown to increase the g astro-intestinal motility causing 
loose stools. To evaluate the drugs under investigation and to com­
pare them with reserpine, experiments were performed on rats and mice. 
Method
Male albino rats weighing from 200 to 250 g. and mice weighing 
from 15 to 18 g. were used in these investigations.
Rats in groups of twenty were used; ten out of the twenty were 
used as controls and the other ten for the drug. Drugs under 
investigation were injected intraperitoneally and the effects on motor 
activity, ptotic response and intestinal activity were observed for 
from six to ten hours.
Mice in groups of twenty were used for the ptotic response; ten 
members of each group were used as controls and the other ten given 
the drug.
(b) Experiments on pentobarbitone-induced sleeping time in mice. 
Method
The method adopted for the experiment was essentially that 
described by Cronheim, Brown, Cawthorne, Toekes and Ungari (1954) but 
using 60 mg. per kg. of pentobarbitone by intraperitoneal injection. 
The mean sleeping time of a group of 500 male mice weighing from 15 to 
16 g. was estimated one week before the drug experiment. The 
individual /
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individual sleeping times were found to vary very widely and the 
variability of the animals was reduced by putting them into groups of 
twenty according to their sleeping times. From each group ten were 
used for the drug and ten for the control. This procedure was repeated 
five times at each dose level. An intraperitoneal injeotion of 60 mg. 
per kg. of pentobarbitone sodium was preceded two hours before by the 
intraperitoneal injection of the drug or control solution. The period 
which elapsed between the loss of consciousness and the re-appearance of 
the righting reflex was noted and called the sleeping time.
5* The determination of acute toxicity in mice.
(a) Determination of the approximate median lethal dose.
Method
The median lethal dose was determined using male mioe weighing from 
16 to 18 g. and the drugs were administered intraperitoneally to groups 
of twenty. Ten out of each group were used for control purposes and 
the other ten were injected with the drug. The dose at which five out 
of ten died in a period of three hours was taken to be the median lethal 
dose for that particular group of mice and was expressed in terms of 
mg* per kg. of body weight. The calculation of the medial lethal dose 
was carried out according to the method of Miller and Tainter (1944)*
The difference in the body weight of the mice of any one group was not 
more than 1 g. The quantity of the drug solution used for intra­
peritoneal injections was kept oonstant at 0.15 ml.
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RESULTS
Blood pressure of the anaesthetised oat,
10-Methoxydeserpidine at dose levels of 2 to 6 mg. per kg. 
produced a slow and sustained fall in the arterial blood pressure of 
the anaesthetised cat. This response was more marked when the initial 
blood pressure level was high (Pig. 10, page 62 )• In cats with a low 
blood pressure, (100 mm. Hg. or less) no reduction was noted even up to 
six hours following the intravenous administration of 10-methoxy- 
deserpidine. Bradycardia accompanied the reduction of the blood 
pressure level and was more distinct in the second and third hours of 
the experiment (Pig. 11, page 63 )•
Deserpidine 2 to 4 mg. per kg. when given intravenously produced
an immediate, slight fall followed by a sustained decrease in the 
arterial blood pressure level of the cat (Pig. 12, page 6 4)* The
hypotensive response to deserpidine in the cat was more marked and
more clearly defined than that of 10-methoxydeserpidine. The 
reduction in blood pressure level caused by deserpidine was also 
accompanied by a significant bradycardia which was more prominent in 
the second and third hours following the injection of the drug.
Reserpic acid and methyl reserpate in the dose range of 2 to 4  
mg. per kg. caused no observable reduction in the blood pressure level 
of /
Fig. 10.
Effect of 2 mg. per kg. of 10-methoxydeserpidine (DIO) on the 
respiration (upper record) and blood pressure (lower record) of the 
pentobarbitone-anaesthetised cat.
Blood pressure record taken from the common carotid artery.
Drugs injected intravenously.
Time interval (lowest trace) = 30 seconds.
63.
Fig, 11.
The effect of intravenous injection of 2 mg, per kg, of 10-methoxy- 
deserpidine (DIO) on the electrocardiogram of the pentobarbitone- 
anaesthetised cat,
(a) Before drug injection.
(b) 60 minutes after the drug injection.
Time interval (lower trace) = 5 seconds.
rnm
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Fig. 12.
Tracing a. Effect of 2 mg. per kg. of deserpidine (Des) on the 
arterial blood pressure level of the pentobarbitone- 
anaesthetised cat.
Blood pressure record taken from the common carotid artery. 
Drugs administered intravenously.
At C, 1.0 ml. of control solution injected.
Tracing b. Blood pressure level 60 minutes after the drug injection.
Time interval (lower trace) = 30 seconds.
of the anaesthetised cat, A small delayed fall in the blood pressure 
level was observed when larger doses, of the order of 5 to 10 mg, per 
kg., were used,
A slight depression of the respiration was observed, following the 
administration of 2 to 4 mg, per kg, of 10-methoxydeserpidine or 1 to 
2 mg, per kg, of deserpidine in the anaesthetised cat,
10-Metho2Qrdeserpidine in the dose range of 2 to 6 mg, per kg, and 
deserpidine 1 to 2 mg, per kg, did not inhibit the pressor responses 
elicited by intravenous injections of from 2 to 5 P©r kg* 
adrenaline or noradrenaline, In the same dose range, 10-methoxy­
deserpidine and deserpidine produced a characteristic potentiation of 
the pressor responses (Fig,13, page 66 ) which was more marked in the 
second and third hours of the experiment. Methyl reserpate and 
reserpic acid in dose levels of from 5 to 10 mg. per kg, did not cause 
an observable modification of the pressor responses to adrenaline and 
noradrenaline in the cat,
When given intravenously, 10-methoxydeserpidine, 2 to 6 mg, per 
kg,, deserpidine 1 to 2 mg, per kg,, and methyl reserpate and reserpic 
acid, 3 to 10 mg, per kg, did not alter the vasodepressor effeots in 
the anaesthetised cat due to the intravenous injections of from 2 to 
5 Pg* per kg, of acetylcholine and 2 to 5 pg* per kg, of histamine 
(Pig,14, page 67 )•
The pressor response to bilateral occlusion of the common carotid 
arteries /
Fis- J-3-
Effect of 2 mg. per kg. of deserpidine (Des) on the response 
of the blood pressure of the pentobarbitone-anaesthetised cat 
to noradrenaline (NA) or adrenaline (Ad).
At NA, 2 pg. per kg. noradrenaline.
At Ad, 2 pg. per kg. adrenaline.
At C, control solution (l ml.).
Blood pressure record taken from the common carotid artery. 
Drugs injected intravenously.
Tracing b. 60 minutes after deserpidine.
Tracing c. 120 minutes after deserpidine.
Time interval (lower trace) = 30 seconds.
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F ig . 14.
Effect of 1.5 per k6» deserpidine (Des) injected intra­
venously, on the depressor response of the pentobarbitone- 
anaesthetised cat to acetylcholine (A) and histamine (Hm).
At A - A pg* P®r kg. of acetylcholine.
At Hm - A Pg» per kg. of histamine.
Blood pressure recorded from the common oarotid artery.
Drugs injected intravenously.
Time interval (lower trace) = 30 seconds.
arteries was markedly reduced following 2 to 4 mg. per kg. of 10- 
methoxydeserpidine (Fig. 15, page 69 ), and 1 to 2 mg. per kg. o»f 
deserpidine (Fig. 16, page 70). The depression of this response was 
more marked following the administration of deserpidine than fallowing 
that of 10-methoxydeserpidine.
Following the intravenous injection of from 2 to 6 mg. per kg. of 
10-methoxydeserpidine, pressor responses due to occlusion of the 
abdominal aorta or stimulation of the cut central end of the left 
greater splanchnic nerve were not modified (Fig. 17,page 71 )• Unlike 
10-methoxydeserpidine, both the responses were markedly reduced, 
following the administration of from 1 to 2 mg. per kg. of deserpidine 
but they showed a tendency to recover to normal levels after two to 
three hours had elapsed (Fig. 18, page 72). No modification of these 
responses was observed following the administration to the cat of 5 to 
10 mg. per kg. of reserpic acid or methyl reserpate.
Ten minutes following the intravenous administration of 4 to 6 mg. 
per kg. of 10-methoxydeseipidine (Fig. 19, page 73 ) and 1 to 2 mg. per 
kg. of deserpidine (Fig. 20, page 74) the magnitude of the pressor 
response elicited by electrical stimulation of the cut central end of 
the right vagus was reduced. In some experiments on cats, an actual 
reversal of this reflex response was observed*
Deserpidine 2 to 5 rag* per kg. caused a slight reduction in the 
level of the blood pressure which had been raised by continuous 
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Tracing a. Effect of 2 mg. per kg. of deserpidine (Des) on the
response to carotid artery occlusion in the pentota.*
anaesthetised cat.
At CO both carotid arteries were occluded for 10 seconds.
Tracing b. 45 minutes after the drug injection.
Tracing c. 75 minutes after the drug injection.
At zero time deserpidine was given intravenously.
Time interval (lower trace) = 30 seconds.
Effect of 5 mg# per kg. of 10-methoxydeserpidine on the pressor 
responses to stimulation of the central end of the left, greater 
splanchnic nerve and compression of the abdominal aorta in the 
pentobarbitone-anaesthetised cat.
Tracing a.
Tracing b. 
Tracing c. 
Tracing d.
At St, electrical stimulation of the greater splanchnic 
nerve (10 volts, 1,000 impulses per minute, pulse width 
1.5 m.sec) for 15 seconds.
At A, compression of the abdominal aorta for 10 seconds. 
All drugs injected intravenously.
10-methoxydeserpidine injected between (a) and (b).
50 minutes after the drug injection.
105 minutes after the drug injection.
150 minutes after the drug injection.
Time interval (lower trace) = 30 seconds.
Fig. 18
Effect of 2 mg. per kg. of deserpidine (Des) on the pressor 
responses to compression of the abdominal aorta and stimulation 
of the central end of the left greater splanchnic nerve in a 
pentobarbitone-anaesthetised cat.
Tracing a. At A, compression of the abdominal aorta for 10 seconds. 
At St, electrical stimulation of the greater splanchnic nerve 
(10 volts, 1,000 impulses per minute, pulse width 1.5 m.sec) 
for 15 seconds.
All drugs injected intravenously.
At C, control solution (2 ml.) injected.
Tracing b. 50 minutes after the drug injection.
Tracing c. 80 minutes after the drug injection.
Tracing d. 190 minutes after the drug injection.
Time interval (lower trace) = 30 seconds.
73.
Fig. 19.
Tracing a. Effect of 6 mg. per kg. of 10-methoxydeserpidine on the 
pressor response to stimulation of the cut central end 
of the vagus nerve in a pentobarbitone-anaesthetised cat.
At VS, electrical stimulation of the cut central end of 
the vagus nerve (10 volts, 1,000 impulses per minute, 
pulse width 1.5 m.sec) for 15 seconds.
10-methoxydeserpidine injected intravenously between 
(a) and (b).
Tracing b. 5 minutes after the drug injection.
Time interval (lower trace) = 30 seconds.
Effect of 2 mg. per kg. of deserpidine (Des) on the pressor responses 
to stimulation of the cut central end of the vagus nerve in a 
pentobarbitone-anaesthetised cat.
At VS, electrical stimulation of the cut central end of the vagus 
nerve (10 volts, 1,000 impulses per minute, pulse width 1.5 m.sec) 
for 15 seconds.
Deserpidine injected intravenously.
Time interval (lower trace) = 30 seconds.
infusion of from 50 to 100 pg. per ml* per minute of adrenaline 
(Fig* 21, page 76) or noradrenaline (Fig. 22, page 77)* No such 
effect was observed following the injection of from 2 to 6 mg. per kg. 
of 10-methoxydeserpidine, reserpic acid and methyl reserpate.
Blood pressure of the anaesthetised rat.
A fall in the arterial blood pressure level of the rat was 
recorded following 1 to 2 mg. of 10-methoxydeserpidine, 0*1 to 0.2 mg. 
of deserpidine, 2 to 3 nig. of reserpic acid and methyl reserpate. The 
hypotensive response was more marked with deserpidine and 10-methoxy- 
deserpidine than with methyl reserpate and reserpic acid. In the 
same dose range deserpidine, 10-methoxydeserpidine (Fig. 23, page 78), 
methyl reserpate (Fig. 24, page 79) and reserpic acid (Fig. 25,page 80) 
when given intravenously to the rat, did not antagonise the hyper­
tensive responses to injections of 1 pg. of adrenaline and 1 pg. of 
noradrenaline.
Isolated strips of guinea pig ileum.
10-Methoxydeserpidine in bath concentrations of from 20 to 100 mg. 
per ml. caused an inhibition of the stimulant responses induced by 
0.1 to 1 pg. per ml. of acetylcholine (Fig. 26, page 82), 0*01 to 
0.1 pg. per ml. of histamine (Fig. 27, page 83), 0*25 to 1 mg. per ml. 
of barium chloride (Fig. 28, page 84), and 1.0 to 5»0 pg* Per 
5-hydroxytiyptamine (Fig. 29, page 85).
Deserpidine /
Effect of 2 mg. per kg. of deserpidine (Des) injected intravenously 
on the hypertension caused by slow infusion of adrenaline (Ad).
Adrenaline (Ad) 50 pg* per ml. infused at the rate of 1 ml. per 
minute using a Palmer's slow injection apparatus.
At C, control solution injected into the vein.
At Zero, drug solution injected into the vein.
Infusion discontinued at "Stop>; IfO minutes after the injection of 
deserpidine.
Time interval (lov/er trace) = 30 seconds.
Fig. 22.
Effect of 5 mg. per kg. of deserpidine (Des) injected intravenously 
on the hypertension caused by slow infusion of noradrenaline (NA).
Noradrenaline (NA) 50 pg. per ml. infused at the rate of 1 ml. per 
minute using a Palmer*s slow injection apparatus.
At C, Control solution injected into the vein.
At Zero, Drug solution injected into the vein.
Infusion discontinued at " Stop" 45 minutes after the injection of 
deserpidine.
Time interval (lower trace) = 30 seconds.
Fig. 23
Tracing a.
Tracing b.
Effect of a single dose of 1 mg. of 10-methoxy­
deserpidine (DIO) upon the responses of the rat blood 
pressure to adrenaline (Ad) and noradrenaline (NA). 
Blood pressure recorded from the common carotid artery• 
Drugs injected into the femoral vein*
At Ad, 1 pg. adrenaline.
At NA, 1 pg. noradrenaline.
90 minutes after the injection of drug.
Time interval (lower trace) = 30 seconds.
79
Fi
Effect of a single dose of 1 mg. of methyl reserpate (MR) on the 
response of the rat blood pressure to noradrenaline (NA) and 
adrenaline (Ad).
Blood pressure recorded from the common carotid artery.
Drugs injected into the femoral vein.
At C, 0.1 ml. of control solution.
At NA, 1 pg. noradrenaline.
At Ad, 1 pg. adrenaline.
Time interval (lower trace) = 30 seconds.
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Deserpidine in much lower dose levels (5 to 15 pg. Pe** nl«) 
produced a more marked and prolonged inhibition of the contractions 
produced by acetylcholine (Fig. 30* page 86), histamine (Fig. 31, 
page 87), barium chloride (Fig. 32, page 88) and 5-hydroxytiyptamine.
Methyl reserpate 150 to 900 pg. per ml. and reserpic acid 50 to 
100 pg. per ml. produced a short-lived inhibition of the responses to 
acetylcholine (Fig. 33, page 89, and Fig. 34, page 90), histamine 
(Fig. 35, page 91), barium chloride (Fig. 36, page 92), and 5- 
hydroxytiyptamine (Fig. 37, page 93).
Isolated strips of rabbit duodenum.
10-Methoxydeserpidine, 75 to 100 pg. per ml; deserpidine, 15 to 
20 pg. per ml; methyl reserpate, 100 to 200 pg. per ml; and reserpic 
acid, 50 to 100 pg. per ml., depressed the rhythmic contractions of the 
isolated rabbit duodenum. The effect of deserpidine (Fig. 3®, page 94) 
was the most prolonged, and a period of from 30 to 40 minutes was 
required by the gut for the rhythmic activity to return to control 
levels. 10-Methoxydeserpidine (Fig. 39, page 95) caused a short­
lived, depressant effect upon the rhythmic activity of the gut. This 
returned to control levels in from 10 to 15 minutes.
Methyl reserpate (Fig. 40, page 96) and reserpic acid had a veiy 
slight and short-lived effect upon the rhythmic activity of isolated 
strips of rabbit duodenum.
Contractions of the isolated duodenum following addition to the 
bath /
82.
Fig. 26.
W *» .t  Of 50 Per ^  of 10. . „ hoxJde,
response of the isni»+^ • v ; n 1
S°lated ileum to acetylcholine (
All contractions are due tn n i ,*° 0 a  w .  Per .1. of »e. tylchol.ee 
Time interval (lower trace, . 30
’ feet of 100 pg. per ml. of 10-methoxydeserpidine (DIO) on the 
response of the isolated guinea pig ileum to histamine (Hm).
All contractions are due to 0.1 pg. per ffll. of histamine.
Time interval (lower trace) = 30 seconds.
gig. 27.
Effect of 50 pg. per ml. of 10-methoxydeserpidine on the response 
of the isolated guinea pig ileum to barium chloride (b ).
All contractions are due to 0.25 mg* per ml. of barium chloride. 
Time interval (lower trace) = 30 seconds.
Effect of 100 pg* per ml. of 10-methoxydeserpidine (DIO) on the 
response of the isolated guinea pig ileum to 5“hydroxytryptamine (HT).
All contractions are due to 0.5 per ml* 5-kydroxytiyptamine.
Time interval (lower trace) = 30 seconds.
.22*
86
gj-fi* ?°*
Effect of 10 pg. per ml* deserpidine (Des) on the response of the 
isolated guinea pig ileum to acetylcholine (A).
All contractions are due to 0,02 pg. per ml. of acetylcholine.
At C, 0.1 ml. of control solution added to the bath.
Time interval (lower trace) = 30 seconds.
87.
Pifcjl.
Effect of deserpidine (Des) on the response of the isolated guinea pig 
ileum to histamine (Hm).
All contractions are due to 0*01 pg. per ml. of histamine.
At a, 10 pg. per ml. deserpidine (Des).
At b, 5 Pg. P©r deserpidine (Des).
At c, 15 Pg* per ml* deserpidine (Des).
Time interval (lower trace) = 30 seconds.
88
Fig. 32.
Effect of deserpidine (Des) upon the response of the isolated 
guinea pig ileum to barium chloride (B).
All contractions sire due to 50 Pg* per dlL of barium chloride*
At a, 7*5 pg* per ml. of deserpidine.
At b and c, 15 pg* per ml* of deserpidine*
Time interval (lower trace) = 60 seconds.
gis. 33
Effect of methyl reserpate (MR) on the response of the isolated 
guinea pig ileum to acetylcholine (A).
All contractions due to 0*2 pg. per ml. of acetylcholine.
At a, 600 pg. per ml. methyl reserpate (MR).
At b, 300 pg. per ml. methyl reserpate (MR).
Time interval (lower trace) = 30 seconds.
«&> Ik-
Effect of reserpic acid (RA.) on the response of the isolated guinea 
pig ileum to acetylcholine (A).
All contractions are due to 0.1 pg. per ml. of acetylcholine.
At a, 100 pg. per ml. reserpic acid (RA).
At b, 75 pg» per ml. reserpic acid (RA).
At c, 50 pg. per ml. reserpic acid (RA).
Time interval (lower trace) = 30 seconds.
Fig. 35.
Effect of reserpic acid (RA.) on the response of the isolated 
guinea pig ileum to histamine (Hm).
All contractions are due to 0,1 ug. per ml. histamine.
At a, 50 pg. per ml. reserpic acid (RA).
At b, 75 pg* per ml* reseipic acid (RA).
At c, 100 pg. per ml. reserpic acid (RA.). .
Time interval (lower trace) = 30 seconds.
92
F ig . 36.
Effect of reserpic acid (EA) on the response of the isolated 
guinea pig ileum to barium chloride (b ).
All contractions are due to 0.25 mg. per ml. of barium chloride.
At C, control solution, 0.2 ml. added to the bath.
At a, 45 pg. per ml. reserpic acid (RA).
At b, 90 pg. per ml. reserpic acid (RA).
At c, 65 pg. per ml. reserpic acid (RA).
Time interval (lower trace) = 30 seconds.
Effect of methyl reserpate (MR) on the response of the isolated 
guinea pig ileum to 5-hydroxytryptamine (HT).
All contractions due to 1 pg. per ml. of 5-hydroxytiyptamine.
At a, 600 pg. per ml. methyl reserpate (MR).
At b, 300 pg. per ml. methyl reserpate (itfR).
At c, 150 pg. per ml. methyl reserpate (MR).
Time interval (lower trace) = 30 seconds.
gig- 37.
Effect of 15 pg* per ml* of deserpidine (Des) upon the peristaltic 
movements of the isolated rabbit duodenum.
At C, control solution (0.1 ml.) added to the bath.
At W, bath washed out; washing out was repeated at 10 minute intervals. 
Time interval (lower trace) = 30 seconds.
gig- 38.
Fig. 39.
Effect of 75 pg* per ml. of 10-methoxydeserpidine (DIO) on the 
peristaltic movements of the isolated rabbit duodenum.
At C, control solution (0.2 ml.) added to the bath.
Time interval (lower trace) = 30 seconds.
Fig. 40.
r
Effect of methyl reserpate (MR) on the peristaltic movements of the 
isolated rabbit duodenum.
At a, 100 pg. per ml. of methyl reserpate (MR).
At b, 200 pg. per ml. of methyl reserpate (MR).
Time interval (lower trace) = 30 seconds.
hath of acetylcholine, 0.01 to 0.1 pg. per ml# and the reduction 
in the tone produced by 0*01 to 0.05 pg* per ml. of adrenaline 
were depressed by the addition of 10-methoxydeserpidine and 
deserpidine (Fig. 41* Pag© 98, and Fig. 42, page 99)* The 
effect of deserpidine was the more prolonged in duration.
Methyl reserpate (Fig. 43* page ICO), and reserpic acid 
(Fig. 44* page 101) at the same dose levels also caused some 
reduction in the magnitude of the contractions induced by 0*01 
to 0.1 pg. per ml. of acetylcholine. They were, however, less 
potent in this respect than 10-methoxydeserpidine or deserpidine.
In all experiments in which the drugs were dissolved in a 
solution of acetic acid, the drug-free acid solution was used 
as the control. It can be seen from inspection of the tracings 
that this solution was not inert but caused, for example, a 
brief, reversible fall in tone (Figs. 58, 39* 41 and 44* pages 
94* 95* 98, and 101) or a biphasic effect upon tone - which was 
first reduced and then increased (Fig. 39* page 95 anl Fig. 44* 
page 101). In the latter case, peristalsis was also reduced.
The effects of the control solution could be readily distinguished 
from those of the drug-containing solution.
Isolated /
97a.
Isolated strips of horse carotid artery
10-Methoxydeserpidine in the dose range of from 100 
to 200 pg. per ml. relaxed sustained contractions of artexy 
strips induced by adrenaline 0.1 to 0.2 pg. per ml. and nor­
adrenaline 0.1 to 0.2 pg. per ml. The degree of relaxation 
depended upon the magnitude of the dose of 10-methoxydeserpidine 
used. 10-Methoxydeserpidine also depressed reversibly con­
tractions of the strips induced by adrenaline, 0.01 to 0.02 pg. 
per ml. (Fig. 45, page 102), noradrenaline, 0.01 to 0.02 pg. 
per ml. (Fig. 46, page 103), 5-bydroxytryptamine 0.3 pg. per 
ml., and acetylcholine 0.01 to 0.1 pg. per ml. (Fig. 47, 
page 104).
Deserpidine, 50 to 200 pg. per ml. also caused relax­
ation of the sustained contractions induced by adrenaline 
(Fig. 48, page 105), noradrenaline 0.1 to 0.2 pg. per ml.
(Fig. 49, page 106), and 5-hydroxytryptamine 1 to 5 pg. 
per ml. Like 10-methoxydeserpidine, an inhibition of the 
responses induced by the addition of 0.01 to 0.02 pg. 
per /
*
Effect of 14 pg. per ml. of deserpidine (Des) on the response of 
isolated rabbit duodenum to acetylcholine (A).
All responses are due to 0.01 p.g. per ml. of acetylcholine.
At C, control solution 0.2 ml. added to the bath.
Time interval (lower trace) = 30 seconds.
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Effect of methyl reserpate (MR) on the response of the isolated 
rabbit duodenum to acetylcholine (A).
All responses are due to 0.1 pg. per ml. of acetylcholine.
At a, 200 pg. per ml. methyl reserpate (MR).
At b, 100 pg. per ml. methyl reserpate (MR).
Time interval (lower trace) = 30 seconds.
101.
Fi
Effect of reserpic acid (RA) on the response of the isolated rabbit 
duodenum to acetylcholine (A). All responses are due to 0.1 pg. 
per ml. of acetylcholine.
At a, 24 Pg. per ml. of reserpic acid (RA).
At b, 18 pg. per ml. of reserpic acid (RA).
At c, 8 pg. per ml. of reserpic acid (RA).
At C, Control solution (0.2 ml.) added to the bath.
Time interval (lower trace) = 30 seconds.
102
Fig. 45.
Effect of 100 fig. per ml. of 10-methoxydeserpidine (DIO) upon the 
response to adrenaline (Ad) of a strip of horse carotid artery. 
All responses due to 0.2 }ig. per ml. of adrenaline (Ad).
Time interval (lower trace) = 30 seconds.
Effect of 200 pg. per ml. (at a) and 100 pg. per ml. of 10- 
methoxydeserpidine (DIO) (at b) upon the response to noradrenaline 
(NA) of a strip of horse carotid artery.
All responses due to 0*2 pg. per ml. of noradrenaline (NA).
Time interval (lower trace) = 30 seconds.
Fiz. 46.
HT HT D10 HT
200/ug/ml
Fig. 47*
Effect of 200 pg. per ml# of 10-methoxydeserpidine (DIO) on the 
response to 3-hydroxytiyptamine (HT) of a strip of horse carotid artery* 
At HT, 1 pg. per ml. of 5-hydroxytryptamine.
Time interval (lower trace) = 30 seconds.
%Fig. 48.
Effect of 200 pg. per ml, of 10-methoxydeserpidine (DIO) or deserpidine 
(Des) on the sustained response of a strip of horse carotid artery to 
adrenaline (Ad).
At Ad, adrenaline 0.5 pg» per ml.
At W, bath washed out.
Time interval (lower trace) = 30 seconds.
Fig. U 3 .
Effect of 200 pg. per ml. of (a) 10-methoxydeserpidine (DIO) and
(b) deserpidine (Des) on the sustained response of a strip of
horse carotid artery to noradrenaline (NA).
At NA - Noradrenaline 0.01 pg. per ml.
At W - Bath washed out.
Time interval (lower trace) = 30 seconds.
per ml. of adrenaline and noradrenaline; 0.01 to 0.02 pg. per ml. of
acetylcholine, and 1.0 to 5*0 pg. per ml. of 5-hydroxytryptamine was 
observed. No direct effect was seen with 10-msthoxydeserpidine and 
deserpidine in doses of from 30 to 200 pg. per ml. on the isolated 
arteiy strips. Slight reversible inhibition of the responses to 
adrenaline, noradrenaline, and acetylcholine was noticed with reserpic 
acid and methyl reserpate in doses of from 0.1 to 0.2 mg. per ml. The 
control solution had no observable effect on the contractions produced 
by the stimulant drugs.
Isolated perfused hindquarters of the rat.
When added to the fluid perfusing the isolated hindquarters of the
rat, 10-methoxydeserpidine, 0.3 to 2 mg., deserpidine 30 to 200 pg., 
methyl reserpate 1 to 2 mg., and reserpic acid 1 to 2 mg. did not cause 
vasodilatation. 10-Methoxydeserpidine, 0.5 to 2 mg. did not antagonise 
the constrictor responses elicited by adrenaline, 1.0 to 2.0 pg.; 
noradrenaline. 1.0 to 2.0 pg. (Fig. 50, page 108); barium chloride,
100 to 250 pg. and 5-bydro3qytryptamine, 1 to 2 pg. (Fig. 51, page 109)* 
Deserpidine, 50 to 200 pg. produced on the other hand an inhibition of 
the constrictor responses to adrenaline, 1 to 2 pg. and noradrenaline,
1 to 2 pg. (Fig. 52, page 110). No suoh effect was observed upon the
constrictor responses elicited by barium chloride, 100 to 250 pg. and 
5-hydroxytryptamine 1 to 2 pg. The effects of deserpidine were 
prolonged in duration and irreversible.
Methyl /
Effect of a single dose of 1 mg. of 10-methoxydeserpidine (DIO) on 
the response of the isolated, perfused rat hindquarters to noradrenaline 
(NA) and adrenaline (Ad).
At NA, 1 pg. of noradrenaline injected into the cannula.
At Ad, 1 pg. of adrenaline injected into the cannula.
Time interval (lower trace) = 30 seconds.
♦
HT wr HT
30"
51.
Effect of a single dose of 500 pg. of 10-methoxydeserpidine (DIO) on 
the response of the isolated perfused rat hindquarters to 5-hydroxy- 
tryptamine (HT).
At HT,lpg. of 5-^ydroxytiyptamine injected into the cannula.
Time interval (lower trace) = 30 seconds.
The effect of perfusion of the isolated rat hindquarters with a 
solution of 20 pg. per ml. of deserpidine (Des) for 5 minutes on the 
response to adrenaline (Ad) and noradrenaline (NA) injected into the 
cannula.
At Ad, 1 pg. adrenaline injected into the cannula.
At NA, 1 pg. noradrenaline injected into the cannula.
Time interval (lower trace) = 30 seconds.
Methyl reserpate (Fig. 53, page 112) and reserpic acid (Fig. 54, 
page 113 ) in dose levels of from 1 to 2 mg. produced a slight but 
transient inhibition of the responses to 1 to 2 pg. of adrenaline, and 
noradrenaline. The responses returned to normal levels in about 10
to 15 minutes. No effect was observed on the responses due to 5"
hy dr oxytiypt amine, 1 to 2 pg. and barium chloride 100 to 250 pg.
The control solution had no apparent effect upon these responses.
Isolated frog rectus abdominis muscle.
10-Methoxydeserpidine and deserpidine, when used at dose levels
of from 80 to 100 pg. per ml* produced a direct stimulant effect upon
the isolated frog rectus abdominis muscle. A slow contractural
response was observed, the magnitude of which varied from one pre-
« -
paration to the other even when the same dose was used and was not 
reduced by the previous addition of atropine, 1.0 to 5 Pg* per ol* or 
tubocurarine 5 to 10 pg. per ml. The control solution did not cause 
any effect.
In the same dose range, deserpidine (Fig. 53, page 114 ) and 10- 
methoxydeserpidine (Fig. 5 ,^ page 11^ ) antagonised the contractions 
induced by 1.0 to 2 pg. per ml. of acetylcholine, 2 to 5 pg* per ml. 
of decamethonium, and 1 to 10 pg. per ml. of nicotine. The con­
tractions of the isolated frog rectus abdominis muscle failed to return 
to the original level on washing. At small dose levels (10 to 20 pg. 
per ml.) of deserpidine and 10-methoxydeserpidine, there was no direct 
stimulant /
Effect of perfusion of the isolated rat hindquarters with a solution 
of 400 pg. per ml* of methyl reserpate (MR) for 6 minutes on the 
response to adrenaline (Ad) and noradrenaline (NA).
At Ad, 1 pg. adrenaline injected into the cannula.
At NA, 1 pg. noradrenaline injected into the cannula.
Time interval (lower trace) = 30 seconds.
Effect of perfusion of the isolated rat hindquarters with a solution 
of 400 pg. per ml. of reserpic acid (RA) for 5 minutes, on the 
response to adrenaline (Ad) and noradrenaline (NA).
At Ad, 1 ug. adrenaline injected into the cannula.
gift. 34 .
At NA, 1 pg. noradrenaline injected into the cannula.
Time interval (lower trace) = 30 seconds.
Effect of 80 pg* per ml0 of deserpidine on the response to acetyl­
choline (A) of the isolated frog rectus abdominis muscle.
All responses are due to 2 i^g. per ml. of acetylcholine (A).
At C, control solution added.
Time interval (lower trace) = 30 seconds.
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Effect of 80 jag. per ml* of 10-methoxydeserpidine (DIO) on the 
response to acetylcholine (A) of the isolated frog rectus abdominis 
muscle.
All responses are due to 2 pg. per ml. of acetylcholine.
At C, control solution added.
Time interval (lower trace) = 30 seconds.
stimulant effect and no inhibition of the responses to spasmogens was 
observed.
Isolated guinea pig auricles.
When 10-methoxydeserpidine in a concentration of from 20 to 60 pg. 
per ml. was added to the bath, no reduction was seen in the rate or 
amplitude of the contractions of the auricles. In contrast, a marked, 
but reversible decrease in the rate and amplitude of the contractions 
of the auricles was noted with doses of from 8 to 16 pg. per ml. of 
deserpidine. The control solution had no effect. Reserpic acid and 
methyl reserpate, 10 to 50 pg. per ml. had no depressant effect on the 
contractions of the auricles.
The increase in the rate and amplitude of the contractions of the 
auricles induced by adrenaline and noradrenaline, 1 to 2 pg. per ml. 
was slightly antagonised by 10 to 30 pg. per ml. of 10-methoxydeserpidine 
(Pig.57, page 117) but the responses returned to normal within a period 
of 10 minutes. A more marked inhibition of such responses was noted 
following the addition of 8 to 16 pg. per ml. of deserpidine (Pig. 58, 
page 118). The responses returned to control levels in from 20 to 
30 minutes. Reserpic acid and methyl reserpate, 0.1 to 1 mg. per ml. 
had a veiy slight effect upon the responses of the auricles to the 
addition of 1.0 to 2.0 pg. per ml. of adrenaline and noradrenaline to 
the bath (Pig.59, page 119). In the same dose range, 10-methoxy- 
deserpidine, deserpidine (Pig.60, page 120), reserpic acid and methyl 
reserpate /
Fig. 57.
Effect of 80 pg. per ml. of 10-methoxydeserpidine (DIO) upon the
response of the isolated guinea pig auricles to noradrenaline (NA),
adrenaline (Ad) and histamine (Hm).
At NA, noradrenaline, 0.1 pg. per ml.
At Ad, adrenaline, 0.1 pg. per ml.
At Hm, histamine, 0.1 pg. per ml.
At C, control solution (0.2 ml.) added to bath.
Time interval (lower trace) = 30 seconds.
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Effect of 10 pg. per ml. of deserpidine (Des) on the response 
of the isolated guinea pig auricles to acetylcholine.
At Ach, acetylcholine 0.05 pg. per ml. added to the bath.
At W, bath washed out.
Time interval (lower trace) = 30 seconds.
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reserpate did not modify the depressor effects of 0.1 to 0.5 pg. per 
ml. of acetylcholine.
Isolated perfused rabbit heart.
When 18 to 50 pg. of 10-methoxydeserpidine (Pig. 61, page 122 ) or 
10 to 50 pg. of deserpidine (Pig. 62 , page 123 ) were injected into the 
cannula, a sharp, progressive and irreversible decrease in the rate and 
amplitude of the contractions of the heart was produced. This effect 
on myocardial activity was accompanied by a significant increase in the 
outflow from the heart. When given at the same dose levels, the 
control solutions had qualitatively similar hut quantitatively much 
weaker actions. Reserpic acid 0.125 to 0.5 mg. per sal* a*id methyl 
reserpate 20 to 80 pg. per ml. (Pig. 63, page 224) when perfused, pro­
duced a transient but sharp decrease in the rate and amplitude together 
with a small increase in the outflow from the heart.
G-anglion-blocking activity.
No direct effect upon the nictitating membrane of the anaesthetised 
cat was observed following the intravenous administration of 4 to 6 mg. 
per kg. of 10-methoxydeserpidine (Pig. 64, page 125) or 1 to 2 mg. per 
kg. of deserpidine (Pig.65, page 126). In the same dose range, these 
diugs did not antagonise the contractions induced by stimulation of the 
cervical sympathetic.
10-Methoxydeserpidine 2 to 4 og* P®r kg. potentiated the responses
of /
Effect of a single dose of 18 pg. of 10-methoxydeserpidine (DIO) 
upon the amplitudey (upper record) and outflow (lower record)
of the isolated perfused rabbit heart*
At C, 0*1 ml* of control solution injected into the cannula supporting 
the heart*
Time interval (lower trace) = 30 seconds*
Effect of a single dose of 10 pg. of deserpidine (Des) on the 
amplitude^ (upper record) and outflow (middle record)
of the isolated, perfused rabbit heart.
Time interval (lowest trace) = 30 seconds.
Pig. 62.
Effect of perfusion for 10 minutes of 20 pg. per ml. of methyl 
reserpate (MR) solution on the rate and amplitude of the beat of the 
isolated, perfused rabbit heart. Perfusion of the drug solution 
took place between the vertical arrows.
Numbers above the upper record indicate the heart rate at that time. 
Time interval (lower trace) = 30 seconds.
Fig* 63.
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Tracing a.
Tracing b.
Effect of 2 mg. per kg. of deserpidine (Des) on the 
responses of the arterial blood pressure (upper record) 
and contractions of the nictitating membrane (lower record) 
of the pentobarbitone-anaesthetised cat to stimulation of 
the preganglionic fibres of the cervical sympathetic 
(10 volts^ pulse width 1.5 m.sec at a frequency of 1,000 
impulses per minute for 10 seconds).
Blood pressure recorded from the femoral artery.
60 minutes after the drug injection.
Time interval (lowest trace) = 30 seconds.
Effect of single dose of 4*0 mg. per kg. of 10-methoxy- 
deserpidine on the response of blood pressure to 
injection of adrenaline (upper record), on respiration 
(middle record) and on the response of nictitating 
membrane to adrenaline (Ad) (lower record).
All responses are due to 20 pg. per kg. of adrenaline (Ad). 
10-Methoxydeserpidine was given as a single intravenous 
dose between (a) and (b).
30 minutes after the injection of the drug.
80 minutes after the injection of the drug.
All drugs given intravenously.
Time interval (lowest trace) = 30 seconds.
of the nictitating membrane to injections of 10 to 20 ^ ug. per kg. of 
adrenaline (Eig. 66, page 127). Reserpic acid and methyl reserpate 
in doses of the order of 5 to 10 mg. per kg. neither produced any 
direct effect, nor modified the contractions of the nictitating 
membrane induced by stimulation of the cervical sympathetic.
Tranquillizing and central nervous system depressant effects.
Effects of 10-methoxydeserpidine and deserpidine on the
motility of mice and rats.
When given intraperitoneally, 10-methoxydeserpidine (5 to 40 mg. 
per kg.) did not produce any observable change in the motor activity 
of rats or mice. On the other hand, deserpidine in much smaller doses 
(0.05 to 5 nig. per kg.), produced a marked reduction in motility. In 
mice, high intraperitoneal doses (40 to 80 mg. per kg.) of 10-methoxy- 
deserpidine caused a reduction in the motor activity but even at these 
dose levels, it \Yas much less active than deserpidine or reserpine.
Effects of 10-methoxydeserpidine and deserpidine on.
gastro-intestinal activity in rats and mice.
Reserpine has been shOY/n to cause increased gastro-intestinal 
activity in a number of animal species, including the dog, rabbit, 
rat and mouse.
When given intraperitoneally in the dose range of from 5 to 40 
mg. per kg., 10-methoxydeserpidine did not produce diarrhoea or loose 
stools /
stools in rats or mice whereas in the same species deserpidine in much 
smaller doses (0.03 to 3 rag. per kg.) produced loose stools.
Effect of 10-methoxydeserpidine on the ptotic response in mice.
10-Methoxydeserpidine in the dose range of from 3 to 60 mg. per kg. 
did not produce ptosis in mice.. On the other hand, deserpidine has 
been shown to produce marked ptosis in mice (Packman, Abbott and 
Harrisson, 1936)* absence of the ptotic response in rats and
mice and the lack of interference with the motor activity of the 
animals when 10-methoxydeserpidine was given, indicated an absence of 
the type of central nervous system depressant activity associated with 
reserpine-like drugs.
Effects of 10-methoxydeserpidine on pentobarbitone-induced
sleep in mice.
10-Methoxydeserpidine at a dose level of 40 mg. per kg. produced 
an increase of border-line significance in the duration of pento­
barbitone-induced sleep (P = 0.1). Eeserpine and deserpidine in dose 
levels of 2.3 rag. per kg. produced a significant increase in the 
sleeping time of mice (P = 0.03 ^  O.l) (Table 1, page 13l)*
Prolongation of the sleeping time as compared to the control 
group, was taken as an indication of an increase in the sedative 
activity of the drug.
Acute toxicity in mice.
Approx iihate /
Approximate median lethal dose.
The median ’lethal dose (LD 50) in mice following the intra- 
peritoneal injection of 10-methoxydeserpidine was found to be 82 i 
2.6 mg. per kg. (Table 2, page 132). The dose sufficient to kill
fifty per cent of the drug-injected animals within three hours 
was considered to be the approximate median lethal dose (LD 50)#
The intraperitoneal injection of from 40 to 180 mg. per kg. of 
10-methoxydeserpidine to mice was followed by a small period of 
excitation, after which the animals became sluggish and cyanosed.
The cyanosis was first noted in the tail and then in the ears and the 
face. Cyanosis was accompanied by laboured breathing, followed by 
cessation of respiration and death. The heart continued to beat for 
some time after the respiration had failed. The results are given in 
Table 2, page 132 and are shown in Pig. 67, page 133-
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DISCHSSIOIT
Deserpidine has been shorn to possess pharmacological properties 
qualitatively identical with those of reserpine (Schneider, Plummer, 
Earl, Barrett, Rinehart and Dibble, 1935). Reserpine exhibits a 
complex pattern of activity* Its antihypertensive and sedative 
actions are regarded as being mainly due to effects on the central 
nervous system, but there are some which are peripheral in nature 
(Bein, Gross, Tripod, and Meier, 1933» and. Plummer, Earl, Schneider, 
Trapold and Barrett, 1954). Characteristic features of the action of 
reserpine are its typical sedative and hypnotic properties which differ 
from those of other central nervous system depressants such as the 
barbiturates. Eollowing the administration of reserpine there is 
observed a fall in the arterial blood pressure level, accompanied by 
bradycardia, some respiratory inhibition, increased gastrointestinal 
motility, miosis, ptosis, relaxation of the nictitating membrane and 
a fall of body temperature.
10-Methoxydeserpidine has antihypertensive actions, qualitatively 
very similar to those of reserpine and deserpidine, but does not cause 
ptosis, sedation or increased gastrointestinal activity. To approach 
the mechanism by which 10-netho:xy deserpidine produces a fall in the 
blood pressure, an account of the pharmacological actions of this 
compound /
compound and of deserpidine will be given®
10-Methoxydeserpidine and deserpidine both produce a slow, and 
delayed fall in the arterial blood pressure of the normotensive, 
anaesthetised cat and rat* Deserpidine is, however, more potent in 
its hypotensive actions in the rat than 10-methoxydeserpidine* In 
the cat, hypotension, following the administration of both deserpidine 
and 10-methoxydeserpidine, is associated with bradycardia. These 
observations are in agreement with those of Peterfalvi and Jequier, 
(i960); La Barre, (i960); Slater, Rathbun, Henderson and Neuss,
(1955) aud Schneider, Plummer, Earl, Barrett, Rinehart and Dibble,
(1955).
The characteristic latency in the onset of action of reserpine 
(Bein, 1953) was also noted in the cat and rat following the use of 
10-methoxydeserpidine and deserpidine*
Methyl reserpate and reserpic acid had little effect on the blood 
pressure level of the cat and rat except Then doses 5 to 10 times 
greater than those of deserpidine were used. These observations 
support the views of earlier workers, that removal of the ester group 
caused almost complete loss of the typical reserpine-like hypotensive 
and sedative actions (Plummer, Barrett and Rutledge, 1954 aud Bein, 
1956). 10-Methoxydeserpidine and deserpidine both potentiated the
hypertensive responses to adrenaline and noradrenaline ♦ The augmented 
response of the nictitating membrane to adrenaline following the 
administration /
administration of 10-methoxydeserpidine noted by the author of this 
thesis, does not confirm the observations of Peterfalvi and Jequier, 
(I960).
The observations that deserpidine and 10-methoxydeserpidine did 
not inhibit contractions of the nictitating membrane elicited either 
by adrenaline or by electrical stimulation of the preganglionic fibres 
of the cervical sympathetic is an indication that these drugs do not 
reduce the blood pressure level by a depressant action upon sympa­
thetic ganglia.
The response to bilateral carotid artery occlusion was also 
reduced by 10-methoxydeserpidine. This effect was not, however, 
abolished or reversed as claimed by Peterfalvi and Jequier (i960). 
Deserpidine markedly depressed the pressor response to bilateral 
occlusion of the eommon carotid arteries.
The reflex rise in the blood pressure following occlusion of the 
abdominal aorta or stimulation of the central end of the greater 
splanchnic nerve was not affected by 10-methoxydeserpidine; deser­
pidine, on the other hand, caused a prolonged reduction of both 
reflexes. Bein (1953)> using reserpine, observed similar effects 
in cats anaesthetised with dial—urethane, but in contrast to 
deserpidine, and like 10-methoxydeserpidine, reserpine did not cause 
inhibition of the pressor response to stimulation of the afferent 
splanchnic nerves. Bein (1953) considered that reserpine acted 
upon /
upon the central nervous system and had a direct effect upon the 
sympathetic autonomic centres in the brain which were responsible for 
the regulation of the blood pressure* The pressor response to the 
stimulation of the cut central end of the vagus was abolished or 
reversed following the administration of deserpidine and 10-methoxy- 
deserpidine*
Bein (1955) using reserpine, made a detailed analysis of the 
effects of reserpine upon centrally mediated reflex activity in the 
cat and concluded that the actions of reserpine were mainly central 
in origin, Following the intravenous administration of from 10 to 
20 yug* per kg* of resexpine to the anaesthetised cat, the carotid 
sinus pressor reflex was depressed but the activity of the carotid 
sinus press or-receptors was not inhibited. When the brain stem was 
sectioned at a point just lower than the inferior corpora quadrigemina, 
these small doses of reserpine were ineffective* The reflex responses 
which had been inhibited with resexpine returned to normal levels after 
the brain stem was sectioned. He pointed out that a physiological 
contact between the medulla oblongata and the mid-brain was essential 
for the characteristic effects of reserpine. When the brain stem was 
severed, much larger doses of reserpine were required to inhibit the 
pressor reflex than when it was intact. Bein (1955) suggested that 
resexpine may act on central regulatory mechanisms which integrate 
autonomic and somatic functions* The similarity in the effects of 
deserpidine /
deserpidine and 10-methoxydeserpidine on the blood pressure and vaso­
motor reflexes of the oat may indicate that in some respects 10-methoxy­
deserpidine has a qualitatively similar mechanism of action to 
deserpidine or reserpine but it is puzzling to find that they resemble 
one another in this respect only.
Depression of the rhythmic activity of preparations of isolated 
cardiac muscle was observed following the use of deserpidine and 10- 
methoxydeserpidine. The rate and amplitude of the contractions of 
the isolated rabbit heart were decreased and cardiac outflow was 
markedly increased. In these preparations the drug seems to act 
directly upon the cardiac muscle. On the other hand, the character­
istic stimulant action of adrenaline and noradrenaline on the isolated 
heart was slightly reduced following the use of deserpidine whereas 
10-methoxydeserpidine had no effect. A slight depression of the 
spontaneous activity of the isolated auricles was noted. The responses 
of the auricles to adrenaline and noradrenaline were slightly depressed 
whereas the depressant effects of acetylcholine were unaltered.
No vasodilator effect was observed in the isolated rat hind­
quarters preparation following perfusion by deserpidine or 10-methoxy­
deserpidine. McQueen and Blackman (1955) using deserpidine, however, 
observed a vasodilatation in the perfused rat hindquarters in which 
vasomotor tone had been increased by infusion of noradrenaline, vaso­
pressin or barium chloride.
Deserpidine /
Deserpidine markedly depressed the vasoconstrictor responses to 
injections of adrenaline and noradrenaline. but had no observable 
effect upon those due to injections of 5-hydroxytiyptamine. 10- 
Methoxydeserpidine did not modify any of the vasoconstrictor responses 
to adrenaline, noradrenaline or 5~hydroxytryptamine in the isolated 
perfused hindquarters of the rat. Methyl reserpate and reserpic acid 
both reduced these responses reversibly but only when doses about 10 
to 20 times larger than those of deserpidine were used.
In experiments performed using isolated strips of horse carotid 
arteiy, deserpidine and 10-methoxydeserpidine- caused no direct 
relaxant effect but produced relaxation of the contractions of artery 
strips which had been elicited by adrenaline, noradrenaline, 5-bydroxy- 
tiyptamine and acetylcholine. Prior addition of deserpidine and 10- 
methoxydeserpidine also reduced the stimulant responses to these 
drugs.
In the isolated guinea pig ileum, 10-methoxydeserpidine and des­
erpidine antagonized the stimulant action of acetylcholine, histamine, 
barium chloride and 5-bydroxytzyptamine. The inhibition of the stimu­
lant responses of the isolated guinea pig ileum was also observed with 
methyl reserpate and reserpic acid but the effect was very shortlived.
A slow contraction of the frog rectus abdominis muscle was seen 
following the use of 10-methoxydeserpidine and deserpidine. This 
effect was followed by a reduction in the magnitude of acetylcholine-
induced /
140
induced contractions of the isolated rectus abdominis muscle, which was 
irreversible in nature, showing that a disturbance in the cellular 
activity of the muscle had taken place* G-illis and Lewis (1956), 
using reserpine, noted a similar effect on the isolated frog rectus 
abdominis muscle but the doses used were much smaller (10 pg* per ml*) 
than those used in investigation of deserpidine and 10-methoxydeser- 
pidine. The isolated tissue preparations used in this investigation 
differ widely in their sources, structure and properties* From the 
data presented above, certain characteristic properties of the 
reserpine-like hypotensive agents on isolated tissue preparations and 
intact animals can be demonstrated. These actions are the general 
depressant effects on the increased tone and motility of preparations 
of smooth or skeletal muscle produced by the use of stimulant drugs 
and the non-specific nature of these antagonistic effects.
10-Methoxydeserpidine seems to lack the characteristic sedative 
and tranquillizing effects of reserpine and deserpidine. When used 
in doses 10 to 3® times larger than deserpidine, 10-methoxydeserpidine 
did not produce sedation or inertia in mice or rats; this is evidence 
of the lack of a typical feature associated with reserpine-like central 
nervous system depressants* These observations confirm the results of 
Peterfalvi and Jequier (i960) but do not agree with those of La Barre 
(i960) who presented evidence of tranquillizing activity in rats 
following the intramuscular injection of 4 to 6 mg. per kg* of 10- 
methoxydeserpidine. /
methoxy deserpidine.
Unlike reserpine and deserpidine, gastrointestinal activity was 
not increased in rats or mice following intraperitoneal injection of 
10-methoxydeserpidine, yet a reserpine-like inhibition of the rhythmic 
contractions of the isolated rabbit duodenum was observed. This 
observation may indicate that there is a difference in the mechanism 
by which 10-methoxydeserpidine acts upon the intact intestine in situ 
from that which is involved in its action upon isolated intestinal 
tissue. The lack of reserpine-like sedative and tranquillizing 
actions which is associated with 10-methoxydeserpidine may be 
attributed to properties conferred on the molecule by the change in 
the position of the methoxy group from position 11 to position 10 in 
ring A. More marked central activity is found in reserpine and 
deserpidine. In the former there is a 11-methoxy group which is 
absent from the latter. This may mean that the 10-methoxy group in 
10-methoxydeserpidine either hinders the fit of the molecule on to the 
central receptor sites or perhaps prevents the drug from reaching them. 
The hypotensive actions of reserpine are thought by some to be due to 
effects upon stores of catechol amines in the heart, arteries and at 
various other peripheral sympathetic neuro-effector sites. The fact 
that the antihypertensive actions of reserpine are linked with an 
action upon peripheral stores of noradrenaline is suggested by the 
observations of B u m  and Rand (1958). 0n other hand, 10-methoxy- 
deserpidine /
deserpidine has hypotensive actions but no demonstrable sedative 
effects, yet does not deplete stores of catechol amines in the brain 
or heart (Leroy and Schaepdiyver, 1961). It is not possible to 
suggest a definite site or mechanism of action which can account for 
all of the effects of 10-methoxydeserpidine observed in the intact 
animal and in isolated tissues* While 10-methoxydeserpidine has no 
marked effects upon the central nervous system, it appears from a 
study of its effects upon isolated tissue preparations that it may 
have a peripheral site of action*
Many of the observations may, however, be explained by assuming 
that 10-methoxydeserpidine, like reserpine or deserpidine, acts by 
depressing the ability of the smooth muscle to contract* This implies 
that a process common to contraction - whether myogenic or drug-induced 
- is influenced by the drug* From the data presented it is felt that 
these non-specific effects of 10-methoxydeserpidine are due to an 
interference with metabolic processes in the normal cell*
The experimental work to be described in the next chapter deals 
with attempts to investigate in more detail the possibility of a site 
of action of 10-methoxydeserpidine at cellular level* 10-Methoxy- 
deserpidine may lower the level of the labile high energy phosphate 
compounds present in different tissues* Interference at the cellular 
level may also be reflected in the oxygen uptake of various tissues in 
the presence of 10-methoxydeserpidine* It may, for example, inhibit 
tissue /
tissue respiration, as does cyanide, or it may stimulate it, as does 
2f4“dinitrophenol* In the next chapter the in vitro effects of 10- 
methoxydeserpidine on the respiration, ATP-ase activity and anaerobic 
glycolysis of rat brain, liver and skeletal muscle are described*
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Biochemical Investigations
1* Determination of the effects of 10-methoxydeserpidine 
on tissue respiration
Method
The experiments were carried out by Warburg* s direct method 
(Warburg, 1930)*
Male rats weighing from 173 to 200 g. were used* The animals were 
killed by a blow on the back of the neck. The brain and liver were 
rapidly removed and transferred to ice-cold oxygenated Krebs-Ringer 
phosphate solution (Appendix I, page 452). Tissue slices of 0.26 mm* 
thickness were prepared using a Mollwain tissue slicer. One hundred mg. 
wet weight of tissue slices were added to 2.5 nl. of Krebs-Ringer 
phosphate solution contained in the main chamber of the flask. The 
centre well of the flask contained 0.2 ml. of 20 per cent ^ /y potassium 
hydroxide solution. In the side arm of the flask was placed 0*3 ml* of 
drug solution, control solution or distilled water. After equilibration 
for 10 minutes at 37° t, 0.5°C., the contents of the side arm were tipped. 
Readings were taken at ten minute intervals for one hour. An atmosphere 
of air was used and the rate of shaking the flasks was 105 por minute.
The total volume in the flask was 3 ®1* 10-methoxydeserpidine at dose 
levels /
levels of 100 and 200 per ml. were used for both liver and brain 
tissues.
(a) Potassium stimulated respiration in rat liver 
and brain slices
Method
The procedure adopted was the same as that described above, with 
the addition to the contents of the main chamber of 0.1 ml. of 0.1 molar 
potassium chloride solution (Ashford and Dixon, 1935)*
2. Determination of the effects of 10-methoxydeserpidine on the 
adenosinetriphosphatase activity in rat brain, liver and 
skeletal muscle.
Method
Adenosinetriphosphatase (ATP-ase) activity was measured by the 
method of Lardy and Wellman (1953)* The amount of inorganic phosphate 
liberated from adenosinetriphosphate (ATP) in the presence of a sus­
pension of brain, liver or skeletal muscle was used to measure the 
ATP-ase activity. Inorganic phosphate was measured by the method of 
Furchgott and de Gubareff (1956)*
Rats weighing from 150 to 200 g., which had been fasted overnight 
to reduce the tissue glycogen level,were used. They were killed by a 
blow on the back of the neck and the brain and liver removed rapidly and 
transferred /
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transferred to ice-cold 0*25 molar sucrose solution. The tissues were
removed ffom the sucrose solution, blotted dry, weighed and,using an
i W /M*S*E* homogeniser, a 33$ per cent homogenate in 0,23 molar sucrose 
solution was prepared* 0*3 ml* of this homogenate containing 100 mg* 
wet weight of tissue was used in each experiment* The reaction was 
carried out in Warburg flasks* The main chamber contained 0*1 ml* of 
0*15 molar potassium chloride solution, 0*1 ml* of 0*1 molar adenosin- 
etriphosphate and the drug solution, oontrol solution or distilled water* 
The total volume of the flask was adjusted to 1 ml* with distilled water* 
The pH of the flask oontents was 7*4* The flasks were stoppered and 
placed in a water bath at 25°C* and shaken at a rate of 105 per minute 
for 5 minutes to attain equilibrium* The reaction was then started by 
tipping the contents of the side arm into the main chamber and the flasks 
shaken for a period of 10 minutes* The reaction was then stopped by the 
addition of 1 ml* of 10 per cent of perchloric acid* Inorganic 
phosphate liberated in the blank flask was estimated in the same manner* 
In experiments using rat skeletal muscle the homogenate was prepared 
in a manner similar to that described on page 150.
3. DeternHnation of the effects of ID-methoxydeserpidine on anaerobic 
glycolysis in rat liver, brain and skeletal muscle*
Method
The method used was similar to that of Warburg (1923) but flasks 
with /
150.
with two side arms were used (TJmbreit, Burris and Stauffer, 1957)*
Male rats weiring from 175 to 200 g. were fasted overnight to 
reduce the glycogen content of the tissues* They were killed by a blow 
on the back of the neck and the brain and liver rapidly removed and 
transferred to ice-cold Krebs-Ringer bicarbonate solution (Appendix I, 
page 452). The chilled tissues were sliced "by means of a Mcllwain
tissue slicer giving slices of 0,26 mm* thickness* One hundred mg* wet 
weight of these were put into the main chamber of the flask which con­
tained 1.6 ml* of Krebs-Ringer bicarbonate solution* 0*2 ml* of the 
drug solution was placed in one side arm and 0*2 ml* of glucose solution 
containing 10 /imoles in the other* Control flasks were set up in which 
one side arm contained 0*2 ml* of distilled water or 0*2 ml* of the 
solvent used to prepare the drug solution* The final flask volume was 
2 ml* Each flask was gassed for 5 minutes with a mixture of 95 per cent 
nitrogen and 5 per cent carbon dioxide* The flasks were stoppered, 
placed in a water bath at 37 1 0*5°C*, and shaken for 5 minutes to allow 
equilibration to take place. After tipping the side arm contents, the 
reaction was stopped at zero time, 30 minutes and 60 minutes by the 
addition of 4 ml* of 0*3 M* barium hydroxide solution and 4 ml* of 5 per 
cent solution of zinc sulphate (M* Somogyi, cited by Nelson, 1944)* 
Clucose was estimated by the method of Nelson (1944)* 1m both brain and
i
liver experiments 200 pg, per ml* of lO-methoxydesexpidine was used*
(a) Anaerobic glycolysis in rat skeletal muscle
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The method used was similar to that described for liver and brain 
but sifter killing the rat, the hind leg muscles were quickly removed 
and dropped into liquid nitrogen. The frozen tissue was powdered by 
grinding in a pestle and mortar. Five g. of the powder was weighed 
and mixed thoroughly with 20 ml. of Krebs-Ringer bicarbonate solution. 
0.5 ml* of this suspension was placed in the main chamber of the flask 
which also contained 1.1 ml. of Krebs-Ringer bicarbonate solution.
Results
Tissue respiration in vitro.
10-Methoxydeserpidine at a dose level of 100 |ig. per ml. produced 
a significant depression (P, = 0.05) of the respiration of rat brain 
slices (Fig. 68, page 151) and of liver slices (Fig. 69, page 152) 
after a period of 60 minutes. In the potassium-stimulated respir­
ation of the brain in vitro, this effect was more marked during a 
period of from 20 to 60 minutes (Fig. 70, page 153)- At the same 
dose level no effect was observed on the potassium-stimulated 
respiration of liver slices (Fig. 71, page 133)*
When used in doses of 200 yig. per ml., 10-methoxydeserpidine 
caused a significant depression (P = 0.05 <1 0.001) of both potassium- 
stimulated and non-stimulated respiration of rat brain slices (Fig.72, 
page 156, and Fig. 73, page 137) and rat liver slices (Fig. 74, 
page 158, and Fig. 73, page 159)*
Anaerobic glycolysis in vitro.
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10-Kethoxydeserpidine 200 pg* per ml* did not alter anaerobic 
glycolysis in homogenates of rat liver (Fig. 76, page l6l), brain 
(Fig. 77, page 162 ) and skeletal muscle (Fig. 73, page 16 3)*
Adenosinetriphosphatase-aotivity (ATP-ase activity) in vitro.
The ATP-ase activity of rat skeletal muscle was significantly 
depressed (P, = 0*02 C. 0*05) following the use of 200 pg. per ml. of 
deserpidine (Fig. 79a,page 164)* At the same dose level of 10-methoxy- 
deserpidine, no effect was observed upon the in vitro ATP-ase activity 
of homogenates of rat brain (Fig* 80b,page 165) and liver (Fig.Blb, 
page 166). When a larger dose, 600 pg. per ml., of 10-methoxy- 
deserpidine was used, a significant depression of the liver ATP-ase 
activity was notea (Fig. 8la page 166) whereas that of brain remained 
unaltered (Fig. 80a page 165)*
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C H A P T E R  VI 
DISCUSSION
When the results obtained from experiments on isolated tissue 
preparations are considered, it seems that, in general, 10-methoxy­
deserpidine acts by depressing the ability of the smooth muscle cell 
to contract*
The energy required by muscle for contraction or for the mainte­
nance of tone, is known ultimately to be derived from chemical reactions 
taking place within the cell (Needham, I960). It is also generally 
assumed that the enzymatic splitting of adenosine triphosphate provides 
energy for the musoular contraction (Peny, 1956, and G-elfan, 1958)* 
Acoording to Szent-Gyorgyi(l960) "muscle contraction is an interaction 
of adenosine triphosphate, actin and myosin, an interaction which 
entails violent changes in colloidal state and involves a shortening 
of the fibrous particles of the protein complex, actomyo0in. The free 
energy which enabled the shortening fibres to lift a weight and do work 
is supplied by adenosine triphosphate, the terminal bond of which is 
hydrolyzed in the process." Hunch-Petersen (1953) ami Lange (1955) 
obtained direct evidence that the contracting muscle contained less 
adenosine triphosphate than the resting muscle. They concluded that 
the bond energy of adenosine triphosphate was utilised during the 
process /
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process of muscular contraction. It is also though^ that the metabolic 
processes of the cell, such as respiration and glycolysis which 
indirectly support the muscular activity, do so by virtue of the 
synthesis of adenosine triphosphate. The high energy phosphate bond 
of adenosine triphosphate is synthesized by the oxidative reactions of 
carbohydrate metabolism. These are, firstly, the anaerobic conversion 
of glycogen to lactic acid; secondly, the oxidation of lactic acid to 
pyruvate by the mitochondrial system; and thirdly, the reaction of 
adenosine diphosphate (ADP) with inorganic phosphate to form adenosine 
triphosphate. This is also known as Lohmanns' reaction and can be 
shown as follows
Creatine phosphokinase
(1) Creatine phosphate ------- {--------  Creatine + Adenosine
+ Adenosine diphosphate
triphosphate ATJjase
(2) Adenosine triphosphato 1 > Adenosine diphosphate +
Lohmann (1934) was the first to demonstrate the significance of 
these reactions. He postulated that before creatine-phosphate break­
down could yield the energy required for muscular contraction, hydro­
lysis of adenosine triphosphate must have occurred. This reaction 
was the energy-yielding reaction and took place close to the time of 
the actual muscular contraction.
As with striated muscle, the immediate source of energy for con­
traction in smooth muscle is probably the high energy phosphates such 
as /
as adenosine triphosphate and creatine phosphate. Furchgott (1935) 
has shown that determination of these compounds in rabbit thoracic 
aorta, freed of extraneous fat and connective tissue and inoubated in 
oxygenated Krebs1 glucose solution at 37°C. for a period of 45 minutes, 
gave average values of about 0.2 mM. per g. of phosphooreatine and 
0.7 mM. per g. of adenosine triphosphate and adenosine diphosphate.
Detailed investigations by Csapo (1948# 1950 and I960) suggest that 
the uterine muscle of the rabbit is qualitatively similar in its bio­
chemical activity to that of striated muscle. Using rabbit uterus, 
Csapo (1955) repeated the early observations of Lundsgaard (1934) and 
obtained identical results. Lundsgaard (1934) demonstrated that when 
treated with iodoacetic acid under anaerobic conditions, the isolated 
frog rectus abdominis muscle could produce only a limited number of 
contractions and that the contractions ceased when the stores of high 
energy phosphates (creatine phosphate and adenosine triphosphate) in 
the muscle were exhausted.
The biochemical properties of the contractile proteins of vascular 
smooth muscle have not been investigated. From the smooth muscle of the 
uterus Csapo (1950) obtained less actin and myosin than from the 
skeletal muscle. He also found the actin to myosin ratio to be lower 
in the uterine smooth muscle than that on skeletal, muscle. On the 
addition of adenosine triphosphate, actomyosin threads from uterine 
muscle contracted more slowly and to smaller extent than those from 
skeletal muscle.
When /
When 10-methoxydeserpidine was used in larger doses (200 fig. per 
ml.) it significantly depressed the in vitro respiration of rat brain 
and liver slices. When it was used in lower concentrations (100 fig. 
per ml.), however, it produced, after a delay of from 40 to 60 minutes, 
an inhibitory effect upon the in vitro respiration of these tissue 
preparations (Chapter V, page 15i). Kirpekar and Lewis (i960) have 
shown that reserpine (100 fig. per ml.) produced a significant 
depression of the respiration of rat brain homogenates, whereas the 
respiration of rat liver homogenates remained unaffected. Earlier 
observations of G-illis and Lewis (1957) indicated that reserpine (90 pg. 
per ml.) was capable of depressing the respiration of the isolated 
smooth muscle of the rabbit intestine. From their observations, G-illis 
and Lewis pointed out that the effects of reserpine upon spontaneous or 
drug-induced tone were similar in many aspects to those of experimentally- 
induced anoxia. They concluded that reserpine appeared to make the 
tissue anoxic by virtue of its ability to interfere with the energy- 
producing reactions of carbohydrate metabolism.
The energy required for muscular contraction is derived both from 
aerobic and anaerobic processes, the former probably contributing the 
greater amount of energy. It has been known for many years (G-ross and 
Cl*rk, 1923, and G-arry, 1928) that the contractile properties of isolated 
smooth muscle alter reversibly when the supply of oxygen or substrate is 
stopped.
G-ross /
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Gross and Clark (1923), using the isolated intestine of the 
rabbit or rat, found that the substitution of oxygen by nitrogen in 
the bath fluid led to an immediate loss of tone in the isolated intes­
tine and that the tissue beoame insensitive to the application of 
adrenaline or pilocarpine. No diminution in the response of the gut 
to direct muscle stimulants (potassium chloride and barium chloride) 
was observed. Garry (1928), using the isolated intestine and uterus 
of various animal species including the guinea pig, rabbit, cat and 
dog, observed that lack of oxygen in the bathing fluid resulted in a 
significant loss of tone. Prasad (1935 a and b) carried out detailed 
investigations upon the contractile activity and carbohydrate metabolism 
of the isolated rabbit ileum and isolated cat colon* He estimated the 
quantity of glucose consumed by the muscle during activity and resting 
periods under aerobic and anaerobic conditions. The effects of 
anoxia and metabolic inhibitors such as iodoacetic acid on the 
glycolysis and tone of the muscle were also determined.
Prasad concluded that the loss in the tone of the isolated gut was 
due to anoxia which further depressed the carbohydrate metabolism of 
the cell. He also pointed out that when treated with iodoacetic acid 
under anaerobic conditions, isolated intestinal smooth muscle retained 
very little contractile activity. Under aerobic conditions it was not 
much affected. He suggested that the reservoir of available anaerobic 
energy was very small. West, Hadden, and Farah (1951) also considered 
that /
that the amount of available anaerobic energy was only & small fraction 
of that available daring aerobic activity.
The normal spontaneous activity of smooth muscle requires the 
steady production of energy from readily available sources# Under 
aerobic conditions, the metabolism can easily meet the requirements, 
but anoxia eliminates the most efficient sources of energy, namely 
oxidative metabolism (Lipmann, 1942).
The effects of anoxia, of substrate deficiency (Feldberg and 
Solandt, 1943) &&& of metabolic inhibitors such as cyanide, have been 
attributed to an interruption of the normal supply of chemical energy 
to the muscle. Such an interruption might show itself as a fall of 
the concentrations of metabolic high-energy phosphate compounds such as 
adenosine triphosphate and creatine phosphate which are generally 
thought to be the immediate sources of chemical energy for muscular 
activity.
Anoxia has been shown to cause a reduction in the adenosine 
triphosphate content of intestinal smooth muscle (Furchgott and Shorr, 
1948). It has also been demonstrated by Boro (1936),using the iso­
lated taenia coli of the guinea pig, that when the muscle is deprived 
of oxygen or glucose it loses its spontaneous tone and motility. It 
also loses the ability to maintain increased tension during stimulation. 
Those changes developed more rapidly in the absence of oxygen than in 
the absence of glucose and they were accompanied by a significant 
decrease /
decrease (50 to 80 per cent) in the creatine phosphate level of the 
tissue. The adenosine triphosphate content of the taenia coli did 
not change markedly. Born (195&) concluded that a correlation existed 
"between the active tension and the creatine phosphate concentration of 
isolated smooth muscle in the absence of glucose or oxygen.
In more recent investigations, Furchgott and de Gubareff (1958) 
have demonstrated that when guinea pig atria were suspended in Krebs* 
bicarbonate medium which was gassed with 95 per cent nitrogen and 5 per 
cent carbon dioxide, thqy lost their contractile activity.. There was 
reduction in the amplitude of the electrically-induced contractions of 
the isolated atria and within 15 to 20 minutes this was reduced to 10 
per cent of the initial level. This effect was associated with a 
marked reduction in creatine phosphate and adenosine triphosphate 
levels, the former being the more affected. Furchgott and de Gubareff 
confirmed the suggestion of Greiner (1952) that the decrease in the 
adenosine triphosphate level might not be the cause of the depression 
of the contractile activity of the cardiac muscle under anoxic con­
ditions but could be due to other intracellular changes resulting from 
oxygen lack.
It has been observed (Chapter III, Fig.49, PaS© 106) that the 
ability of arterial smooth muscle to maintain drug-induced tone was 
markedly reduced in the presence of 10-methoxydeserpidine. Under the 
influence of this drug, the muscle lost tone. Similar observations
were /
were reoorded using reserpine by G-illis and Lewis (1957) and by 
Kirpekar and Lewis (1958). These workers also employed the isolated 
guinea pig ileum and isolated strips of horse carotid arteiy. The 
effects of reserpine upon drug-induced tone were similar to those of 
experimentally produced anoxia. Using reserpine, Kirpekar and Lewis 
in 1959 estimated the adenosine nucleotide levels of different tissues 
of the rat inoluding the liver, heart, skeletal muscle and brain. It 
was shown that reserpine significantly depressed adenosine triphosphate 
levels in brain and liver with a corresponding increase in adenosine 
diphosphate levels. Reserpine did not, however, cause any change in 
the adenosine triphosphate content of the heart and skeletal muscle. 
From their in vivo studies, they concluded that reserpine inhibited 
oxidative phosphorylation. It has also been shown by Abood and 
Romanchek (1957) that in in vitro oxidative phosphorylation, reserpine 
acts as an "uncoupling agent". Uncoupling agents can disturb the 
metabolism of the cell by depressing the formation of high energy 
phosphate bonds without depressing, or even slightly stimulating, the 
oxygen consumption of the system. This dissociation of oxidation 
from phosphorylation is termed "uncoupling", and the agents which do 
this are known as "uncoupling agents". (Brody, 1955)* 2,4-&initro- 
phenol is a typical example of this type of compound.
It has also been shown by Kirpekar and Lewis (1958) that when 
isolated horse carotid artery strips are rendered anoxic, the drug- 
induced /
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induced contractions are reduced in magnitude but never completely 
eliminated.
Since oxidation proceeds both aerobically and anaerobically, it 
is possible that the small response obtained after rendering the 
tissue anoxic is due to the energy supplied by anaerobic glycolysis. 
10-Methoxydeserpidine does not produce an in vitro inhibition of 
anaerobic glycolysis in the rat brain , liver and skeletal muscle 
(Chapter V, page I £o )• Gillis and Lewis (1957), using reserpine, 
observed similar effects upon anaerobic glycolysis in isolated intest­
inal smooth muscle of the rabbit. Since 10-methoxydeserpidine and 
reserpine resemble one another in their actions upon the anaerobic 
glycolysis and respiration of isolated tissues, it is possible that 
10-methoxydeserpidine, like reserpine, inhibits aerobic oxidative 
processes more effectively than anaerobic ones.
During the present investigation, it was observed that 10-methoxy­
deserpidine (200 jig. to 600 jig. per ml.) caused a significant in vitro 
inhibition of the adenosine triphosphatase activity of homogenates of 
rat liver and skeletal muscle. No such effect was observed upon the 
adenosine triphosphatase activity of the rat brain, even when very 
large doses of 10-methoxydeserpidine (600 pg. per ml.) were used.
These observations are in agreement with those of Kirpekar and Lewis 
(i960) who, using reserpine, obtained a depression of the in vitro 
adenosine triphosphatase activity of rat liver homogenates.
The /
The dose used to produce inhibition of the adenosine triphosphatase 
activity of rat liver homogenates was veiy high (600 pg. per ml*) but 
10-methoxydeserpidine at the same dose level was incapable of producing 
an effect upon the adenosine triphosphatase activity of rat brain homo- 
genate. This may show that the mechanisms in the rat liver and * 
skeletal muscle are more sensitive than those in the rat brain.
It has been shown (Carlsson and Hillarp, 1956) that adenosine tri­
phosphate plays an important role in the storage and release of cate­
chol amines from the adrenal medulla. These authors observed that the 
depletion of the adrenal medulla of catechol amines by morphine and 
insulin was accompanied by a parallel depletion of adenosine triphosphate. 
Reserpine has been shown to cause depletion of noradrenaline and sero­
tonin from brain and other tissues (Holzbauer and Vogt, 1956, and 
Pletscher, Shore and Brodie, 1955)* These observations have been 
extended by Kirpekar, Goodlad and Lewis (1958) who found that reserpine 
depleted the rat adrenal medulla, both of its catechol amines and 
adenosine triphosphate. It has also been suggested (Sulser and Brodie, 
I960) that the alterations in catechol amine levels of the brain are 
linked with the central nervous system depressant effects of reserpine.
It is not, however, certain that these changes are the cause of its 
pharmacological actions, nor is it clear that the primary point of 
action of the drug is upon the mechanisms which influence or control 
binding,uptake, release or metabolism of the amines. There is also 
some /
some evidence (Leroy and Schaepdzyver, 1961) that analogues of 
reserpine which lack its characteristic central nervous system 
depressant actions do not modify catechol amine levels in the brain. 
These authors found that in mice, 5 mg, per kg* of syrosingopine had no 
effect upon brain noradrenaline levels although it reduced them in the 
heart. 10-Methoxydeserpidine (25 mg. per kg.) had no effect upon the 
catechol amine levels of brain or heart. Neither compound possessed 
reserpine-like central nervous system depressant actions yet both were 
capable of lowering the blood pressure ^ level. These effects can be 
looked upon as an indication that the antihypertensive properties of 
compounds of this type are not necessarily linked with a depletion of 
cardiovascular stores of catechol amines. The sedative activity is 
however linked with an effect of this kind in the brain (San an and 
Vogt, 1962).
The fact that the central nervous system depressant actions of 
reserpine are linked with the depletion of the brain of its noradren­
aline and serotonin is strengthened by the observations of Grarattini, 
Lamesta, Mortari and Valzelli (1961) who investigated the antihyper­
tensive and sedative actions of certain analogues of reserpine including 
10-methoxydeserpidine. These compounds possessed antihypertensive 
activity but were not sedative and did not, even at very high dose 
levels, cause depletion of serotonin or noradrenaline from the rat 
brain. On the other hand, Orlans, Finger and Brodie (i960) found 
that antihypertensive drugs such as syrosingopine were much more potent
in releasing peripheral noradrenaline than brain noradrenaline - an 
effect which was associated with the induction of bradycardia and 
hypotension and with a reduction in the responsiveness of certain 
pressor reflexes and in that to ganglion stimulants. It was not 
associated with sedation* They concluded that the tranquillizing 
actions of reserpine were due to an effect on the central nervous 
system and that the antihypertensive actions were due to its peripheral 
effects*
The mechanism by which 10-methoxydeserpidine lowers the blood 
pressure level seems to be different from that of syrosingopine. The 
similarity between the actions of 10-methoxydeserpidine and reserpine 
on cellular metabolic processes may indicate a partial resemblance in 
the properties of these two drugs.
The evidence presented supports the view that 10-methaxydeserpidine 
has a peripheral site of action* 10-M ethoxy deserpidine may exert its 
actions by interfering with tissue metabolism, probably that part which 
supplies the energy for muscular contraction* It is also considered 
possible that 10-methoxydeserpidine depresses the aerobic metabolic 
activity of the cell more effectively than the one under anaerobic con­
ditions. By doing so, 10-methoxy deserpidine may affect the oxidative 
reactions of carbohydrate metabolism which are involved in the synthesis 
of adenosine triphosphate. It is suggested that in vitro adenosine 
triphosphatase activity of the rat liver and the skeletal muscle is 
more /
more sensitive to the presence of 10-methoxydeserpicline than that of 
the brain. The observations of Garattini, Lamesta, Mortari and 
Valzelli (1961) support the view that 10-methoxydeserpidine possesses 
antihypertensive actions due to an action at peripheral sites and has 
no central nervous depressant activity.
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SUMMARY OP PART I (a)
In the introductory chapter, a brief review of the literature 
upon the pharmacological properties of 10-methoxydeserpidine, deser­
pidine, reserpic acid and methyl reserpate together with a short 
historical account of the discovery and properties of reserpine are 
presented.
In Chapter II, the experimental techniques used in the investi­
gation of the general pharmacological properties of 10-methoxydeser­
pidine, deserpidine, reserpic acid and methyl reserpate are described.
In Chapter III, the results of the investigation upon the pro­
perties of 10-methoxydeserpidine, deserpidine, methyl reseipate and 
reserpic acid are described. lO-Methoxydeserpidine was found to 
possess hypotensive actions qualitatively similar to those of reserpine 
and deserpidine but not to exhibit similar central nervous system 
depressant actions.
10-Methoxydeserpidine caused a fall in the blood pressure level 
of the anaesthetised oat and rat but was less potent in the rat. It 
caused a generalised depression of preparations of isolated cardiac 
muscle, vascular or intestinal smooth muscle and skeletal muscle. 
10-Methoxydeserpidine also antagonized the contractile responses of 
these tissues elicited by different spasmogens. Reserpic acid and 
methyl /
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INTRODUCTION
Early in 1933 the German pharmacologist Domagk published his 
 ^ observations on the antibacterial properties of p-aminobenzene sulph-
of a group of bacterial infections including puerperal sepsis, 
erysipelas and many other diseases due to streptococcal, meningococcal 
and gonococcal infections*
The introduction of sulphanilamide (Fig. 82, page 200) as a chemo­
therapeutic agent was soon followed by the observations of Southworth 
(1937) and Strauss and Southworth (1933) that it was capable of causing 
a metabolic acidosis in human subjects. While treating patients with 
sulphanilamide these authors observed a drop in the carbon dioxide- 
combining capacity of the plasma with a definite increase in the urine 
flow and in the renal excretion of sodium and potassium ions. A fall 
in the carbon dioxide content and pH of the plasma, coupled with a rise 
in the pH of the urine following the administration of sulphanilamide 
was also observed in dogs by Marshall, Cutting and Emerson in 1933. 
These authors also suggested that sulphanilamide depressed the tubular 
reabsorption of bicarbonate and thus tended to cause a metabolic 
acidosis. These findings were confirmed by Beckman, Rossmeisl, 
Pettengill /
This discovery revolutionised the treatment
Pettengill and Bauer (1940) in their studies on human subjects. They 
demonstrated a sharp rise in the urinaiy excretion of sodium and 
bicarbonate ions during the first day of administration of sulphon- - 
amides with a corresponding decrease of sodium and bicarbonate levels 
in the blood. The potassium and chloride excretion was less affected. 
The significance of these observations was not fully appreciated at 
that time, but in 1940 Mann and Keilin discovered that sulphon amides 
which possessed unsubstituted sulphonamido groups, for example, benzyl- 
sulphanilamide, pyridine-3-sulphonamide and aminonaphthalene- 
sulphonamide exerted a marked inhibitory effect on carbonic anhydrase 
activity* Carbonic anhydrase is the enzyme which catalyses the 
reaction between water and carbon dioxide to form carbonic acid and 
is a source of hydrogen ions in the body.
H20 + C02 CA -■■■•— H2C03 r  ■ CA  ^  H+ + HCO,
The presence of carbonic anhydrase in the body was first reported 
by Meldrum and Houghton in 1932. The renal tubules (Davenport and 
Wilhelmi, 1941) like the erythrocytes (Meldrum and Houghton, 1933)» 
the gastric mucosa (Davenport and Fisher, 1938), the lens and the 
retina of the eye (Bakker, 1941) contain substantial amounts of this 
enzyme. Carbonic anhydrase occurs in lower, but still significant, 
concentrations in the brain (Ashby, 1943 Ashby, 1944) $ liver, 
pancreas and spleen (G-oor, 1940).
The importance of carbonio anhydrase in the physiology of the
kidney /
kidney was understood from the early observations on the rise in urinary 
pH, the loss of sodium and the aoidosis which accompanied the admini­
stration of sulph anil amide • The first experimental exploration of 
the effects of carbonic anhydrase inhibitors on renal function was 
that of Hober in 1942 who showed that sulphanilamj.de and a series of 
other unsubstituted sulphonamides caused the urine of the perfused frog 
kidney to become alkaline* Hober (1942) concluded that carbonic 
anhydrase was involved in the reabsorption of bicarbonate by the kidney* 
The theoiy of urine acidification by bicarbonate reabsorption at that 
time implied that the acid excreted was derived largely from * carbonic 
acidf in the glomerular filtrate. In 194-5 an important change took 
place in the concept of renal tubular function when Pitts and Alexander 
showed that in acidotio dogs infused with, and excreting large amounts 
of buffer, the amount of titratable acid excreted was several times 
that which could be derived from the filtered carbonic acid by 
reabsorption of the filtered bicarbonate. They, therefore, concluded 
that the urine must be acidified by the secretion of acid and proposed 
that this secretion was actually an exchange of hydrogen ions from the 
tubule cells for sodium ions from the lumen of the tubules* Demon­
strating that the excretion of titratable acid in mildly acidotic dogs 
could be partially suppressed by sulphanilamide, these authors postu­
lated that carbonic acid was the immediate source of the secreted 
hydrogen ions and that carbonic anhydrase was involved in the conversion
200.
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of metabolic carbon dioxide to .carbonic acid* It was assumed at that 
stage that the reduction in the rate of excretion of titratable acid, 
when the enzyme was inhibited by sulphanilamide, represented the effect 
of a reduction in the rate of hydration of carbon dioxide (Beckman, 
Rossmeisl  ^Pettengill and Bauer, 1940)# The significance of these 
findings has been fully reviewed by Berliner and Orloff (1956)*
Schwartz in 1949, taking advantage of the saluretic property of 
sulphanilamide, administered it to patients suffering from congestive 
heart failure but he found it too toxic to be used as a natriuretic 
and diuretic agent.
Prom the investigations referred to above, it was now apparent 
that an inhibitor of carbonic anhydrase more potent and more specific 
than sulphanilamide might be a valuable therapeutic agent.
A study of the struoture-activity relationships in the sulphonamides 
resulted in the synthesis of more highly potent carbonic anhydrase 
inhibitors. Thus in 1950 Roblin and Clapp synthesised a number of 
unsaturated sulphonamides, including acetazolamide (Pig. 82, page 200 ). 
Miller, Dessert and Roblin in 1950 demonstrated that acetazolamide was 
300 times as potent as sulphanilamide in inhibiting carbonic anhydrase 
in vitro. Doses of acetazolamide could, therefore, be given which 
would bring about almost complete inhibition of carbonic anhydrase 
in vivo. The rise in urinary pH and increase in bicarbonate excretion 
which followed the administration of sulphanilamide, were observed more 
strikingly /
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strikingly after the use of acetazolamide. The effects of acetazolamide 
have been studied in detail in the dog (Berliner, Kennedy and Orloff,
1951 and Berliner, 1952), the rat (Maren, Wadsworth, Yale, Alonso,
1954), the rabbit (Holtmeier, Spuhler, Buhlmann and Labhart, 1953)» 
in man (Counihan, Evans and Milne, 1954; Priedberg and Halpera, 1952; 
Priedberg, Taymor, Minor and Halpem, 1953; and Taymor, Minor and 
Priedberg, 1954), as well as in other species, including fish (Hodler, 
Heinemnn, Fishman and Smith, 1955), the alligator (Hernandez and 
Coulson, 1954; Coulson and Hernandez, 1957; and Coulson, Hernandez 
and Beebe, 1957) end the chicken (Wolbach, 1955)*
Administration of a single therapeutic dose of acetazolamide to 
the dog was followed by a marked increase in the urinary excretion of 
sodium, potassium and bicarbonate, accompanied with an increase in the 
urine flow and a decrease in the excretion of ammonia and titratable 
acid. The excretion of chloride was not, however, significantly 
changed (Berliner, Kennedy and Orloff, 1951)* Except for the increase 
in potassium excretion these changes could be attributed to an inter­
ference with the hydrogen-sodium exchange mechanism. The direct 
effects of the diminished exchange would be the decrease in the 
reabsorption of sodium and bicarbonate and consequently a failure to 
acidify the urine. The increase in the excretion of potassium ions 
in the urine was attributed to the suppression of hydrogen ion trans­
port. In the alligator, in contrast to the results obtained from 
mammals, /
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reabsorption of bicarbonate, the 
acidification of the urinary buffers, 
and the excretion of ammonia.
mammals, acetazolamide increased excretion of chloride without 
increasing that of sodium bicarbonate, thus causing a systemic alka­
losis (Coulson and Hernandez, 1957).
Berliner and his associates (1951) also observed that following 
the administration of acetazolamide, as much as 30 per cent of the 
filtered bicarbonate appeared in the bladder urine, showing that 
proximal, as well as distal tubular reabsorption of bicarbonate, was 
dependent on the rate of hydration of carbon dioxide. It was, there­
fore, suggested by Gilman (1956) that a single underlying mechanism 
of hydrogen ion-sodium ion (H+-Na+) exchange, could account for the 
reabsorption of bicarbonate along the length of the nephron* He 
also suggested that there were three important renal mechanisms 
responsible for maintaining the levels of extracellular bicarbonate 
and these were (a) reabsozption of bicarbonate ions, (b) acidification 
of urinary buffers and (c) exchange of urinary sodium with ammonia* 
Gilman (1956) has explained the role of the H+-Na+ exchange in the 
reabsorption of bicarbonate, the acidification of the urinary buffers 
and excretion of ammonia in the way shown in Pig* 83, page 203* He 
considered that the rate of hydrogen ion transport was responsible for 
the renal control of acid-base metabolism* When hydrogen ion trans­
port went on at the maximum rate the reabsorption of bicarbonate was 
complete, the urinary buffers were maximally acidified and the ammonia 
mechanism worked efficiently* The bicarbonate ions, derived from the 
hydration /
hydration, of oarbon dioxide, were returned to the extracellular fluid 
in combination with the fixed cation sodium exchanged for hydrogen ions# 
Conversely when the rate of hydrogen ion transport was reduced, the 
reabsorption of bicarbonate was complete, there was no acidification of 
the urinary buffers and ammonia disappeared from the urine; sodium 
bicarbonate was mobilised from the extracellular fluid and excreted 
together with water#
Although the detailed studies of Maren, Wadsworth, Yale and 
Alonso (195^) and Maren, Mayer and Wadsworth (195k) defined the pattern 
of the renal effects of acetazolamide, they did not enable an evaluation 
of its potential usefulness as a diuretic to be made# The dog, when 
given acetazolamide in oral doses of 3 mg. per kg# once daily, responded 
with a diuresis but this was followed by a recovery phase which was 
marked by the complete retention of bicarbonate and sodium ions and by 
increased amounts of titratable acid and ammonia, together with small 
quantities of potassium in the urine# This recovery phase lasted 
until the metabolic balance for sodium and bicarbonate ions was restored# 
They also reported that this refractory state was not due to an absence 
of inhibition of carbonic anhydrase but was presumably due to reduction 
of the plasma bicarbonate concentration# These workers also observed 
that following administration of acetazolamide, hypopotassaemia developed 
and persisted for as long as the administration of the drug continued# 
These findings suggested that acetazolamide, even in the refractory 
state, /
state, caused the usual rise in cellular pH. They also observed that 
fatal potassium depletion occurred in two dogs following the adminis­
tration of 1,000 mg. per kg. of body weight of acetazolamide daily for 
a period of three days.
The mechanism of the development of the refractory state following 
the repeated use of acetazolamide was clearly explained by Gilman 
(1953), who showed that the repeated use of a carbonic anhydrase 
inhibitor might result in the exoretion of an acid urine due to the 
diminution of the bicarbonate levels of the plasma. The use of aceta- 
zolamide in a severe metabolic acidosis might, therefore, have no effect 
on the diuresis and little effect on the titratable acidity of the urine. 
Prom these observations it was clear that when the bicarbonate load in 
the system was low, the reabsorption of bicarbonate ions could take 
place without the catalytic hydration of carbon dioxide. On the other 
hand, in bicarbonate-loaded subjects, the inhibition of carbonic 
anhydrase would reduce the hydrogen ion-transport which was directed 
towards bicarbonate reabsorption. This is the reason that the 
carbonic anhydrase inhibitor, acetazolamide, is effective only in 
subjects with normal bicarbonate levels and ineffective in a metabolic 
acidosis. It is also ineffective in an acidosis induced by the admini­
stration of ammonium ehloride (Maren, 1956).
Although in normal animals the diuretic effects of aoetazolamide 
have been found to compare favourably with those of the mercurial 
diuretics /
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diuretics (Moyer, Spurr and Ford, 193k; and Cardillo, Mullin, Schiffer 
and Iyons, 193k) $ investigators who have used acetazolamide in patients 
severely ill with cardiac disease have generally found it far less 
effective than the mercurial diuretics (Counihan, Evans and Milne,
193k; and Reiman, Leaf and Schwartz, 193k) •
There are very few pharmacodynamic agents whose mechanism of 
action is so well understood as that of acetazolamide. As a result 
it has not only proved useful therapeutically but has also been of 
great value in the study of the mechanism of formation of the urine 
(Berliner, Kennedy and Orloff, 1951; and Pitts, 1952), the formation 
of the gastric juioe (janowitz, Coloher and Hollander, 1952) and the 
formation of the ocular fluids (Westrand, 1952)*
Since acetazolamide has a tendency to cause hypopotassaemia it is 
undesirable to use this drug in the treatment of conditions such as 
congestive heart failure, where prolonged treatment may cause serious 
potassium loss* Acetazolamide can, however, be employed as a diuretic 
in short term therapy, for example in the oedema of premenstrual tension 
and toxaemia of pregnancy (Assali, Monk, Ullrich, Voskian and Singh,
1955)* Its clinical usefulness is seen also in a reduction of the 
intraocular pressure in glaucoma - an effect due to inhibition of 
ciliary carbonic anhydrase (Becker, 193k&> Becker, 195^b) and its use 
in epilepsy in children (Bergstrom, Carzoli, Lombroso, Davidson and 
Wallace, 1952).
Due /
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Due to the limitations of acetazolamide as a diuretic agent, an 
intensive search was carried out with the object of producing a better, 
but a chemically related, diuretic* As a result of careful chemical 
and pharmacological studies, Novello and Sprague in 1997 reported the 
discovery of chlorothiazide (6-chloro-7-5ulphamyl-l, 2, 4-benzothia- 
diazine-1, 1-dioxide) (fig* 84, page 20$* This can be regarded as 
being formed from an aromatic sulphonamide by ring closure in the manner 
shown in Fig. 85, page 210.
The pharmacological actions of chlorothiazide have been studied by 
a number of groups of workers using different species including man 
(Beyer, Baer, Russo and Haimbach, 1997; Russo, Baer, Noll and Beyer, 
1997; Baer, Leidy and Brooks, 1997; and Ford, Moyer and Spurr, 1997)* 
Chlorothiazide is a stronger carbonic anhydrase inhibitor in vitro 
than acetazolamide but does not retain this activity in vivo except 
when used in larger and repeated doses (Beyer, Baer, Russo and Haim­
bach, 1997). It is an orally effective diuretic which causes an 
increased excretion of sodium and chloride with a weaker, but definite 
effect on potassium and bicarbonate excretion (Ford, Moyer, and Spurr, 
1997)* The enhanced elimination of sodium and chloride is accompanied 
by osmotic amounts of water*
A voluminous literature on the pharmacology and clinical uses of 
chlorothiazide which oontains publications from all parts of the world 
has appeared* The practical importance of this type of drug led to 
an /
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an intensive search Tpy a number of workers for improved and more potent 
diuretics. New and more active compounds of the benzothiadiazine series 
have appeared, including hydrochlorothiazide (De Stevens, Werner, Hala- 
mandaris and Hicoa, 1958); flumethiazide and hydroflumethiazide 
(Holdrege, Babel and Cheney, 1959); benzothiazide (P*An, Soriabine, 
McKersie and Melamore, I960) and triohloromethiazide (Taylor and 
Winbuiy, I960). Compounds such as salamid (5-chloro~2,4-bis- 
sulphonamido aniline) - actually an intermediate in the synthesis of 
chlorothiazide (Lund and Storling, 1959) - and a benzophenone derivative, 
hygroton (Stenger, Wirz and Pulver, 1959) are also reported to have more 
potent diuretic actions than chlorothiazide.
All these benzothiadiazine derivatives are probably carbonic 
anhydrase inhibitors to a greater or lesser degree. The general 
pharmacological properties and the pattern of electrolyte excretion 
exhibited by all the benzothiadiazine derivatives are qualitatively 
similar to those of chlorothiazide.
Effects of chlorothiazide on renal function
All the benzothiadiazine derivatives in clinical use cause 
increased excretion of sodium, chloride, potassium, bicarbonate and 
water. They are inhibitors of carbonic anhydrase, yet their saluretic 
action is more like that of the organo-mercurial diuretics than that of 
acetazolamide. The renal tubular reabsorption of sodium and chloride 
ions is inhibited in nearly equimolar amounts by chlorothiazide and 
these /
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these are eliminated in the urine with osmotic equivalents of water*
In large and repeated doses, the action of chlorothiazide becomes more 
like that of the specific carbonic anhydrase inhibitors such as aceta­
zolamide* Thus at high dose levels chlorothiazide increases the 
excretion of potassium and bicarbonate, resulting in an alkaline urine 
and a corresponding decrease of systemic potassium and bicarbonate 
levels (Baer, Russo and Beyer, 1959).
Hydrochlorothiazide (Fig. 84, page 208) is a more potent diuretic 
and saluretic agent than chlorothiazide* The slight structural 
modification resulting from saturation of the double bond in the 
heterocyclio ring has thus resulted in a marked increase of its 
diuretic potency as compared with chlorothiazide (Barrett, Rutledge, 
Sheppard and Plummer, 1959; end Renzi, Chart and Gaunt, 1959)* 
Hydrochlorothiazide appears to have less tendency to cause excretion 
of bicarbonate (Bartorelli, Gargano and Zanchetti, 1959) and potassium, 
but the relatively greater chloride excretion caused by this compound 
may result in a hypochloraemio alkalosis in contrast to the metabolic 
acidosis of acetazolamide*
Although the natriuretic response to hydrochlorothiazide in human 
subjects is about twenty times greater than that of chlorothiazide, the 
qualitative pattern of electrolyte excretion remains the same (Rich - 
terioh, 1958). Renzi, Chart and Gaunt in 1959 in their experiments on 
fluid-loaded rats have shown that hydroohlorothiazide had from 7 to 20 
times /
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times the relative potency of chlorothiazide* They also demonstrated 
that hydrochlorothiazide modified the antidiuretio effects caused by 
vasopressin, reserpine and syrosingopine in normal animals. In 
adrenalectomized animals it enhanced sodium but not water excretion.
It also antagonised the sodium-retaining effect of aldosterone and 
desoxyoorticosterone and enhanced the natriuretic response caused by 
prednisolone,
Poutsiaka, Piala, Smith, Burke and Thomas (i960) have shown that 
intravenous ad ministration of flumethiazide to alkalotio or acidotic 
dogs enhanced diuresis, causing an increased excretion of sodium and 
chloride. In normal dogs excretion of sodium and chloride was more 
marked, with little observable effects on potassium and bicarbonate 
excretion.
Chlorothiazide can thus retain its diuretic activity both in 
conditions of experimental alkalosis and acidosis (Beyer, 1958), 
Following the administration of large amounts of sodium chloride, 
chlorothiazide caused a substantial increase in both sodium and 
chloride excretion, with a much lesser effect on the excretion of 
potassium and bicarbonate ions and upon the urinaxy pH, In an 
ammonium chloride-induced acidosis in dogs, chlorothiazide caused a 
greater excretion of chloride ions than did sodium, whereas in an 
alkalosis due to administration of sodium bicarbonate there was a 
greater increase in the elimination of bicarbonate than of chloride 
ions. /
ions. No alteration was noted in the saluretic response to chloro­
thiazide in dogs maintained for several days on a low salt diet.
The salt-retaining action of steroids is reversed "by chloro­
thiazide and excretion of potassium is increased, indicating that 
chlorothiazide is not a true antagonist to the effects of steroids 
on kidney function (Beyer, 1958).
The antidiuretic hormone (vasopressin), when given parenterally, 
produced a marked depression in the excretion of electrolytes and 
water. Chlorothiazide has been shown to reverse this effect in dogs 
(Beyer, 1958) and in the rat (Kovacs, David and Horvath, 1959).
Chlorothiazide at therapeutic dose levels has no effect on the 
glomerular filtration rate, renal blood flow, glucose reabsorption or 
tubular secretion of p-aminohippurate. It is a weak competitive 
inhibitor of carbonic anhydrase and can, in veiy high doses, depress 
the clearance of phenol red and the renal tubular secretory capacity 
for p-aminohippurate in dogs (Baer, Beyer, Russo and Titus, 1958).
The physiological disposition of chlorothiazide in the dog has 
been clearly discussed by Baer, Leidy and Brooks (1957) and Baer, 
Leidy, Brooks and Beyer (1959) aud in human beings by Brettel, Gordon
and Aikawa, (1959).
?/hen chlorothiazide (10 mg. per kg.) was given intravenously 
to dogs, 67 to 76 per cent of the dose was excreted within the first 
hour and 86 to 99 per cent was excreted within six hours. The
clearance /
clearance of chlorothiazide from the plasma ocourred with corresponding 
rapidity. Four hours following the intravenous administration of 
20 mg. per kg. of 3-C14 labelled chlorothiazide to a bilaterally 
nephrectomised dog, the plasma level was 26.3 mg./litre and some 40 per 
cent of the dose was eliminated in the bile and another 10 per cent was 
found in the intestinal tract. Small amounts of chlorothiazide were 
found in the liver, lung and spleen. Little or none was detected in 
muscle, fat, brain and the cerebrospinal fluid. No accumulation of 
the drug could be demonstrated in the erythrocytes or other tissues 
following its intravenous administration.
Probenecid, at a dose level that completely inhibited the tubular 
secretion of penicillin, partially depressed the renal tubular secretion 
of chlorothiazide. This indicates that elimination of chlorothiazide 
is carried out by the renal tubules, at the site which is known to be 
responsible for the secretion of penicillin, p-aminohippurate and 
phenol red.
■ leetl
3-014 labelled chlorothiazide hasj^used as a tracer to study the 
metabolism of chlorothiazide in human subjects. In normal individuals, 
following an oral dose of 0*3 g* of chlorothiazide, a maximum serum 
concentration of 4 pg* per ml* was obtained at two hours. Excretion 
rate was greatest during the first five hours. “When 0.5 g* of 
chlorothiazide was given intravenously, SO per cent of the dose was 
excreted within two hours, with a complete disappearance of the drug 
from the blood within 24 hours (Brettell, Gordon and Aikawa, 1959)*
Hydrochlorothiazide /
Hydrochlorothiazide and flumethiazide are handled by the kidneys 
in a similar manner to chlorothiazide* Oral administration of 
tritium-labelled hydrochlorothiazide to water-loaded rats was followed 
by the excretion of 52 per cent of the dose in 24 hours* A greater 
proportion of the dose was retained in animals when larger amounts of 
the drug were administered. In dogs, after oral administration of 
0*31 mg. per kg. of hydrochlorothiazide, blood levels were found to be 
extremely low, as were the levels in the brain and spleen but liver and 
kidney showed much higher concentrations of the tritium-labelled drug. 
These levels were achieved one hour after drug administration 
(Sheppard, Bowen, Mowles and Plummer, 1959)*
Hydrochlorothiazide disappears somewhat more slowly from the 
plasma of nephrectomised dogs than does chlorothiazide. This indi­
cates that extrarenal degradation of hydrochlorothiazide, or its 
elimination in the bile, proceeds more slowly than that of chlorothiazide 
(Baer, Russo and Beyer, 1939).
The renal clearance studies on chlorothiazide indicate that it is 
excreted rapidly and completely in the urine and is secreted by the 
renal tubules. The tubular secretory component is believed to be 
inhibited by probenecid.
Except for a depression in the glomerular filteration rate that 
is produced by large intravenous doses of chlorothiazide and hydro­
chlorothiazide, these compounds appear to have no adverse effects on 
renal /
renal function* Histopathological studies following the administration 
of large doses of chlorothiazide to dogs for many weeks, did not reveal 
lesions which could he attributed to these drugs (Peck, McKinney, Baer, 
McManus and Beyer, 1958).
The diuretic response to hydrochlorothiazide was depressed when it 
was given intravenously at a dose level of 800 mg* per day to human 
subjects, thus indicating that high doses exerted toxic effects on 
renal tubular function (Moyer, Fuchs, Irie and Bodi, 1959). The 
toxicity of the benzothiadiazine derivatives is, however, very low and 
this was demonstrated by Peck, McKinnay, Baer, McManus and Beyer (1958) 
in their investigations on different species^ including' the dog* In
rmice the acute oral and intravenous LD50 of 8*5 and 1*1 g* per kg. 
respectively, indicated good oral absorption and an excellent margin 
of safety. Chronic oral administration of dose levels of up to 
600 mg. per kg. per day to dogs for six months and 500 to 1,000 mg* 
per kg. per day intravenously for periods of three weeks, without 
apparent signs of toxicity provided added evidence of its safety as 
a diuretic*
Mode of diuretic action of chlorothiazide
The mode of diuretic action of chlorothiazide has been discussed 
by Beyer (1958) who compared its effects on kidney function with those 
of the carbonic anhydrase inhibitor, acetazolamide and the organo— 
mercurial diuretics* So far as it is loiown the influence of chloro­
thiazide / \
chlorothiazide on the transport mechanisms of the nephron is directed 
specifically towards the transfer of electrolytes. This effect is 
said to be primary and is not dependent upon extrarenal drug effects. 
Lavender and Pullman (1958) collected urine samples separately from 
the two kidneys of the same dog following the unilateral renal arterial 
infusion of chlorothiazide. They found an increased excretion of 
water, sodium, chloride and,to a lesser degree, of potassium in the 
experimental kidney. The effects were independent of alterations in 
glomerular filtrcLtlCtti rate. A secondary effect upon the contra­
lateral kidney was observed as the drug gained access to this through 
the systemic circulation.
The nature of the diuretic activity of chlorothiazide and its 
mode of action can also be approached by a consideration of the effects 
of other diuretic agents. The pattern of sodium, chloride, potassium 
and water excretion of chlorothiazide is similar to that of the organo- 
mercurial diuretics but a marked increase of urinary pH is not typical 
of the latter. The increased pH and natriuretic effects resemble 
those of acetazolamide, but this compound does not induce a notable 
ohloruresis (Maren, Wadsworth, Yale, and Alonso, 195^)*
The known sensitivity of certain enzymes to heavy metals has made 
it attractive to speculate that enzymatio inhibition is responsible for 
the diuretic activity of the organic mercurials. Compounds of mercury 
have a high affinity for thiol enzymes. Because of their abiliiy to 
combine / .
combine with thiol groups the increased electrolyte and water excretion 
induced by mercurials can be antagonised by the administration of 
dime rcaprol (Brunner, 1959)*
The onset of diuresis with the mercurial diuretics is YclaJtively 5low^ 
reaching a maximum in from one to two hours and this persists for some 
hours. The diuresis consists of an increase in sodium, chloride and 
water excretion, with minimum effects on potassium and bicarbonate 
levels. The response to mercurial diuretics is enhanced by the co­
administration of acidifying salts such as ammonium chloride (Axelrod 
and Pitts, 1952) and is decreased in an alkalosis (Levy, Weiner and 
Mudge, 1958).
Mercurial agents are gastro-intestinal irritants and so cannot be 
used in acute abdominal conditions or in chronic kidney disease.
Maren (1956) reported that the concurrent administration of acetazol­
amide and mercurial diuretics decreases, but does not abolish, the 
response of dogs to the mercurial diuretics. Riggs and Berks on (1958) 
however, have shown that the chloruretic and diuretic responses of dogs 
to 1 to 2 mg. per kg. of a mercurial diuretic given intravenously was 
almost completely suppressed by acetazolamide (20 mg. per kg. per hour) 
given as a continuous intravenous infusion. They concluded that there 
was a good inverse correlation between the urinaxy pH and the response 
to organo-mercurial agents. Vargas and Cafruny in 1958 demonstrated 
that mercurial diuretics produced renal cortical ischaemia and 
increased /
increased the wet weight of dog and rat kidneys* A similar effect was 
not noticed when the animals were treated with chlorothiazide*
Mechanism of the diuretic aotion of chlorothiazide
The precise mechanism of action of the benzothiadiazine diuretics 
is unknown. Histochemioal and chemical data from in vitro studies 
(Cafruny and Farah, 1956; Mann and Keilin, 1940 and Davenport and 
Wilhelmi, 1941) indicate that the merourials and sulphonamides may 
inhibit specific enzyme systems which are required for the activation 
of the ion exchange mechanisms of the kidney, especially those for 
sodium reabsorption. A comparison of the actions of different types 
of diuretics has made it clear that the behaviour of chlorothiazide 
differs from that of other classes of diuretics in a number of 
important ways. The increased urinary pH with enhanced potassium 
excretion, observed with higher doses of chlorothiazide, is almost 
certainly attributable to inhibition of carbonic anhydrase (Beyer,
1958).
Fitts, Kruck, Lozano, Taylor, Heldenreich and Kessler (1958) in 
their experiments on anaesthetised dogs have shown that blockade of 
sodium and chloride reabsorption is additive when chlorothiazide and 
chlormerodrine are given respectively in maximal doses. These authors 
suggest that chlorothiazide either blocks a different reabsorptive 
mechanism from that influenced by the mercurial diuretics, or more 
probably, interferes with the different enzymatic reactions which supply 
energy /
energy to a single reabsorptive mechanism. They suggested that there 
are not less than three biochemically distinct mechanisms or sources of 
energy concerned with the reabsorption of sodium and chloride ions, one 
of which was sensitive to chlorothiazide and one or more resistant to 
both drugs. The mechanisms responsible for bicarbonate reabsorption, 
inoluding the mechanism for sodium, hydrogen and potassium ion exchanges 
were all affected qualitatively in a similar manner by chlorothiazide 
and acetazolamide - presumably as a consequence of their carbonic 
anhydrase inhibiting activities. Acetazolamide was the more potent.
Ford (1957) and Ford and Rochelle (1959) in their clinical studies 
have carefully evaluated the mechanism of diuretic action of chloro­
thiazide by comparing its actions with those of other diuretics. 
Mercurials, acetazolamide and chlorothiazide were administered alone 
and in various combinations in order to determine the effects on the 
excretion of various electrolytes. They found that after a maximum 
increase in the sodium excretion, following the injection of a mercurial 
diuretic (meralluride), the administration of acetazolamide produced 
another significant increase in the sodium excretion thus indicating 
that two non-competitive mechanisms for the tubular reabsorption of 
sodium had been inhibited. At the peak of this second increase and 
while meralluride and acetazolamide were still being infused, the 
administration of chlorothiazide was observed to produce a third 
significant increase over the previous rate of sodium excretion. This 
observation /
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observation indicated that a third mechanism or receptor site was 
affected, resulting in an increased inhibition of the mechanism for 
sodium reabsorption. When acetazolamide followed the administration 
of chlorothiazide no augmentation of sodium excretion was observed.
As part of the mode of action of chlorothiazide involved carbonic 
anhydrase inhibition these authors concluded that it acted upon this 
enzyme by competition with acetazolamide. On the other hand, chloro­
thiazide has other actions, for example an effect upon sodium excretion 
which cannot be blocked following the administration of acetazolamide. 
When administration of mercurial diuretics was followed by the admini­
stration of chlorothiazide, no augmentation in sodium excretion was 
observed but the converse was not true. Chlorothiazide appears, 
therefore, to affect the same mechanism for sodium excretion as the 
mercurials.
Ford and Rochelle (1959) suggested that the mercurial diuretics 
shared a mechanism of action with chlorothiazide. They also suggested 
that acetazolamide shared a mechanism with chlorothiazide and that 
chlorothiazide also appeared to act through a third, non-competitive 
mechanism.
The enhanced excretion of chloride ions does not fit the classic 
picture of renal sodium reabsorption which has been put forward by a 
number of workers to explain the mechanism of urinary acidification 
(Pitts and Alexander, 1945; Pitts, Lotspeich, Schiess and Ayer* 1948
and /
and Berliner and Orloff, 1956). The chloruretic action of chloro­
thiazide may merely reflect the absence of interference with the 
reabsorption of filtered bicarbonate.
Beyer (1958) has differentiated between an agent which inhibits 
the sodium-hydrogen ion exchange in the nephron from drugs such as 
acetazolamide which cause carbonic anhydrase inhibition elsewhere, for 
example in the eiythrocytes. Compounds with aotions similar to those 
of acetazolamide, by depressing the rate of transfer of carbon dioxide 
from the kidney, might increase the bicarbonate excretion as well as 
inhibit the sodium-hydrogen ion exchange. The reciprocal relation 
between chloride and bicarbonate excretion has been explained in more 
detail by Hilton, Capeci, Kiss, Kruesi, G-laviano and Wegaria in 1956.
The site of action of chlorothiazide
Information on the site of aotion of chlorothiazide is mainly 
derived from studies using the *stop flow1 techniques of Malvin, Wilde, 
Vander and Sullivan (1958). These authors investigated the mechanism 
of sodium transport along the renal tubule using the * stop flow* 
analysis. During varying degrees of osmotic diuresis in dogs the 
ureter of one kidney was occluded for 2% to 8 minutes. Following 
occlusion, final urine samples were collected and analysed for sodium, 
creatinine and para-aminohippurate or glucose. Using the urinary 
creatinine concentration as an index of water movements, the mass of 
sodium and water reabsorbed from the proximal segments during 
occlusion /
occlusion was calculated.
Vander, Malvin, Wilde and Sullivan (1959) have performed a series 
of experiments upon dogs using the *stop flow* technique. They 
suggested on the basis of their results that chlorothiazide, like the 
mercurial diuretics, diminished the reabsorption of electrolytes in the 
proximal tubular system. They also indicated that the secretion of 
potassium in the distal tubules was greatly increased by chlorothiazide, 
whereas the potassium reabsorption in the distal tubules was slightly 
decreased. On the other hand, Kessler, Hierholzer, Gurd and Pitts 
(1959) reported depression of sodium and potassium reabsorption in the 
distal tubule, accompanied by an increase in the pH of the distal tub­
ular urine. The effect on electrolyte and fluid composition in the 
proximal tubules confirmed the observations of Vander and his associates 
(1959) and Baer and his co-workers (1959) that chlorothiazide was 
secreted by the renal tubules and that this secretion could be inhibited 
by probenecid. They concluded that the mechanism for the elimination 
of chlorothiazide coincided with that which was responsible for the 
secretion of penicillin, para-aminohippurate and phenol red. Kessler 
and his associates (1959) have localised the tubular secretion of 
chlorothiazide to the proximal segment of the nephron.
The general pharmacology of the benzothiadiazine derivatives. 
Cardiovascular system.
Chlorothiazide f
Chlorothiazide and hydrochlorothiazide in small doses had no 
effect on the function of the isolated guinea pig or rabbit heart, 
whereas high doses appeared to have a slight transient depressant 
effect upon myocardial function. Responses of the isolated heart and 
auricles to adrenaline and noradrenaline were not altered by chloro­
thiazide or hydrochlorothiazide. No electrocardiographic changes were 
observed in rats and rabbits even at high dose levels. (Preziosi, 
Bianchi, Loscalzo, Sohaepdiyver, 1959; and Barrett, Rutledge,
Sheppard and Plummer, 1959)*
In the normotensive cat, dog and rabbit these compounds do not 
alter the heart rate, blood pressure levels or the respiratory pattern 
but in a proportion of vagotomised dogs a slight hypotensive effect was 
seen by Preziosi and his associates (1959)* In dogs, chlorothiazide 
does not modify the responses of the blood pressure to adrenaline or 
noradrenaline and local application of chlorothiazide to the region of 
the carotid sinus has no direct effect on the blood pressure or on the 
carotid sinus pressor reflex. No effect on acute neurogenic hyper*-
tension in dogs was observed. In the same species, chlorothiazide had
no anticholinergic or ganglion-blocking activity and had little or no 
effect on the responses to carotid occlusion or to stimulation of the 
peripheral or central ends of the vagus. It appeared, however, to 
prolong the depressor action of an intravenous injection of acetyl­
choline •
Beavers and Blackmore (1958) suggested that chlorothiazide had a 
direct /
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direct action on vascular smooth muscle. In their experiments on 
anaesthetised dogs they found that the pressor responses to adrenaline 
and noradrenaline and the depressor effects of isoprenaline were 
decreased. It was suggested that chlorothiazide might exert its anti­
hypertensive effects by reducing the responsiveness of the blood vessels 
to agents which alter vascular tone. Barao (1958) had previously 
demonstrated that chlorothiazide did not cause vasodilatation in the 
blood vessels of the kidney perfused with fresh blood and that it did 
not antagonise renal vasoconstriction in the kidney perfused with stored 
blood.
Hydrochlorothiazide potentiated the hypotensive action of hydra­
lazine and increased the depressor response to histamine in dogs 
(Barrett, Rutledge, Sheppard and Plummer, 1959)* It did not alter the 
hypertensive condition caused by chronic administration of hydro­
cortisone to rats. Hydrochlorothiazide when given over a long period 
of time, significantly inhibited the blood pressure rise associated 
with adrenal regeneration hypertension. No similar effect was noted 
following acute treatment with hydrochlorothiazide. The hypotensive 
effect of this compound was related to a marked decrease in the appetite 
of the treated animals for sodium chloride solution (Renzi, Chart and 
Caunt, 1959)* These workers suggested that hydrochlorothiazide lowered 
blood pressure only when sodium intake was reduced or when this drug 
enhanced the sodium loss - effects which are associated with a decrease 
in /
in the volume of plasma or extracellular fluid*
Hydrochlorothiazide had no effect on the heart rate, blood pressure 
or the cardiovascular responses to adrenaline and noradrenaline in the 
anaesthetised dog.
Chlorothiazide and hydrochlorothiazide potentiate the antihyper­
tensive effects of reserpine in the anaesthetised cat. This effect 
was noticed when these compounds were given intravenously prior to the 
injection of reserpine. This observation indicates the possibility 
that the antihypertensive effect of the benzothiadiazines is due, at 
least in part, to a specific pharmacodynamic action, independent of 
the alterations in the electrolyte pattern and the reduction of plasma 
volume (Preziosi, Marmo and Miele, 1961).
In a more recent publication Preziosi, Schaepdiyver, Marmo and 
Miele (1961) have shown that hydrochlorothiazide had no effect on the 
oarotid sinus baroreceptors, the carotid body chemoreceptors or on the 
vasomotor centre. Small doses of hydrochlorothiazide inhibited the 
pressor responses following the stimulation of adrenergic fibres without 
influencing the vascular responses to catechol amines and synthetic 
hypertensine, whereas in high dose levels it decreased the vascular 
responses to adrenaline and noradrenaline. They also observed a marked 
decrease of the adrenaline and noradrenaline content of the liver, heart, 
spleen and adrenals following a single intravenous dose of 10 mg. per 
kg. of hydrochlorothiazide in dogs and mice.
Book and Gross (i960) using normal dogs have shown that the oral 
administration /
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administration of 5 mg. per kg. daily of hydrochlorothiazide for one 
week significantly reduced the pressor responses to various doses of 
adrenaline, noradrenaline and angiotensine. They also observed that 
the antihypertensive activity of chlorisondamine was enhanced when given 
in combination with hydrochlorothiazide.
Merrill, Guinand-Baldo and G-iordano in 1958 have already demons­
trated that chlorothiazide reduced the vasopressor response of patients 
to noradrenaline in the presence of ganglion-blocking agents. They 
suggested that chlorothiazide may exert its hypotensive action in part 
by blocking the response of the blood vessels to increased circulating 
pressor amines, or by inhibiting the release of these at the neuro­
effector sites. It may be significant that a low salt diet also 
decreases the responsiveness of patients to adrenaline and noradrenaline 
(Raab, Humphreys, Makous, De Grandpre and Gigee, 1952).
Poutsiaka, Piala, Smith, Burke and Thomas in I960, using flume- 
thiazide in normotensive dogs, have shown that this compound had 
negligible effects on the blood pressure, the pulse rate, the responses 
of the blood pressure to adrenaline and acetylcholine, the response to 
occlusion of the common carotid artery and the p'ressor responses to 
stimulation of the cut peripheral and central ends of the vagus nerve.
A decrease in the tone of the isolated rabbit gut, with no change 
in the peristaltic movements was also noted following low doses of 
chlorothiazide (Preziosi, Bianchi, Loscalzo and Sohaepdryver, 1959) 
and /
and hydrochlorothiazide (Preziosi, SchaepcLiyver, Marmo and Miele, 196l).
The contractions of the isolated pregnant uterus of the mouse 
induced by synthetic oxytocin were slightly inhibited by low doses of 
hydrochlorothiazide •
Clinical applications of chlorothiazide.
The natriuretio and diuretic properties of chlorothiazide have 
greatly facilitated the management of hypertension, particularly when 
there is oedema formation due to salt and water retention. Oedema is 
found in many disease states in which there is interference with electro­
lyte balance. This results in an accumulation of sodium with osmolar 
amounts of water in the extracellular tissue spaces. Almost all types 
of fluid retention of a systemic or local nature, which can be attri­
buted to the retention of sodium, have responded veiy well to chloro­
thiazide therapy. Total elimination of oedema fluid in such conditions 
as congestive heart failure, nephrosis and portal cirrhosis has been 
achieved and maintained by the administration of chlorothiazide (Laragh 
and Demartini, 1957> Sherlock, Read, Laidlaw and Haslam, 1958; Burch 
and White, 1959; and Eskwith, 1959)*
In cases of advanced cirrhosis of the liver, hepatic coma can be 
precipitated by the increased excretion of potassium caused by chloro­
thiazide. This can be avoided by adding supplements of potassium 
during the period of treatment.
Digitalis intoxication may be induced by the loss of excessive 
potassium /
potassium (Lown, Salzberg, Ensflberg and Weston, 1951) during pro­
longed chlorothiazide treatment in cases of congestive heart failure. 
This can, however, be prevented by using digitalis im smaller doses or 
by giving potassium.
Chlorothiazide has been used in fluid retention due to toxaemias 
of pregnancy (Finnerty, Buchholz and Tuckman, 1958; Assali, Judd, 
Mondz and Dasgupta, 1958 and Lan&esma^Ollstein and Quinton, 1959) and 
premenstrual tension (Jungek, Barfield and G-reenblatt, 1959) •
Other therapeutic uses include the treatment of the anginal 
syndrome (Marshall, 1959), fluid retention due to steroid therapy 
(Warshaw, 1959), obesity (Landes and Peters, 1958) and in local oedema 
(Barker, Carey and Brough, 1959). Due to its safety and effectiveness 
chlorothiazide has attained a world wide clinical popularity.
The advent of chlorothiazide constituted an important advance in 
the management of certain types of arterial hypertension. It has 
proved its value as an adjunct other antihypertensive agents, 
including reserpine and ganglion-blocking agents; (Tapia, Dus tan, 
Schneckloth, Corcoran and Page, 1957; Freis and Wilson, 1957; 
Rochelle, Bullock and Ford, 1958; Heider, Dennis and Moyer, 1958; 
Barnett and Marshall, 1958; Dust an, Cumming, Corcoran and Page, 1959; 
Moser and Macauley, 1959 and Smirk, McQueen and Morrison, I960) and in 
a proportion of cases when it is administered alone (Wilkins, 1957; 
Hall and Owen, 1959; Freis, Wanko, Wilson and Parrish, 1958; and Juel- 
Jensen and Pears, I960).
The mechanism of antihypertensive aotion of chlorothiazide.
Although much effort has been expended in attempts to evaluate the 
mechanisms underlying the antihypertensive action of chlorothiazide, 
these are still obscure. Arguments have been advanced to indicate 
that chlorothiazide has a unique antihypertensive action which is not 
totally dependent upon its diuretic effects. Suggestions include that 
the hypotensive effect is related to a decrease in plasma and extra­
cellular fluid volumes (Wilson and Freis, 1959; Maoleod, Dustan and 
Schneckloth, 1959; and Macleod, Dustan and Page, i960), a fall in 
cardiac output (Dustan, Gumming, Corcoran and Page, 1959 and Crosley, 
Castillo, Freeman, White and Rowe, 1958), dehydration of the arteriolar 
walls (Lauwers and Conway, i960), deoreased arteriolar responsiveness 
to substances which act on vascular smooth musole (Beavers and Black- 
more, 1958 and Merrill, Guinand-Baldo and Giordana * 1958), depression 
of vascular smooth muscle (Preziosi, Bianchi, Loscalzo and Sohaep- 
dryver, 1959)> reduction in the sodium content of the arteriolar walls 
(Aleksandrow, Wysznacka and Gajewski, 1959) and interference with the 
action of aldosterone (Hollander, Chobanian and Wilkins, 1959)*
A relationship between the occurrence of elevated blood pressure 
and a high salt intake has been suggested by a number of workers 
(McQuarrie, Thompson and Anderson, 1936; Lenel, Katz and Rodbard,
1948; Sapirstein, Brandt and Drury, 1950; and Meneely, Tucker, Darby 
and Auerbach, 1953)*
Meneely /
Meneely and his associates and Sapirstein and his co-workers in 
their experiments on rats have shown that administration of hypertonic 
saline with or without the use of sodium—retaining hormones such as 
desoxyoorticosterone acetate, produced a hypertensive state. This was 
similar in most respects to human hypertension. This correlation 
between blood pressure elevation and salt intake in human subjects has 
recently been stressed by Dahl and Love (1957) who also suggested that 
the level of sodium intake was the primary aetiological factor in the 
development of essential hypertension. The observation that salt 
restriction enhances the hypotensive action of diuretics is additional 
evidence that this effect may be due to increased sodium loss, which 
may further result in shrinkage of the extracellular fluid space and a 
reduction of plasma volume (Freis, Wanko, Wilson and Parrish, 1958 ).
There is no doubt that chlorothiazide increases the urinary 
excretion of sodium, potassium, chloride and bicarbonate and there is 
some evidence that antihypertensive potency and sodium depletion are 
linked but the source of the sodium eliminated, whether it comes from 
the extracellular spaces or elsewhere is not known, nor is the point 
in the cell at which the drug acts.
The work described in this part of the thesis was undertaken to 
investigate certain aspects of the mode of antihypertensive action of 
chlorothiazide. The earlier part of this section of the thesis is 
devoted to a study of the pharmacological properties of chlorothiazide 
and some allied compounds. It was felt that interpretation of the 
data /
data obtained in such experiments would give some information as to 
the action of chlorothiazide at the cellular level. It appears, 
however, that the fundamental action of chlorothiazide must ultimately 
involve the electrolyte metabolism of the cell. With this possibility 
in mind the behaviour of sodium and potassium ion movements in the cell 
under the influence of chlorothiazide has also been investigated. The 
fact that some energy-yielding mechanism is necessary for the movements 
of sodium ions from extracellular spaces to the cell has led to some 
experiments being made on the adenosinetriphosphatase activity of rat 
skeletal muscle under the influence of chlorothiazide.
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C H A P T E R  II
A. MATERIALS
The drugs used in the Investigation which is described in this 
section of the thesis, together with their shortened names are as 
follows:-
1. Acetylcholine chloride is described as acetylcholine*
2, (-)-Adrenaline bitartrate is described as adrenaline.
3* (-)-Noradrenaline bitartrate is described as noradrenaline*
4* Histamine aoid phosphate is described as histamine*
5. 5-Hydroxytiyptamine creatinine sulphate is described as 5-hydroxy- 
txyptamine.
The benzothiadiazine compounds investigated were:- 
Chlorothiazide (Merck, Sharp and Dohme) and described as CT* 
Hydrochlorothiazide (Ciba) described as HCT*
Flumethiazide (Glaxo) described as FCT*
Benzothiadiazine derivatives are sparingly soluble in water* A 
one per cent solution of chlorothiazide was prepared freshly each day so 
as to avoidlydrolysis* One gram of chlorothiazide was dissolved in
3.4 ml* of N.sodium hydroxide solution and made up to 100 ml* with 
distilled /
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distilled water, the pH of the solution being 8 to 8.2. The solutions 
were mixed with the appropriate physiological saline before use.
When concentrations of drugs are mentioned in the text then, unless 
otherwise stated, these refer to the final bath concentrations in terms 
of weight in volume.
The conventional abbreviations for volumes and weight of the metric 
system are used throughout this part of the thesis. The statistical 
method employed to calculate the experimental findings is described 
in Appendix I, page 451.
B. EXPERIMENTAL 
A number of benzothiazide derivatives have been reported to possess 
diuretic (Ford, Moyer and Spurr, 1957) and antihypertensive properties 
(Hollander and Wilkins, 1957)• Veiy little information is available 
about the effects of chlorothiazide on the cardiovascular system of 
the cat or on isolated tissues and organs.
In order to evaluate the pharmacology of chlorothiazide and allied 
compounds in more detail, work has been carried out on intact animals 
and isolated tissues with special reference to their antihypertensive 
properties. The object at this stage was to determine whether any 
part of the hypotensive response to chlorothiazide was due to effects 
other than upon electrolyte balance.
Experiments were carried out in the following order: -
1. Experiments on the arterial blood pressure level and vasomotor 
reflexes of normotensive anaesthetized cats and rats.
2. /
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2. Experiments on the responses of isolated tissue preparations t*»ken 
from organs containing smooth, cardiac, vasoular or skeletal muscle,
(a) Isolated strips of guinea pig ileum.
(b) Isolated strips of rabbit duodenum.
(c) Isolated strips of horse carotid artery.
(d) Blood vessels of the isolated perfused rat hindquarters 
in situ.
(e) Isolated cardiac muscle, including the isolated guinea 
pig auricles and the isolated, perfused rabbit heart.
3. Studies on the influence of chlorothiazide on ion fluxes in 
isolated strips of the thoracic aorta of the rabbit and 
isolated sartorius muscle of the frog.
(a) Uptake of potassium-42.
(b) Efflux of potassium-42.
(c) Uptake of sodium-24*.
(d) Efflux of sodium-24.
4-* Biochemical investigations.
(a) Studies on the adenosine triphosphatase aotiviiy of rat 
skeletal muscle.
(i) Experiments on the blood pressure of the anaesthetised cat.
The experimental procedure used in this investigation was similar 
to the one described previously (page 26). Chlorothiazide was given 
in /
in the form of a slow intravenous infusion at a rate of 1 ml* per 
minute* The doses of chlorothiazide administered were from 50 mg* 
to 2.00 mg. per kg. of body weight*
The effect of intravenous administration of chlorothiazide 
(30 to 200 mg. per kg.) upon the vasopressor responses to adrenaline 
or noradrenaline (10 to 20 jig. per kg.) were studied (page 3 1)*
Using similar doses of adrenaline and noradrenaline the effects of 
chlorothiazide (30 to 200 mg. per kg*) given by intravenous injection 
upon the contractions of the nictitating membrane were also observed*
(ii) Experiments on the blood pressure of the anaesthetised rat*
The experimental procedure was the same as that described 
previously (page 35). Drugs were administered intravenously into 
the femoral vein and the effects of intravenous administration of 3 
to 10 mg. chlorothiazide on the pressor responses to adrenaline, 1 to 
2 pg. and noradrenaline * 1 to 2 pg. were studied.
(iii) Experiments on the isolated, perfused hindquarters 
of the rat*
Experiments on the isolated, perfused hindquarters of the rat 
were carried out to study the effects of the drugs under investigation 
on an isolated vascular bed. The experimental procedure was the same
as that described previously (page 44 ). Chlorothiazide in dose levels 
of from 5 to 20 mg. was infused for 5 to 10 minutes and the effects were 
studied on the vasoconstrictor responses elicited by injections of 
adrenaline, 1 to 2 pg., noradrenaline 1 to 2 pg., 5-kydroxytrypt amine,
1 to 5 pg., and barium chloride from 50 to 250 pg.
(iv) Experiments on isolated strips of horse carotid artery.
Experiments were carried out on isolated strips of horse carotid
artery to determine the direct effects of 0.125 to 1 mg. per ml. of 
chlorothiazide and hydrochlorothiazide on the arterial smooth muscle 
and on the responses elicited by 0.01 to 0.1 pg. per ml. of acetyl­
choline, 1 to 2 pg. per ml. 5-hydroxytiyptamine, 1 to 2 pg. per ml. of 
adrenaline and 1 to 2 pg. per ml. of noradrenaline. The experimental 
procedure was the same as that described already (page 42 ).
(v) Experiments on the isolated, perfused rabbit heart.
Experiments were carried out on the isolated, perfused rabbit
heart to observe the effects of chlorothiazide, hydrochlorothiazide and 
flumethiazide on the rate, tone and outflow of this organ. Chloro­
thiazide in doses of 1 to 10 mg., hydrochlorothiazide and flumethiazide 
in doses of 0.1 to 0.25 mg. were injected into the cannula supporting 
the heart. The method adopted was the same as that previously 
described (page 51 )•
(vi) Experiments on isolated guinea pig auricles.
The experimental procedure adopted was the same as that described 
elsewhere (page 49 )• Chlorothiazide, 1 to 2 mg. per ml., 
hydrochlorothiazide /
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hydrochlorothiazide 0*1 to 0.2 mg. per ml. , and flumethiazide 0.1 to 
0.2 mg. per ml. were used. The effects of the drugs on the rate and 
the amplitude of the auricles and also upon the responses of the 
auricles to adrenaline, 0.1 to 1.0 jig. per ml., noradrenaline. 0.1 to 
1.0 pg. per ml., and acetylcholine, 1.0 to 2.0 pg. per ml. were studied.
(vii) Experiments on isolated strips of rabbit duodena.
The procedure adopted to perform these experiments was the same as 
that described already on page 41 . Chlorothiazide in doses of 1 to 
2 mg. per ml., hydrochlorothiazide 0.1 to 1 mg. per ml., and flume— 
thiazide 0.1 to 1 mg. per ml., were used and their effects on the 
rhythmic activity of the isolated, duodenal strips studied.
(viii) Experiments on isolated strips of guinea pig ileum.
The experimental procedure was the same as that described pre­
viously (page 39 )• The effect of chlorothiazide 1 to 2 mg. per ml., 
hydrochlorothiazide 0.1 to 1 mg. per ml., and flumethiazide, 0.05 to 
0.2 mg. per ml. on the tone of the gut and also on its responses to 
acetylcholine, 0.1 to 1 pg. per ml., histamine 0.1 to 1 pg. per ml.,
5-hydroxytrypt amine 1 to 5 pg. per ml.» and barium chloride 0.25 to 
0.5 pg. per ml. were observed.
(dx) Studies on the influence of ohlorothiazide on ion 
fluxes in the isolated, vasoular smooth muscle of 
the rabbit and isolated, skeletal muscle of the frog.
To /
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To study the effects of chlorothiazide on ion movements across the 
cell membrane, experiments were conducted using isolated strips of rabbit 
aorta and frog sartorius muscle* An investigation was made on the 
effeots of chlorothiazide on the output and uptake of sodium-2 4 and 
potassium-42*
(a) Experiments on isolated strips of rabbit aorta*
Uptake of potassimn-42*
Adult male rabbits weighing from 2*0 to 2*3 kg*, were killed by a 
blow on the head and bled out* About 3 to 6 cm* of thoracic aorta was 
carefully removed and transferred rapidly into the ice-cold Krebs- 
Ringer solution (Appendix I , page 432)*
The piece of the aorta was opened longitudinally using sharp- 
pointed iris scissors and divided transversely in the middle into two 
strips* The strips were weighed on the torsion balance and adjusted 
to be approximately equal* One strip was used as a control and the 
other for the experiment. The paired strips of aorta were blotted dry 
and hooks made from No* 20 hypodermic needles were attached to each end* 
The strips were suspended from one end, from the barrel of the hypo­
dermic syringe into two centrifuge tubes, each containing 9 ulU of 
Krebs-Ringer solution at room temperature and which was oxygenated 
continuously throughout the experiment* Part of the stable potassium 
in the bathing fluid had been replaced by isotonic 42 KC1 solution which 
contained 1.- to 1.2 me. per 10 ml. at the time of dispensing* The 
volume /
Fig. 86.
Diagram of the apparatus used for 
measuring radioactivity in muscle.
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volume usually added was 0*25 ml.
One centrifuge tube contained chlorothiazide, from 1 to 2 mg# per 
ml., and the other contained the same volume of the control solution. 
Before immersing the muscle in the tube the radioactive Krebs-Binge r 
solution was counted by placing the tube in the central well of a 
thallium-activated, sodium iodide, scintillation crystal (Ekco type 
N.597) (Fig. 86, page 26iJ linked through a photomultiplier unit to 
an automatic scaler (Ekco type N.530D).
Each strip of aorta was exposed to the drug or control solution 
for 30 minutes after which the muscle was removed from the tube and 
washed with a stream of normal, non-radioactive Krebs-Ringer solution 
for 5 seconds, blotted dxy and counted in a well type scintillation 
counter for a period of one minute. This procedure was repeated at 
30 minute intervals until a steady state was reached. This was usually 
from 2 to 3 hours. The total radioactive counts left in the muscle 
were measured at the end of the experiement. Each of the muscles was 
dissolved in 2 ml# of concentrated nitric acid by wanning it slightly 
on an electric hot plate. This mixture was adjusted to 5 nil. and 
counted by resting the test tube in the central well of a thallium- 
activated, sodium iodide, scintillation crystal linked through a photo­
multiplier unit to an automatic scaler*
Corrections for decay were not made in each series of experiments 
as parallel control experiments were performed under identical con­
ditions • /
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conditions. Corrections were made for background and the counts 
were expressed as counts per minute.
(b) Potassium-42 efflux.
Rabbits weighing from 2 to 2.5 kg* were injected intraperitoneally 
with 1 ml. per kg. of isotonic solution of 42-KCl which contained 1.0 
to 1*20 me. in 10 ml. at the time of dispensing.
The animal was left for 2 hours to attain equilibration and then 
killed by a hard blow on the head and bled out. The aorta was removed 
in the way described previously (page 263) and two strips of approxi­
mately the same weight were prepared as before. Two series each con­
taining nine 10 ml. oentrifuge tubes were set up in parallel. Each 
tube contained 10 ml. of non-radio active, Krebs-Ringer solution at room 
temperature which was continuously oxygenated throughout the experiment. 
One series of tubes was used for the control and the other for the drug. 
Each of the strips of aorta was suspended from one end by means of a 
steel hook made from an entomological pin and stretched by a weight made 
out of a No. 20 hypodermic needle which was attached to the lower end of 
the aortic strip. The paired strips were suspended, one in the first 
member of the control series of tubes and the other in the corresponding 
tube in the test series. After a period of 10 minutes in the first 
tube the muscles were transferred to the second in the series, and so 
on. The fluid remaining in the previous tubes was counted using an 
M6 /
M6 counter linked to an automatic scaler (Ekco type N53GD)* Ea “tiie 
test series the drug was present in the fourth, fifth and sixth tubes 
and the control solution in the corresponding tubes of the other 
series. After immersing the aortic strips in the ninth tube of the 
series the muscle was removed and digested in 2 ml. of concentrated 
nitric acid; the volume was adjusted to 10 ml. with Krebs-Ringer 
solution and counted in the usual manner. Chlorothiazide in doses of 
from 1 to 2 mg. per ml. was used.
(o) Uptake of sodium-24*
These experiments were carried out in a similar manner to that 
described in the investigation of potassium-42 uptake (page 263 ) but 
an isotonic solution of 24-NaCl was used in place of 42-KD1. Of this 
solution 0.2 ml. was added to 30 ml. of Krebs-Ringer solution and 9 ml. 
of this solution was used in each series of test and control experiments,
(d) Sodium-24 efflux.
These experiments were carried out in the same manner as that 
described in the investigation of potassium-42 efflux (page 266) but 
an isotonic solution of 24-RaGl was used in place of 42-KCl. Two ml. 
of this solutionwere injected intravenously 2 hours before the removal 
of the aorta. The radioactive solution was counted by resting the 
tube in the central well of the thallium-activated, sodium iodide 
sointillation crystal (Ekco type N.597) linked through a photomultiplier 
unit to an automatic scaler (Ekco type N530D)*
Experiments /
Experiments investigating the efflux and uptake of potassium-42 
and sodium-24 on frog sartorius musole were performed in the manner 
described previously (page 263, and 266).
(x) Biochemical investigations
Experiments on the adenosinetriphosphatase 
activity of rat skeletal muscle.
Method. The procedure adopted for estimation of the adenosinetri­
phosphatase activity of rat skeletal muscle was that described 
previously (page 143), but chlorothiazide (l to 2 mg. per ml.) was 
used in place of 10-methoxydeserpidine.
C. RESULTS
Blood pressure and respiration of the anaesthetised oat.
Chlorothiazide in dose levels of from 50 to 200 mg. per kg. had 
no observable effect on the blood pressure and the respiration of the 
normotensive anaesthetised cat (Fig. 86,page 269)* No bradycardia 
was observed during or after the administration of the drug.
The responses to small doses of adrenaline, 2 pg. per kg. were 
depressed after or during the infusion of 166 to 200 mg. per kg. of 
chlorothiazide, whereas responses to 2 pg. per kg. of noradrenaline 
were not modified.
The pressor response to bilateral occlusion of the common carotid 
arteiy was also reduced following infusion of ohlorothiazide (total 
do3e /
268.
269.
- p
t CJ
S ° •
°  ^  I d  £?
o  to  ©  
Eh O *rl -P 
O  r l  P  H  — ✓ rO <D Gj
©  H  P  ^  
•rJ cd to *h
•H »H ©  P
• H P  CO 
O rH CO 
© PM © © 
,p  P  >  Pi
P  ©  PM 
©  rH  
©
O
*H
COP
i
•H
bO
1  .
<H © © 
pq rl PM Eh
.3
O c
O
to O
© ©
p w
•5 oa
o II
LO
H
P. ©
© o
P ©
^3
p
p
rH Pi
© ©
> £
© orl H
m
s
P H
to >
to u
© ©
Pi p
Pi
rtf
•n
o ©
o a
H •H
PQ EH
P-J
00
b£
K
a5 rO
8
<*C
P2
♦H
O
•H
o
-0 aJ
fn Pi
EH Eh
rd .o •»O
•H ^ Ou <q © S ©©
© © T* •
u S
U© £
© H
> cfl
P
Jh
©£o £ © o© £
U ©Eh 'O •rl >o ©,,P ©
^  Jh P U' ° P,§ Cl •rl O h 5
£c
oo©
co
*Ho<w
• • o
$ 8 $
© © <x{ k  
.£  © w  © P  P  r© 0 © O
.s.9*
<j fd oJz; <J o
p  p  p<3j <J« <4
Moo
bo♦rl
to
aj
t*0
•5Oaj£Eh Tr
ac
in
g 
b. 
300
 
mi
nu
te
s 
aft
er 
the
 
end
 
of 
in
fu
si
on
.
Tim
e 
in
te
rv
al
 
(lo
wer
 
tr
ac
e)
 
= 
30 
se
co
nd
s
271.
Fig. 88,
Tracing a. Effect of the infusion of 125 rag* per kg, of chloro­
thiazide (CT) over a period of 10 minutes upon the 
respiration (upper record) and the pressor responses 
to electrical stimulation of the cut central end of the 
right vagus (lower record) in a pentobarbitone- 
anaesthetised cat.
At VS, electrical stimulation of the cut central end of the right
vagus (10 volts, 1,000 impulses per minute, pulse width
1,5 msec.) for 15 seconds. %
Tracing b. 150 minutes after the drug infusion. Chlorothiazide 
was infused between the two vertical arrows.
Time interval (lowest trace) = 30 seconds.
Fig. 89
Tracing a*
Tracing b. 
Tracing c.
Effect of a single dose of 200 t t \ s #  per k g .  of chloro­
thiazide upon the pressor responses to adrenaline (Ad, 
upper record) and the response of the nictitating mem­
brane to adrenaline (lower record).
All responses are due to 20 pg. per kg. adrenaline (Ad). 
Chlorothiazide was given as a single intravenous injection 
between (a) and (b).
40 minutes after the injection of the drug.
65 minutes after the injection of the drug.
All drugs given intravenously.
Time interval (lowest trace) = 30 seconds.
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dose of 150 to 200 mg. per kg.). This effect was reversible after 
about 3 to 5 hours (Fig. 87,page 270).
Following the infusion of chlorothiazide (total dose of 100 to 
200 mg. per kg.) the pressor response due to the stimulation of the 
central end of the vagus nerve was not modified (Fig. 88, page 271)*
Single intravenous injections of chlorothiazide in dose levels of 100 
to 200 mg. per kg. did not reduce the responses of the blood pressure 
and nictitating membrane to high doses of adrenaline (10 to 20 pg. per 
kg.) and also had no effect on the responses of the nictitating membrane 
to electrical stimulation of preganglionic sympathetic fibres (Fig. 89, 
page 272).
Blood pressure of the anaesthetised rat.
Chlorothiazide in dose levels of from 5 to 10 mg. when injected 
intravenously into the femoral vein of the rat had no effect on the 
blood pressure but after 15 to 20 minutes reduced the responses of the
'n
blood pressure to adrenaline 1 pg. and noradrenaline 1 pg. (^ig* 90, 
page 275).
Isolated perfused hindquarters of the rat.
No vasodilatation was observed following the infusion of 5 to 20 mg. 
of chlorothiazide over a period of 5 to 10 minutes. There was a 
slight reduction observed in the constrictor responses to adrenaline 
1 jig. and noradrenaline 1 ^ ig. but only when chlorothiazide was given 
in large doses, i.e., 10 to 20 mg. (Fig.91, page 276). Responses to 
the /
274
the injection of 1 to 5 pg# of 5-hydroxytxyptamine were not modified 
(Fig. 92, page 277).
Isolated strips of horse carotid artery*
Chlorothiazide in doses of 0*125 to 1 mg. per ml* reduced the 
responses of arterial strips to acetylcholine 0 .1 to 1 pg* per ml.
(Fig*93, page 278), adrenaline 0.2 to 1 pg* per ml. (Fig.94, page 279), 
noradrenaline from 0.2 to 2 pg. per ml. (Fig.95, page 280) and 5- 
hydroxytiyptamine 0.5 pg. par ml. (Fig.96, page 281). Hydrochloro­
thiazide 1 mg. per ml. reduced the responses to noradrenaline and 
adrenaline, 0.2 to 2 pg. per ml.
Isolated perfused rabbit heart.
Chlorothiazide in doses of from 1 to 10 mg. had no effect on the 
tone, rate, amplitude and outflow of the rabbit heart (Fig.97, page282). 
Hydrochlorothiazide 0.5 to 2 mg. also showed no effect (Fig. 98, 
page 283)# .
Isolated guinea pig auricles.
Chlorothiazide 0.1 to 0.2 mg. per ml. and hydrochlorothiazide 0.1 
to 0.2 mg. per ml. did not influence the rate and amplitude of the 
contractions (Fig.99, page 284). When large doses of the order of 
1 to 2 mg* per ml. of chlorothiazide were used a transient depressant 
effect on the normal contractions was noticed (Fig.100, page 285). No 
antagonism of responses to adrenaline 0.1 to 1 pg. per ml. and nor­
adrenaline 0.1 to 1 pg. per ml. was observed.
Isolated strips of rabbit duodenum.
No /
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Effect of perfusion of the isolated rat hindquarters with a solution 
of 2 mg. per ml. of chlorothiazide for 5 minutes on the response to 
adrenaline (Ad) and noradrenaline (NA).
At Ad, 1 pg# of adrenaline injected into the cannula.
At NA, 1 pg. of noradrenaline injected into the cannula.
Time interval (lower trace) = 30 seconds.
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gig- 92.
Effect of injecting 5 nig. and 10 mg. of chlorothiazide on the responses 
of the isolated perfused rat hindquarters to 5-hydroxytryptamine (HT).
At HT, 1 fig. 5-hydroxy tiyptamine injected into the cannula.
Time interval (lower trace) = 30 seconds.
Effect of 0.5 nig. per ml. of hydrochlorothiazide (HCT) and 0.25 
per ml. of chlorothiazide (CT) on the response to acetylcholine (A) 
of an isolated strip of horse carotid artery.
All contractions are due to 0.1 pg. per ml. of acetylcholine (A). 
Time interval (lower trace) = 30 seconds.
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Effect of 0*2 mg. per ml* of chlorothiazide (CT) on the response 
to adrenaline (Ad) of an isolated strip of horse carotid arteiy*
All contractions are due to 0.1 pg. per ml. of adrenaline (Ad).
Time interval (lower trace) = 30 seconds.
Effect of chlorothiazide (CT) and hydrochlorothiazide (HCT) on the 
response to noradrenaline (NA) of isolated strips of horse carotid 
artery.
All contractions are due to 0.1 jug. per ml. of noradrenaline.
Time interval (lower trace) = 30 seconds.
Fig. 95.
Effect of 0.25 mg. per ml. of chlorothiazide (CT) on the response 
to 5-hydroxy tryptamine of an isolated strip of horse carotid arteiy.
All contractions are due to 0.5 )ug. per ml. of 5-hydroxytryptamine.
Time interval (lower trace) = 30 seconds.
Effect of 2 mg, of chlorothiazide upon the amplitude and rate (upper 
record) and outflow (lower record) of the isolated perfused rabbit 
heart.
At C, control solution injected into the cannula.
The heart rate is indicated above the upper tracing.
Time interval (lowest trace) = 30 seconds.
At C, control solution injected into the cannula.
Time interval (lower trace) = 30 seconds.
Effect of a single dose of 250 pg. of hydrochlorothiazide (HOT)
upon the amplitude and tone of the isolated perfused rabbit heart.
284.
Fig. 99.
Effect of 0.5 mg* per ml. of chlorothiazide (CT) on the response 
of the isolated guinea pig auricles to adrenaline (Ad) and 
noradrenaline (NA).
At Ad, adrenaline, 0.1 pg. per ml.
At NA, noradrenaline, 0.1 jug. per ml.
Time interval (lower trace) = 30 seconds.
Fig. 100.
Effect of 1 mg. per ml. of chlorothiazide (CT) upon 
amplitude and tone of the isolated guinea pig auricles.
At C, control solution added to the hath.
Time interval (lower trace) = 30 seconds.
Effect of hydrochlorothiazide (HCT) and chlorothiazide (CT) on the 
peristaltic movements and tone of the isolated rabbit duodenum.
At C, control solution added to the bath.
At HCT, 10 mg. of hydrochlorothiazide added to the bath.
At CT, 10 mg. of chlorothiazide added to the bath.
Time interval (lower trace) = 30 seconds.
287.
Fig. 102.
Effect of 2 mg. per ml. of hydrochlorothiazide (HCT) and 2 mg. per
ml. of chlorothiazide (CT) on the responses of the guinea pig ileum
to acetylcholine (A).
All contractions are due to 0.1 p.g« per ml. of acetylcholine.
Time interval (lower trace) = 30 seconds.
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No effect was observed on the rhythmic activity of the rabbit 
duodenum following doses of 0.5 to 1 mg. per ml. of chlorothiazide. 
Hydrochlorothiazide 0.1 to 1 mg. per ml. increased the tone of the gut 
and decreased the rhythmic activity of the duodenum (Fig. 101, page 286). 
Isolated strips of guinea pig ileum.
Chlorothiazide from 1 to 2 mg. per ml. and hydrochlorothiazide 
0.1 to 1 mg. per ml. increased the response to acetylcholine and also 
increased the tone of the gut. No antagonism was observed to responses 
elicited by acetylcholine 0.1 to 1 pg. per ml., 5-hydroxytxyptamine 1 
to 5 pg* per ml., histamine 0.01 to 1 pg. per ml. and barium chloride 
0.15 to 0.25 pg* per ml. (Fig. 102, page 287).
Uptake of sodium-24.
(a) Isolated strips of rabbit thoracic aorta.
Chlorothiazide in dose levels of 1 to 2 mg. per ml. depressed
uptake of sodium-24 in the sections of rabbit thoracic aorta. The 
depression in the uptake of sodium-24 was very significant (P = 0.001) 
as compared to that of the control experiments (Fig. 103, page 289,
Table 10, page 298).
(b) Isolated frog sartorius muscle.
Chlorothiazide in dose levels of 1 to 2 mg. per ml. depressed 
(P = 0.05) uptake of sodium-24 in the isolated frog sartorius muscle 
(Pig. 1.04, page 290, Table 10, page 298). The depression in the uptake 
of sodium-24 in this tissue was not as significant as that observed in
the /
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the isolated strips of rabbit aorta.
Efflux of sodium-24*
There was no apparent increase in the efflux of sodium-24 from 
the isolated strips of rabbit thoracic aorta (Pig* 105, page 292,
Table 13, page 301) and from the isolated frog sartorius muscle.
Uptake of potassium-42.
There was no observable effect on the uptake of potassium-42 in 
the isolated strips of rabbit thoracic aorta (Pig* 106, page 293,
Table 11, page 299) or in the isolated frog sartorius muscle (Pig* 107, 
page 294, Table 11, page 299)*
Efflux of potassium-42.
Chlorothiazide in dose levels of 1 to 2 mg. per ml* did not cause 
release of potassium-42 from the isolated strips of rabbit aorta 
(Pig. 108, page 295, Table 12, page 300) and from the isolated frog 
sartorius muscle*
Experiments on the adenosinetrlphosphatase activity 
of rat skeletal muscle.
Chlorothiazide in dose levels of 1 to 2 mg* per ml* did not 
modify the adenosinetriphosphatase activity of a suspension of rat 
hind leg muscles (Pig. 110, page 297, Table 14, page 302).
T i m e  i n  m i n u t e s
Fig. 105
Effect of chlorothiazide 1 mg. per ml. (CT) on the release of
sodium-24 from isolated strips of rahhit aorta. The vertical
arrows indicate the points of exposure of the test muscle to the drug.
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Fig, 106,
Uptake of potassium-42 by isolated strips of rabbit aorta.
The vertical bars signify the standard deviation of the mean.
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Uptake of potassium-42 by the isolated frog sartorius muscle
The vertical bars signify the standard deviation of the mean
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Effect of chlorothiazide 2 mg, per ml, (CT) on the release of 
potassium-42 from isolated strips of rahbit aorta. The vertical 
arrows indicate the points of exposure of the test muscle to the drug.
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Fig. 109*
Effect of chlorothiazide 1 mg* per ml. (CT) on the release of 
potassium-42 from isolated frog sartorius muscle. The vertical arrows 
indicate the points of exposure of the test muscle to the drug.
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304
C H A P T E R  i n  
Discussion
Among all the many synthetic and natural substances which produce 
a fall in the blood pressure level of normotensive animals there are few 
which induce hypotension of a sufficiently specific type to justify their 
therapeutic use as antihypertensive agents« Since the ability to 
produce a fall in blood pressure is an insufficient criterion in itself 
for the choice of an antihypertensive agent, the purpose of making a 
pharmacological analysis of the general, and especially of the oirculatoxy 
properties, of hypotensive drugs is to bring out those characteristics 
which may indicate the mode of its antihypertensive action* To do this 
it is necessary to correlate the results obtained by different groups of 
workers*
Chlorothiazide does not produce a fall in the arterial blood pressure 
level of the normotensive anaesthetised oat* This has been confirmed by 
a number of workers using other animal species, including the dog and the 
rabbit (Preziosi, Bianchi, Loscalzo and Schaepdxyver, 1 9 3 9  and Preziosi, 
Schaepdryver, Marmo and Miele, 1 9 6 1 ) *  It is also interesting to note 
that chlorothiazide does not reduce the arterial blood pressure level in 
normotensive human subjects, although it exhibits saluretic actions to 
the same extent as in hypertensive subjects (Preis, 1939)* The absence 
of a hypotensive action in normotensive individuals may be due to the 
existence /
existence of a vascular compensatory mechanism which appears to be 
lacking in hypertension (Wilson and Freis, 1959).
The pharmacological studies of Preziosi, Marmo and Miele (1961) 
have revealed that chlorothiazide and hydrochlorothiazide potentiate 
the antihypertensive effects of reserpine in the anaesthetised cat. 
Clinically it is well established that chlorothiazide potentiates the 
antihypertensive actions of ganglion-blocking agents (Tapia, Dustan, 
Schneckloth, Corcoran and Page, 1957) aud other antihypertensive agents 
including reserpine, hydrallazine and the Veratrum alkaloids (Moser and 
Macaulay, 1959 and Smirk, McQueen and Morrison, i960). It has also 
been shown to potentiate the reduction of the blood pressure level 
produced by sympathectomy and adrenalectomy (Sellers, Barends, G-oldman, 
Lindauer and Jeffers, 1958) and that due to a restricted intake of sodium.
Clinical data published in 1958 suggested that chlorothiazide could 
on its own reduce the blood pressure level in a proportion of hyper­
tensive individuals (Wilkins, Hollander and Chobanian, 1958 and Freis, 
Yfanko, Wilson and Parrish, 1958). These early observations were con­
firmed by Hall and Owen (1959) and Juel-Jensen and Pears (i960) who 
presented the results of a double blind trial of the effects of chloro­
thiazide used both alone and together with ganglion-blocking drugs in 
the treatment of hypertension. It was found that chlorothiazide was 
camble of producing a significant fall in the blood pressure level of 
5 Jut of 15 hypertensive patients when given in doses of 250 mg. three 
tines /
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times daily for a period of 6 weeks.
The mechanism by which chlorothiazide exerts its antihypertensive 
action has been disputed. As already mentioned (Chapter I), suggestions 
for possible mechanisms of action have been put forward by a number of 
groups of workers and these will be taken up at appropriate points in 
the discussion which follows.
A fall in the plasma volume following the administration of chloro­
thiazide was independently observed by Tapia, Dustan, Schneckloth, Cor­
coran and Page (1957) and Freis, Wanko, Wilson and Parrish (1958) and was 
confirmed by the investigations of Dustan, Cumming, Corcoran and Page 
(1959) aud Macleod, Dustan and Page (i960). Nine patients were given 
1 g. of chlorothiazide twice daily for a period of from 4 to 6 days.
The cardiac output was decreased in 6 out of the 9 patients and there 
was a simultaneous fall in the blood pressure level. A consistent 
decrease in the plasma volume with an increase in the peripheral resis­
tance was also observed. To explore the possibility that the decrease in 
cardiac output was due to a reduction in plasma volume one patient was 
given 300 ml. of dextran solution intravenously in the form of a slow 
infusion. This procedure increased the cardiac output and blood pressure 
levels, together with a reduction in the total peripheral resistance.
An increased sensitivity to the depressor effects of tetra-ethylammonium 
chloride was also observed following chlorothiazide administration. On 
the basis of the above observations Dustan, Cumming, Corcoran and Page
(1959) /
(1959) postulated that oligaemia with increased vasomotor activity was 
the primaiy mechanism by which chlorothiazide potentiated the action of 
antihypertensive agents such as reserpine and ganglion-blocking drugs* 
Crosley, Castillo, Freeman, White and Rowe (1958) also found that the 
hypotensive response to chlorothiazide was associated with a decrease in 
the pressure in the right heart and a fall in cardiac output* The normal 
arterial blood pressure is the product of the cardiac output and the 
peripheral resistance; a decrease in one without a compensatory increase 
in the other faotor will result in a fall in the blood pressure level*
It seems probable that the depletion of the plasma volume and shrinkage 
of the extracellular space, secondary to the loss of interstitial fluid, 
cause a fall in the filling pressure of the right heart*
Unlike Dustan, Cumming , Corcoran and Page (1959) > Wilson and Freis 
(1959) and L&uwers and Conway (i960) did not find a reduction in the 
plasma volume during long term therapy with chlorothiazide* The period 
of their clinical investigations extended from 26 days to one year* A 
partial explanation for this difference resides in the fact that the 
studies of Dustan and her associates (1959) were performed on patients 
who were treated for a period of less than 8 days* This reduction of 
plasma volume in the short term studies was also confirmed in I960 by 
Conway and Lauwers* A significant reduction in the plasma volume of 
non-oedematous hypertensive subjects following a period of from 3 to 8 
days of chlorothiazide therapy was also observed by Wilson and Freis
(1959), /
(1959), whereas the same was not true in patients treated for a period 
of one year.
If it is true that the reduction of the arterial blood pressure is 
associated with a fall in the cardiac output, which is dependent on the 
reduction of plasma volume, then restoration of the latter should return 
the blood pressure level to pre-treatment values. The effect of 
re-expansion of the plasma volume was determined by Wilson and Freis 
(1959) on patients who had been under continuous treatment with chloro­
thiazide for periods of two weeks to three months and who had shown a 
fall in the blood pressure. The administration to these patients of 
300 ml. of 6 per cent dextran solution in isotonic saline resulted in 
an immediate rise in the blood pressure level. In order to determine 
whether the sodium ion was important in the reversal of the hypotensive 
effect of chlorothiazide, an infusion of dextran in 3 Por cent glucose 
was given. A significant rise in blood pressure to the pre-treatment 
level was still observed. A further attempt to determine the factors 
responsible for the haemodynamic changes was made by Wilson and Freis 
(1959) and Conway and Lauwers (i960). These workers investigated the 
relationship between the boty fluids and exchangeable sodium and other 
electrolytes following long term therapy with chlorothiazide. Following 
a period of control observations in patients, 500 mg. of chlorothiazide 
was given 3 times daily. During the first 48 hours a loss of sodium 
and chloride over and above the level of the intake occurred together 
with /
with a considerably less degree of potassium loss. The initial 
saluretic response gradually became less but the loss of the sodium and 
chloride was maintained. Serum concentrations of sodium and chloride 
did not change significantly and the potassium concentrations of the 
serum fell to a moderate extent. This reduotion in serum potassium 
tended to increase when treatment was continued for a period of months. 
Since the serum concentration of sodium did not change significantly it 
was assumed that the extent of the sodium loss could be accounted for by 
depletion of the extracellular fluid volume. Wilson and Freis (1939) 
postulated that reductions in the plasma and extracellular fluid volumes 
in the early phase of chlorothiazide treatment were the factors causing 
the fall in blood pressure.
As alreacty' described Lauwers and Conway (i960) could find no 
significant changes in extracellular fluid or plasma volume but recorded 
a fall in bocfcr weight in almost evexy patient under treatment with 
chlorothiazide. They attributed this to a reduction in the total body 
water. On the basis of these observations it was concluded that the 
fluid loss was from the intracellular compartment of the body. Although 
the reduction in intracellular fluid following the administration of 
chlorothiazide may have been directly induced by the drug, it could 
also be a secondary effect due to vascular dehydration of another kind. 
Potassium depletion oould be responsible for this change as it is known 
to ooour during chlorothiazide therapy, (Wilkins, Hollander and 
Chobanian, /
310
Chobanian, 1958), It is also reported (Black and Milne, 1952) that a 
low potassium diet may reduce blood pressure levels in experimental 
animals and man (Perera, 1953)*
Aleksandrow, Wysznacka and Gajewski (1959) suggested that the anti­
hypertensive aotion of chlorothiazide was due mainly to its natriuretic 
effects They observed a reduction in the peripheral resistance, 
without a significant fall in the cardiac output* The peripheral 
resistance was lowered soon after the onset of the natriuresis and 
disappeared when the stores of the body sodium were restored to normal 
after the withdrawal of the drug*
It has long been known that a low sodium intake or the increased 
elimination of sodium from the boty enhances the effectiveness of 
various antihypertensive agents* In 1948, Stead, Reiser, Rapaport and 
Ferris observed that when the blood pressure level was reduced following 
the administration of a test dose of tetraethylammonium, a further 
decrease could be obtained by placing the patient on a low salt diet* 
Freis (1948) observed that adequate salt restriction augmented the 
hypotensive response to surgical sympathectomy or to antihypertensive 
agents such as the Veratrum alkaloids*
The role played by the sodium ion in hypertension is undoubtedly 
important, although it is not very clearly defined. Dahl and Love 
(1957) found that a close relationship existed between the incidence of 
hypertension and higher levels of sodium intake* It is also interesting 
to /
to note that early observations made by a number of workers (Eichel- 
berger, 1943J Laramore and G-rollman, 1950 and Ledingham, 1953) have 
shown that there is a rise in the extracellular water and sodium levels 
in animals in which renal hypertension was produced experimentally. 
Laramore and G-rollman (1950) observed that when experimental renal hyper­
tensive rats were compared with normal animals the sodium and water con­
tent of all the tissues were greatly increased and the potassium content 
was decreased. On the other hand, Ledingham (1953) using inulin to 
estimate the volume of the extracellular fluid, has demonstrated an 
increase in the total extracellular fluid during the early stages of 
experimental renal hypertension. After a period of three months, 
despite the persistence of the hypertension, the extracellular fluid 
volume tended to return to a normal level. There is also evidence that 
the sodium and potassium content of aortic tissues was significantly 
increased in rats in which experimental renal and desoxycorticosterone 
hypertension was induced (Tobian and Binion, 1954)* In similar experi­
ments Tobian (1956) noticed that the smooth muscle cells in the wall of 
the rat aorta contained more water, sodium, potassium, magnesium and 
phosphorus per unit cell solids in the hypertensive than in the normo­
tensive rat. He also observed that when the blood pressure level 
dropped to normal as a result of the low sodium diet, the sodium, pot­
assium and phosphoius levels also returned to normal. These findings 
indicated that changes of this kind in the electrolyte content of 
arterial smooth muscle cells may be associated with renal hypertension.
Intracellular /
Intracellular ooncentratlona of sodium and potassium ions in the 
rat aorta were found to be increased in desojqrcorticosterone hypertension, 
adrenal regeneration hypertension and in the elevation of the blood 
pressure level which persisted after the excision of the ischaemic kidney 
(Tobian and Redleaf, 1938). Further, an elevation of the potassium 
content of the aorta in renal hypertensive rats was observed by Freed, 
George and Rosenman (1959) * who noted a fall in the blood pressure level 
following potassium deprivation. This was followed by a proportional 
decrease in the potassium content of the aorta. Return of the blood 
pressure level to earlier values following administration of cortisone 
was associated with a return of the potassium content of the aorta to 
the elevated levels. These authors suggested that the arterial 
potassium content may also influence arterial tone and by altering 
peripheral resistance may be a significant factor in the regulation of 
the arterial blood pressure level.
It is possible to assume that in hypertension there may exist some 
derangement in the electrolyte metabolism of the cell but whether this 
is the cause or the result of the elevated blood pressure level is not, 
however, clear. Chlorothiazide, through its effeots upon electrolyte 
excretion, may correot this deranged balance of the cellular electrolytes.
On the other hand, Heider, Dennis and Hoyer (1958) and Wilkins, 
Hollander and Chobanian (1958) while agreeing that sodium loss may play 
an important role in the reduction of the blood pressure level by 
chlorothiazide, /
chlorothiazide, suggested that it might not be the only factor involved 
in. the continued hypotensive response to chronic oral therapy with this 
drug. They based their conclusion on the following findings. Firstly, 
af^ ter the therapeutic use of chlorothiazide over a period of four weeks, 
they were unable to find significant changes in extracellular fluid 
volume or in total body sodium and potassium. Secondly, in splanchnic- 
ectomised patients or in those treated with ganglion-blocking drugs, the 
oral or intravenous administration of chlorothiazide frequently resulted 
in a hypotensive response within a few hours, i.e., before any considerable 
loss of sodium or body fluids had occurred. Thirdly, oral or intravenous 
administration of hydrochlorothiazide produced a marked reduction in the 
blood pressure level of hypertensive patients. Administration of the 
steroidal antagonist (3-(3-oxo-17-hydrozy-19-hor-4“androsten-17CL-yl) to 
patients who had already responded to chlorothiazide, produced further 
losses of body sodium associated with a decrease in blood pressure levels.
Hollander, Chobanian and Wilkins (1959) postulated that chloro­
thiazide may reduce the blood pressure by inhibiting the formation of 
some pressor agent such as renin and also by interfering with the salt- 
retaining action of aldosterone. The observation that when chloro­
thiazide was given to sympathectomised patients and those receiving 
ganglion-blocking drugs ptproduced a hypotensive response before any 
significant saluresis occurred could be explained by the fact that the 
blood pressure of the patients with impaired sympathetic vasoconstrictor 
reflexes /
314.
reflexes responds even to small degrees of blood loss (Freis, Stanton, 
Finnerty, Schnaper, Johnson, Hath and Wilkins, 1931).
The arterial blood pressure of normotensive subjects does not change 
following the administration of chlorothiazide and yet the same reduction 
of plasma volume and extracellular fluid space is induced (Wanko and 
~ Freis, 1933)* The vascular responsiveness to pressor and depressor 
stimuli is, however, considerably altered (Merrill, Guimard — Baldo and 
Giordano, 1933)* Wanko and Freis observed that the hypertensive 
response to a given rate of infusion of noradrenaline was reduced when 
compared with that before the administration of chlorothiazide, An 
increase in the hypotensive response to trimetaphan camphor sulphonate 
following the use of chlorothiazide was also observed. They suggested 
that although the arterial blood pressure in normotensive subjects 
remains unaltered following the use of chlorothiazide, their cardio­
vascular response becomes less reactive to pressor stimuli and more 
responsive to depressor agents.
As already indicated, chlorothiazide depresses the hypertensive 
response to injection of adrenaline in the cat and to both adrenaline 
and noradrenaline in the rat, but in the dog it has been reported to 
depress the pressor responses to adrenaline and noradrenaline (Beavers 
and Blaekmore, 1958), Bock and Gross (i960) have demonstrated that 
when hydrochlorothiazide was given orally to dogs over a period of one 
week it depressed the pressor responses to adrenaline and noradrenaline* 
It is /
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It is possible that chlorothiazide, by altering the electrolyte compo­
sition of arterial smooth muscle, depresses the vascular reactivity to 
circulating pressor agents. The fact that salt restriction has the 
same effect on these responses supports this view.
The pressor effect of desoxyoorticosterone acetate is enhanced by 
sodium intake and reduced or abolished by sodium withdrawal (Knowlton, 
Loeb, Stoerkand Seegal, 1947, Gross, 1950 and Stamler, Pick and Katz, 
1951)* It is also known that the pressor effects of injected or infused 
noradrenaline in man are potentiated by the pre-administration of 
desozycorticosterone• In adrenalectomised animals, however, the hyper­
tensive responses to injections of adrenaline and noradrenaline were 
lowered when compared with those of normal dogs (Humphreys and Lepeschkin, 
1950). These observations indicate that the activity of the adrenal 
cortex by virtue of its influence on electrolyte balance may be an 
important factor in determining the degree of cardiovascular responsive­
ness to adrenaline and noradrenaline. It was also pointed out that the 
pressor effect of deso^cortioosterone may be due to an inore&se in the 
vascular reactivity to the actions of intrinsic catecholamines which 
resulted from intracellular deposition of sodium. When given to hyper­
tensive patients the pressor effects of adrenaline and noradrenaline are 
significantly diminished or abolished by a sodium-free diet (Raab, 
Humphreys, Makous, De Grandpre and Gigee, 1952). It was observed by 
these authors that during sodium withdrawal, desoxycorticosterone failed 
to /
to increase the pressor effects of adrenaline and noradrenaline.
These observations indicate that the presence of a certain concentration 
of sodium in the arteriolar smooth muscle cell is necessary to maintain 
the vascular responsiveness to circulating pressor agents. The relation 
which exists between vascular reactivity and exchange of sodium and 
potassium and other free ions in the vascular smooth muscle cell is not 
clear.
The mechanism by which the electrolytes pass through the living 
cell membrane is of extreme importance in the physiological function of 
these ions. There is no evidence for the assumption that the aotivity 
of vascular smooth muscle, like that of the cells of skeletal muscle or 
nerve oells, is accompanied by an exchange of potassium and sodium 
during depolarization and repolarization.
In order to estimate the importance of the sodium ion concentration 
in cellular activity, a short account of the role of sodium ion in the 
living cell will be given.
It is an established fact that nerve fibres become inexoitable 
when the sodium concentration of the medium is less than one tenth of 
that of Ringer^ solution, isotonicity being maintained with glucose or 
sucrose. This fact has been demonstrated in the case of the Loligo 
giant axon (Webb and Young, 1940, and Hodgkin and Katz, 1949), Sepia 
giant axon (Keynes, 1951), Carcinus nerve (Katz, 1947), frog medullated 
nerve (Feng and Liu, 1949, and Huxley and Stampfli, 1951). In most 
oases /
cases conduction block occurs when the sodium in the outside medium is 
replaced by an inert, non-penetrating cation, for example, choline,
Overton in 1902 and 1904 demonstrated that musoles were paralysed 
in the absence of sodium ions even if the osmotic pressure of the medium 
was maintained by the addition of an indifferent non-eleotrolyte such as 
sucrose. This paralysis was fully reversible when sodium was added to 
the medium. The concentration of sodium at which paralysis is complete 
varies from one species to another. Frog muscle loses excitability at 
about 12 mM. of sodium per litre (Teugner, Siebert and G-ottstein, 1933)* 
According to Magee and Reid (1927), lowering of the sodium chloride 
concentration below 0,6 per cent reduces the size of contractions in 
the isolated intestine of the rabbit and ultimately almost abolishes 
them, Streeten (1930) found that guinea pig and human intestine were 
even more sensitive to a reduction in the sodium chloride level than 
was the rabbit gut. Clinical observations have indicated a dose 
correlation between a low sodium chloride concentration in the plasma 
and paralytic ileus (Streeten, 1930, and Marriott, 1947). It was also 
observed that in salt-depleted subjects, water absorption was delayed 
due to gastrointestinal atonia. Streeten and Vaughan Williams (1932) 
studied the effects of sodium chloride depletion upon the rate of 
propulsion of intestinal fluid in the dog. Sodium chloride depletion 
was brought about by intraperitoneal infusions of 4*5 por cent dextrose 
solution containing appropriate amounts of potassium, calcium, 
magnesium /
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magnesium and phosphate Ions* This treatment caused an Initial rise 
in the rate of intestinal propulsion but was soon followed by a marked 
reduction and ultimately by total paralysis of peristalsis * In some 
oases, the intestinal loop became completely toneless. It is of 
interest that the elasticity of the skin was also markedly impaired, 
indicating loss of tone in the plain muscle of the skin. The paralysis 
of intestinal peristalsis could be reversed within one minute by the 
injection of hypertonic sodium chloride solution. Streeten and Vaughan 
Williams suggested that the reduced level of sodium chloride in the 
blood induced a loss of potassium from the musole fibre, which was 
suggested to be the ultimate cause of the paralysis.
The hypothesis advanced by Hodgkin and Katz (1949) implies that a 
lowering of the membrane potential has two effects. One is a rapid and 
transient increase in sodium permeability and the other, a delayed but 
prolonged increase of potassium permeability. Both of these effects 
are assumed to be reversible in the sense that repolarisation restores 
the permeabilities to their original values. Fatt and Katz (1951) 
observed that the depolarising effect of the transmitter-acetyloholine 
led to a change of the potential across the muscle cell membrane.
This was responsible for the initiation of the propagated muscle action 
potential which produced muscular contraction. Subsequent observations 
by Hodgkin (1951) revealed that in nerve, the action potential depended 
upon a rapid sequence of changes in the permeability to sodium and 
potassium /
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potassium ions* The resting membrane was found to be moderately 
permeable to potassium ions and sparingly permeable to sodium ions* A 
large but transient increase in the permeability to sodium ions ooourred 
when the fibre was depolarised* Sodium ions, therefore, entered the 
fibre at a high rate and reversed the potential difference across the 
cell membrane* This increase in permeability to sodium ions was 
followed by a similar rise in permeability to potassium ions* Entry of 
sodium ion was approximately balanced by the leakage of a corresponding 
quantity of potassium ions* It has been suggested that the sodium ion 
enters the fibre during the rising phase of the action potential and the 
potassium ion leaves during the falling phase* The entxy of sodium ions 
and the exit of potassium ions provides an immediate source of energy for 
the propagation of the impulse*
The relation which exists between the action potential and the 
external sodium concentration has been studied by Hodgkin and Katz (1949) 
for the giant axon of the squid and they postulated that the rise in the 
action potential of the cell should be determined by the rate at which 
the membrane eapaoity was discharged by the entxy of sodium into the oell* 
In their experiments Hodgkin and Katz (1949) found that the rate of rise 
of the action potential was roughly proportional to the external sodium 
concentration* It is of interest to note that the falling phase of the 
action potential, during which the fibre is supposed to be vexy slightly 
permeable to sodium, is much less affected by the external sodium con­
centration.
If /
If it is assumed that in hypertension a state of partial depolar­
ization of the muscle cell membrane of the arteriolar smooth muscle is 
present, then it is possible that salt restriction or a lowering of the 
external sodium concentration may interfere with the activity of the 
vascular smooth muscle cells. This view is based on the fact that 
normal activity (action potential or initiation of impulse) is accom­
panied by the increased uptake of sodium by the cell.
A fall in the plasma concentration of sodium and a rise in the plasma 
potassium level was associated with a marked elevation of the blood 
pressure level, when a generalised vasoconstriction was produced by the 
administration of noradrenaline in the dog (Muirhead, Goth and Jones, 
1 9 5 4 -) . Tobian and Fox ( 1 9 5 6 )  have reported that noradrenaline infusions 
decreased the potassium content of the dog femoral artery and in some 
cases elevated its sodium content. On the other hand, the sodium con­
centration of the rat aorta was not altered, whereas its potassium content 
was markedly reduced under the influence of noradrenaline (Daniel, Dawkins 
and Hunt, 1 9 5 7 ) .  It is possible that noradrenaline, by affecting the ' 
membrane of the smooth muscle cell, allows a loss of potassium and a gain 
of sodium ions. Since adrenaline and noradrenaline can induce a con­
traction of arterial smooth muscle, (Furchgott and Bhadrakom, 1 9 5 3 )  it is 
possible that electrolyte shifts take place as a result of the change in 
the membrane potential. Chlorothiazide, by causing sodium depletion, may 
interfere in the normal function of the cell and depress the vascular 
reactivity /
reaotivity to pressor agents.
It has been shown (Chapter 2, page 270) that the magnitude of the 
pressor response due to baroreceptor stimulation and that which follows 
bilateral ocelusion of the common carotid arteries in the oat is also 
slightly reduced following the administration of large doses of chloro­
thiazide. This effect was not seen hy Preziosi, Bianchi, Loscalzo and 
Schaepdiyver (1959)* It has been postulated (Heymans, 1954) that drugs 
which cause the muscular walls of the carotid sinuses to contract, increase 
their intrinsic tone and decrease their distensibility, thus stimulating 
the receptors at the endings of the carotid sinus nerves. This stimu­
lation reflexly reduces the arterial blood pressure and decreases the 
hypertension normally produced by a decrease of the carotid sinus blood 
pressure. The pressor response which follows stimulation of the central 
end of the vagus is in part due to reflex adrenergic vasoconstriction and 
perhaps also due to stimulation of carotid body chemoreceptors following 
reflex hypoxia and the reflex is mediated through the higher centres of 
the brain. The fact that adrenergic blocking agents and ganglion 
blocking agents depress these reflex pressor responses supports this view. 
The observations that chlorothiazide does not modify the pressor responses 
to eleotrical stimulation of the cut oentral end of the vagus and that it 
has no ganglion blocking activity are in agreement with the observations 
of Preziosi, Bianchi, Loscalzo and Schaepdiyver (1959) la the dog.
There is no modification of the rhythmic activity of preparations of 
isolated /
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isolated heart following the injection of chlorothiazide, except for a 
slight reversible depression seen when large doses are used* The 
responses of the isolated guinea pig auricles to adrenaline and nor­
adrenaline are not modified by chlorothiazide* These observations con­
firm the findings of Preziosi and his assooiates (1939)*
No direct vasodilator effect was observed on the isolated hindquarters 
of the rat, following perfusion of chlorothiazide even when the drug was 
used at high dose levels. A slight deorease in the constrictor responses 
to adrenaline and noradrenaline was noted. In the isolated hindquarters 
preparation of the rat, it is perhaps to be expected that little, if any, 
neurogenic vascular tone should remain so that in these circumstances, 
little or no vasodilatation would be expected*
In experiments performed on isolated strips of horse carotid arteiy, 
chlorothiazide had no direct relaxant effect, but markedly depressed the 
contractions of arterial strips elicited by adrenaline, noradrenaline, 
5-hydroxytxyptamine and acetylcholine# No direct depressant effect or 
antagonism to sp&smogens was observed in other smooth muscle preparations, 
such as the guinea pig ileum or rabbit duodenum. These observations do 
not agree with the findings of Preziosi and his associates (1959) who 
founl some depressant effect on the Isolated guinea pig and rabbit colon 
follswing the use of chlorothiazide* Since chlorothiazide does not 
modify the normal tone of intestinal smooth muscle, it is quite probable 
that it may have some specific action on arterial smooth muscle* The 
observation /
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observation that chlorothiazide significantly depresses the uptake of 
sodium-2 4 in isolated strips of rabbit aorta may cast some light upon the 
link which may exist between the electrolyte metabolism of the cell and 
hypertension.
The mechanism by which chlorothiazide depresses the uptake of sodium 
by the muscle cell is not clear. Investigation of the influence of 
chlorothiazide on adenosine triphosphatase activity has not demonstrated 
any measurable effect upon the activity of this enzyme. It is possible 
that a common mechanism is involved in the movement of sodium ions across 
the tubular cell of the kidney and across the wall of the arteriolar 
smooth muscle cell. Chlorothiazide may depress the movements of the 
sodium ion by affecting this mechanism. The lesser effect on sodium-24 
uptake observed on the sartorius muscle of the frog may indicate that the 
action of chlorothiazide on the arterial smooth muscle is relatively 
specific in nature.
From the data presented above it is not possible to suggest a single 
mechanism which can account for all the effects of chlorothiazide on the 
cardiovascular system of animals and in preparations of isolated tissues 
and organs.
The highly specific depression of sodium uptake by strips of aorta 
tends to confirm the views of Aleksandrow, Wysznacka and G-ajewski (1959), 
that chlorothiazide reduces the sodium content of the artery wall by 
depressing sodium uptake from the plasma and extracellular fluid and that 
this /
this contributes to its antihypertensive activity. A fall of sodium 
content may also reduce the water content of the arterial wall (Lauwers 
and Conway, I960) and reduce the swelling or oedema (Redleaf and Tobian, 
1958), if this is present. This reduction in the thickness of the 
artery wall will lower the peripheral resistance which in turn leads to 
a fall in the arterial blood pressure.
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SUMMARY OP PART I (h).
In the introductory chapter, a review of the literature upon the 
pharmacology of chlorothiazide, hydrochlorothiazide and flumethiazide, 
together with a short historical account of the discovery and mode of 
diuretic action of sulphonamide derivatives are presented.
In Chapter II, the experimental techniques used in the investi­
gation of the general pharmacological properties of chlorothiazide, 
hydrochlorothiazide and flumethiazide, and the results of this investi­
gation are described. Chlorothiazide did not produce an observable 
fall in the blood pressure level of the normotensive anaesthetised oat 
or rat. A slight inhibition of the hypertensive response to adrenaline 
in the cat and to adrenaline and noradrenaline in the rat was observed 
following the administration of chlorothiazide. Chlorothiazide 
depressed the responses of isolated strips of horse carotid artery to 
adrenaline, noradrenaline, 5-hydroxytxyptamine and acetylcholine.
Chlorothiazide produced a significant depression in the uptake 
of sodium-24 by isolated strips of rabbit thoracic aorta, but it did 
not produce any demonstrable effects on the uptake and release of 
potassium-42 by this tissue.
Chlorothiazide did not modify the adenosine triphosphatase 
activity of rat skeletal muscle homogenates tending, thereby to
indicate /
333.
indicate that the supply of energy yielded by adenosine triphosphate 
for the movements of sodium ions is not interfered with.
In Chapter III, the antihyp prtensive actions of chlorothiazide 
and their relationship to its saluretic effects are discussed*
The highly specific depression of sodium uptake by strips of 
rabbit aorta suggests that chlorothiazide may reduce the sodium 
content of* the artery wall by depressing sodium uptake from the 
plasma and extracellular fluid and that this property may contribute 
to its antihypertensive activity. A fall in the sodium content may 
also reduce the water content of the artery wail and reduce the 
swelling or OBdema if it is present* This reduction in the thickness 
of the arterial wall may lower the peripheral resistance which may, 
in turn, lead to a fall in the arterial blood pressure level.
P A R T  I I
STUDIES ON THE NATURE OF THE MUSCLE- 
RELAXANT ACTIONS OF ETHER AND SOME 
OTHER VOLATILE ANAESTHETICS.
C H A P T E R  I
Introduction Pages 339 to 362
339.
INTRODUCTION
Since it was first shown by Auer and Meltzer (1914) that 
ether in anaesthetic concentrations was able to depress the 
magnitude of the response of the muscle to indirect stimulation, 
a number of workers have undertaken detailed studies upon the 
nature of this phenomenon. Thus it has been established that 
the muscle relaxant actions of non-depolarizing neuromuscular 
blocking agents such as tubocurarine are potentiated by ether 
(Cullen, 1944 end Wat land, Long, Pittinger and Cullen, 1937). 
This action of ether is shared by chloroform and halo thane. In 
their studies upon rabbits, Watlaad and his associates (1997) 
demonstrated that ether produced a depressant effect upon the 
response of the gastrocnemius muscle to indirect stimulation 
via the sciatic nerve. They also observed that when tubo­
curarine was given during the period of chloroform or halothane 
anaesthesia, there was a marked reduction in the magnitude of 
the muscular contractions when compared with the effect caused 
by tubocurarine alone. The tubocurarine was given to the 
unanaesthetised animal one hour after the termination of the 
anaesthesia. Earlier observations had revealed that ether 
exhibited /
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exhibited curare-like aotions on the motor end-plate (Auer and 
Meltser, 1914-)* Githens and Meltzer (1914a ) stated that during 
ether anaesthesia, even after respiration had ceased, the dia­
phragm muscle and phrenic nerve remained excitable* Forbes, 
McIntosh and Sefton (1916) recorded the action potentials of 
motor nerves during ether anaesthesia* They observed that the 
action potential remained unchanged, at concentrations of ether 
which were deep enough to cause cessation of respiration*
Simon art and Simon art (1934) found that the muscular contractions 
of the cat gastrocnemius muscle-sciatic nerve preparation induced 
by intra-arterial injection of acetylcholine, could no longer be 
elicited during ether anaesthesia, and moreover, that eserine 
could antagonize this ether effect* Gross and Cullen (1943) and 
Poulsen and Secher (1949) using the gastrocnemius musde-soiatio 
nerve preparations of the cat and the dog, found that ether was 
capable of inhibiting contractions due both to intra-arterial 
injection of acetylcholine, and to indirect stimulation of the 
muscle via the sciatic nerve* They also confirmed that neo­
stigmine antagonized the effects of ether on the acetylcholine- 
induced contractions* Gross and Cullen (1943) and Poulsen and 
Secher (1949) concluded that the peripheral action of ether was 
due to an interference with the liberation of acetylcholine at
the neuromuscular junction. In his efforts to differentiate the 
mechanisms of action of ether and of tubocurarine upon neuro­
muscular transmission and the muscle cell itself, Naess (I950a-»b, 
and c) carried out a detailed study of the effects of tubocurarine 
and neostigmine upon ether induced neuromuscular block in the 
rabbit flexor digitorum longus muscle-sciatic nerve preparation. 
Prom his observations, Naess suggested that ether and tubocurarine 
decreased the sensitivity of the end-plate to depolarization but 
that the two drugs acted by different mechanisms. Secher (1950* 
1951 a, b, c and d), using the rat phrenic nerve-diaphragm 
preparation* observed that ether could abolish muscular con­
tractions induced by indirect stimulation and that the contractions 
recovered completely when addition of ether was discontinued.
He also observed, that when given at a concentration which 
abolished contractions induced by indirect stimulation, ether 
did not inhibit contractions of the diaphragm due to direct 
stimulation. Muscle contractions caused by indirect stimulation 
ceased when the ether concentration in the medium was 0.22 per 
cent, whereas direct stimulation of the muscle was only affected 
when the ether concentration of the medium was increased to 0*57 
per cent. Prom these observations, Secher (19513.) concluded that 
ether in the concentrations attained during general anaesthesia had 
very /
veiy little direct depressant effect upon the muscle cell but that 
its effects resulted primarily from an action on the motor end- 
plate. Naess (1950 a,b, and c) and Secher (1951 a*b»e, and d) 
have also indicated that, although the observable effects of ether 
were identical with those of tubocurarine in depressing neuro­
muscular transmission, the precise nature of" the mechanism was 
different.
In contrast to the observations of Githens and Meltser 
(1941b), chloroform in anaesthetic concentrations, has been 
reported by Blume (1925) > Naess (1950a) and Secher (1951&), to 
possess a peripheral action on the neuromuscular junction. These 
authors reported that chloroform had a potentiating action on the 
tubocurarine-induced inhibition of muscular contractions elicited 
by indirect stimulation.
The preoise nature of the mechanism by whioh ether produces 
relaxation of skeletal muscle is not known. The studies 
described in this thesis were carried out in the hope that the 
observations of the effects on the permeability of the cell mem­
brane to sodium and potassium ions, under the influence of ether 
and tubocurarine, would shed further light on the problem.
For an understanding of the mode of action of volatile 
anaesthetics on the neuromuscular junction and its relationship 
to /
342.
to the permeability of the cell membrane to sodium and potassium 
ions, a brief account will be given of the mechanism of neuro­
muscular transmission and of the nature of the cell membrane*
Physiological processes at the neuromuscular junction during 
excitation are extremely complex and so are best considered from 
several viewpoints*
The role of acetylcholine
Transmission of impulses from the neurone to the effector 
oell is mediated by a specific chemical transmitter, acetylcholine, 
which is liberated from the nerve terminals (Katz, 1958a and Nach­
mans ohn, 1959a and b). The specialised role of the motor end- 
plate in the mechanism of neuromuscular transmission has been 
discussed by Katz (1958b)*
Depolarization occurs following the adsorption of acetylcholine 
molecules released by the nerve impulses upon the chollnergio 
receptors of the end-plate* Repolarization is effected following 
its enzymatic hydrolysis (Nachmansohn and Wilson, 1951 and Koelle, 
1962). Depolarization of the end-plate produoes a non-propagated 
end-plate potential (Eocles, Katz and Kuffler, 1941). A spon­
taneous and intermittent release of disorete quantal packets of 
acetylcholine also occurs at the neuromuscular junction during 
rest. This elicits minute potential changes in the post-synaptio 
membrane /
membrane which are insufficient to initiate an action potential and 
consequently a contraction of the muscle fibre (Fatt and Katz, 1952a 
and b, and Katz, 1956 and 1959)* The spontaneous rupture of large 
numbers of quantal packets of acetylcholine in response to impulses 
traversing the motor nerve fibre (Katz, 1956) produces depolariz­
ation of the end-plate sufficient to generate a wave of excitation 
in the muscle fibre. The action potential propagates in both 
directions along the muscle fibre, inducing the muscle contraction* 
This process of depolarization is associated with rapid alterations 
in the permeability of the cell membrane to ions. During the 
passage of an impulse in a nerve or muscle fibre, sodium enters 
the fibre and potassium is subsequently released in equivalent 
amounts (Hodgkin, 1951)* Under normal conditions, however, the 
cell membrane is moderately permeable to potassium ions and 
sparingly permeable to sodium ions. When an impulse travels along 
the motor axon, this exchange of cations proceeds until the impulse 
reaches the nerve terminals. Acetylcholine is liberated from the 
nerve terminals (Dale, Feldberg and Vogt, 1936) and by a specific 
action on the post-synaptic membrane, short-circuits the muscle 
cell membrane (Fatt and Katz, 1931)* A propagated wave of 
excitation is initiated in the muscle fibre, involving an exchange 
of sodium and potassium ions similar to the one produced in the 
nerve axon (Nastuk and Hodgkin, 1930). The precise mechanism by 
which /
which acetylcholine is liberated and its relationship to the changes 
occurring in the permeability of the cell membrane to these ions is 
not clearly understood (Castillo and Katz, 1956 and Kat2, 1958a and b). 
Fatt and Katz (1952a and b) suggested that acetylcholine was liberated 
from the nerve terminals by a specific exchange of sodium ions, which 
entered the terminal during the electrical activity. There is little 
evidence in favour of this hypothesis. A decrease in the release of 
acetylcholine would, therefore, be expected when the external sodium 
concentration was reduced.
The role of inorganic ions
Changes in the concentrations of cations in the environment of 
the neuromuscular junction may influence the release of trans­
mitter (Nastuk, 1959)* There is evidence that an excess of 
potassium ions when applied externally causes a liberation of 
acetylcholine from the nerve endings. This was observed in 
experiments on the perfused sympathetic ganglion (Brown and Feld- 
berg, 1935)* It is possible that an increase of potassium ion 
concentration may depolarize the cell membrane and therefore result 
in the liberation of acetylcholine. Hutter and Kostial (1954) 
observed that the potassium-induced release still occurred in a 
ganglion which had previously been made inexcitable by perfusing 
it with a sodium-free sucrose solution. It is believed that even
under /
under these conditions, potassium depolarizes the oell membrane 
the release of transmitter may therefore be an indirect effect of 
the presence of potassium ions (Castillo and Katz, 1956)*
The magnitude of the action potential of the nerve oell 
appears to depend upon the concentrations of the potassium ions in 
the outside medium* When this increases, the action potential is 
depressed* In the giant axon of the squid, the potential was 
reduced to zero, when the concentration of potassium ions in the 
bathing solution was raised by six times to that found in sea 
water (Curtis end Cole, 1942). When bathed in Ringer1 s solution 
containing four times the normal potassium concentration, isolated 
frog soiatio nerve showed a reduction in the height of the action 
potential (Rosenberg and Kitayama, 1930). Hertz (1945) observed 
an immediate reduction of the amplitude of the action potential, 
on immersing a single frog myelinated nerve fibre in Ringer's 
solution containing six to ten times the potassium concentration 
of normal Ringer's solution* Aocording to Huxley and Stampfli 
(1951), the depolarization of frog medullated nerve fibre by an 
increased potassium concentration takes place in less than one 
minute* Penn (1940) noted that a moderate increase in the potas­
sium concentration of the medium might enhance the mechanical 
response of skeletal muscle, while larger concentrations paralysed 
the muscle* Overton (1904) using an isolated nerve-nruscle 
preparation /
preparation from the frog had already shown that about 10 mM of 
potassium per litre of Ringer's solution produced total muscular 
paralysis.
Nerve fibres become inexcitable when the sodium concentration 
of the medium is 10 per cent less than that of Bingerfs solution, 
the isotonicity of the medium being maintained by suorose or 
glucose. This faot has been demonstrated by Webb and Young (1940) 
and Hodgkin and Katz (1949) using the Loligo giant axon. The same 
effeot was observed in the case of the Sepia giant axon (Keynes, 
1951) and frog medullated nerve (Erlanger and Blair, 1938 and 
Huxley and Stampfli, 1951)*
The relationship between the aotion potential and the external 
sodium concentration has also been investigated by Hodgkin and 
Katz (1949) using the giant axon of the squid. The isotonieity 
of the medium was maintained by substituting dextrose for sodium 
ion3. Hodgkin and Katz (1949) demonstrated that the rate of rise 
of the aotion potential was roughly proportional to the external 
sodium concentration. The falling phase of the action potential, 
during which the oell membrane was supposed to be veiy slightly 
permeable to sodium Ions, was much less affected by the external 
sodium concentration than the rising phase. Hodgkin and Katz 
(1949) suggested that the rise in the aotion potential was 
determined by the rate at which the membrane capacity was dis­
charged /
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discharged by the entry of sodium* Th© detailed studies made by 
3?att and Katz (1950, 1951, 1952a and 1952b) have done much to 
explain the role of sodium in the genesis of the end-plate potential* 
These authors used micro—eleotrodes which were introduced into the 
frog muscle fibre at the site of the end-plate. They found that 
the end-plate potential was reduced and nerve transmission blocked 
when the sodium concentration of the bathing Hinger's solution was 
lowered to from one half to one third of that in normal Hinger's 
solution. The reduction in the size of the end-plate potential 
was comparable to that obtained in a partially ourarised muscle.
The preparation, however, remained sensitive to externally applied 
acetylcholine. Nastuk (1954), using a frog nerve-muscle fibre 
preparation, found that although the magnitude of the resting 
potential of the end-plate was little affected by the complete 
removal of sodium from the bathing fluid, the magnitude of the 
end-plate potential produced by direct application of aoetylcholine 
was significantly reduced. The changes produced by a deficiency 
of sodium ions were suggested to be due to a post-synaptic blocking 
action (Castillo and Katz, 1956).
It has been suggested by Katz (1958b) that the action of 
acetylcholine on membrane permeability persists even though the 
sodium on the outside of the cell membrane has been removed.
Furukawa, Furukawa and Takagi (1957) observed that the substitution 
of /
of ammonium ions for sodium ions, while abolishing the spike 
potentials, did not reduce the spontaneous miniature potentials, 
nor did it interfere with the depolarizing action of externally 
applied acetylcholine*
The studies of Castillo and Engbaek (1934), using micro­
electrodes, demonstrated that high concentrations of magnesium ions 
and low concentrations of calcium ions may reduce the amount of 
acetylcholine liberated* Large concentrations of calcium ions 
stimulate the release of acetylcholine (Castillo and Stark, 1932)* 
Very high ocncentrations of both ions depress the direct excit­
ability of the cell membrane*
The nature and structure of the cell membrane*
The muscle end-plate is a highly specialized development of 
the muscle oell membrane and may be expected to exhibit some of 
the general properties of membranes*
To interpret the results obtained from studies on the perme­
ability of the cell membrane it is necessary to know something of 
its nature and its structure*
Unfortunately it has not been possible in the past to demon­
strate the structure and chemical nature of the cell membrane by 
optical methods. Theories advanced by earlier workers are 
summarized /
summarized by Davson and Danielli (1952) and these are firstly, that the
cell membrane is a thin layer of fatty material; secondly, that the cell
membrane is a sieve with pores of molecular dimensions; thirdly, that 
the cell membrane consists of a mosaic made up of areas of more than 
molecular dimensions, each area possessing a different chemical 
nature; fourthly, that the cell membrane consists of a sieve-like 
structure superimposed upon a lipoid layer; and finally, that the 
cell membrane is a bimolecular leaflet of fatty molecules.
The view of Overton (1895 and 1900) that the cell membrane
consisted of a thin layer of fatty material was based on the 
observation that substances penetrated the cells in the same 
relative order of effectiveness as their oil-water partition 
coefficients varied. Since then, it has been generally assumed 
that such a correlation indicates the presence of a larger pro­
portion of lipoid material in the cell membrane, and that due to 
their higher lipid solubility, substances with high oil-water 
partition coefficients penetrate rapidly.
Overton (1901) and Meyer (1899-1901) believed that the 
potency of anaesthetic agents was directly related to their 
distributions between oil and water, i.e., to the oil-water 
partition coefficient. This was the first attempt in the field 
of pharmacology in which the physical properties of a group of 
drugs /
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After Mullins (1956)*
Diagram showing the arrangement of macromolecules shown in a 
regular hexagonal packing* The pores which exist between any 
three cylinders are characterised by the regularity of their size.
drugs were correlated with their pharmacological actions*
Danielli and Davson (1934) have put forward another theory 
according to idaich the lipoid layer is a few fatty molecules thick, 
with an adsorbed protein layer at each fat-water interface* Doubt 
was cast upon the stability of such a bimolecular lipoid layer 
sandwiched between two aqueous phases* This model of the cell 
membrane has been revised by Mullins (1956) who suggested that it 
was a macromolecular liquid membrane, in which pores were formed 
by the inability of macromolecules to fill all the spaces in the 
liquid* The measurement of the thermodynamic activity of anaes­
thetic agents gave values which implied that narcotic moleoules 
would be orientated at the site of their action on the cell 
membrane as they would be in the pure liquid state* The small 
molecules of narcotics would become distributed almost uniformly 
throughout the membrane sites*
To explain the relationship between the distribution of 
narcotic molecules and increased permeability of the cell membrane 
to inorganic ions the following suggestion was put forward by 
Mullins (1956). It was said that pores formed by the cylind­
rical maoromolecules were constantly undergoing thermal motion and 
scr would show differences in size* The fact that the cell mem­
brane is sparingly permeable to sodium ions and moderately 
permeable /
permeable to potassium ions was said to be due to the size of the 
pores existing in it* A resting cell membrane allowed the entry 
of ions of only a certain size* Sodium ions wefe larger than 
potassium ions, and their larger energy of hydration resulted in a 
slow mobility in aqueous solution end were not therefore capable 
of passing freely through the membrane pores in a resting cell* 
Organic molecules capable of passing through the membrane pores 
would distort the channels by accumulating in them* This effect 
was presumed to cause an increase in the size of neighbouring 
channels and pores on the surface of the cell membrane* Sodium 
rapidly entered and occupied the spaces so formed and a compen­
satory release of potassium ions occurred* Calcium ions were of 
approximately the same size as sodium ions and might compete with 
sodium for entxy into the pores*
Mullins (1936) suggested that only molecules of a certain 
size could pass through the channels formed on the surface of the 
cell membrane* It is possible that the tubocurarine molecule, 
being larger and bulky, may not pass through these pores into the 
channels and may merely block their openings* The view presented 
by Mullins (1956) will be discussed in a later part of this 
chapter*
Recently Ahmed and Lewis (1961 and 1962) have indicated that 
the classification of a muscle relaxant as depolarizing or com­
petitive /
competitive may be made, according to its ability or otherwise to 
increase the permeability of the cell membrane to sodium and 
potassium ions* Non-depolarizing agents such as tubocurarine and 
gallamine even at high dose levels had no observable effect upon the 
release or uptake of potassium and sodium ions. Depolarizing 
agents, for example decamethonium and suxamethonium, were shown to 
be oapable of causing a significant increase in the uptake of 
sodium and in the release of potassium ions*
The literature available on the influence of volatile anaes­
thetics on the pezmeability of the cell membrane is both limited 
and controversial. The early observations of Alcock (1906) 
indicated that when frog nerve was treated with the vapour of 
chloroform or ether, a reversible decrease in the resting 
potential occurred. He interpreted his observations as being 
due to an increased permeability of the tissue to ions. Hober 
(1907) on the other hand, observed that narcotics such as chloro­
form and ether decreased the permeability of the cell membrane to 
ions and he attempted to relate the activity of narootios to their 
activity on colloidal systems in the cell.
Lillie (1909) indicated that a narcotic substance exerted its 
actions by interfering with the permeability of the cell membrane 
during activity. He postulated that an anaesthetio agent
decreased /
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decreased the permeability of the cell membrane by adsorbing on to 
the cell’s surface* This produced a narcotic effect by varying 
the rate of removal of carbon dioxide from the cell*
Winterstein (1916) measured the rate of increase of weight of 
frog sartorius muscles placed in a hypotonic salt solution. He 
concluded that the permeability of the cell to water was decreased 
when aloohol was added to the bath solution.
Davson (1940) and Davson and Reiner (1942), using cat erythrocytes, 
observed that amyl alcohol increased their permeability to potassium 
ions and decreased their permeability to sodium ions. A large variety 
of organic agents (chloroform, ether, benzene and butyl and amyl 
alcohols) had similar actions on the permeability to sodium ions.
The fact that in some cases narcotics cause a reduction in 
cellular permeability while in others they cause an increase in 
permeability to certain ions and to water, indicates that besides 
the chemical nature of the anaesthetic agent, the special nature 
of the membrane, and in addition, the experimental method used must 
also be considered.
Pharmacologically active agents exhibit their actions by 
either specific or non-specific mechanisms (Beckett, 1956*
Ing, 1959). Muscle relaxant drugs are presumed to act in a 
structurally specific manner and to combine with specific 
receptors, a typical example of this group being tubocurarine.
Some /
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Some agents, however, exert a physical or physicochemical effect 
within the cell or on its surface, thereby causing a disturbance 
of cellular metabolic activity. Among compounds of this type are 
volatile anaesthetics such as ether, chloroform and cyclopropane 
and hypnotics (Albert, I960)*
Structural changes in the cellular membrane are known to play 
an essential role in the process of depolarization and in the 
propagation of excitation (Waser, I960); it may therefore be 
assumed that this is a site of the muscle relaxant action of 
general anaesthetics* It has, for example, been shown that 
anaesthetics do not act as depressants when injected into the 
cell but do so when they are allowed to act from without* There­
fore, Warburg (1921) suggested that depressant drugs exerted their 
effects by coating the outer surface of the cell membrane, and 
there inhibiting oxidative processes* Quastel and Wheatley 
(1932, 1934) > using rat brain cortex in vitro, demonstrated that 
the oxidation of glucose, lactate and pyruvate, was inhibited by 
concentrations of narcotics approximately corresponding to those 
which were found during general anaesthesia. Quastel (1939* 1952) 
observed that only certain oxidative processes were inhibited by 
ether* He found that in rat brain slices in vitro* oxidation 
of pyruvate, glucose and lactate were inhibited but no effect was 
seen /
seen on succinate oxidation. Quastel (1939) considered that 
anaesthetic agents attacked the point which acted as the hydrogen 
carrier between pyruvic dehydrogenase and cytochrome oxidase.
Buttler (1950), on the other hand, suggested that depression of 
respiration in cells caused by anaesthetic agents might have been 
the result and not the cause, of the reduoed nervous activity. It 
seems that mechanisms other than oxidative processes probably exist 
and are influenced by narcotics. This view is favoured by the fact 
that xenon, a physically and chemically inert gas, can produce 
narcosis when the total volume of the non aqueous phase of the nerve 
cell is occupied by its molecules. It was suggested by Albert 
(i960) that narcotics in general act by their physical accumulation 
in some part of the cell and not by adsorption at the surface as was 
suggested by Warburg (1921).
G-oldacre (1952) has demonstrated that general anaesthetics can 
cause a reversible increase in the area of the cell membrane of the 
amoeba. He suggested that the membrane was an enzyme which acted 
as a non-diffuseable substrate in the cytoplasm and considered that 
a similar mechanism might be present in the nerve cell. It is vexy 
possible that vital enzyme systems which are located on the surface 
of the cell membrane are interfered with by the presence of narcotic 
agents.
The nature of the cholinergic receptor.
The view that dnigs exert their actions by interacting with 
certain receptors in the tissues has become generally accepted by 
workers in the fields of chemotherapy and pharmacology. Although 
this concept originated from the studies of Ehrlich (Ehrlich and 
Morgenroth, 1910), the original ideas have been considerably modified. 
Clark (1933) an& Clark and Raventos (1937) used the concept to 
treat drug action mathematically and in more recent times, Ariens,
Van Rossum and Simonis (1956) and Van Rossum, Ariens and Linssen 
(1958) have developed this approach to give an elegant theoretical 
interpretation of drug action. They visualize drug-receptor inter­
action in general terms as basically an interaction of fields of 
force originating in the drug molecule and the tissue. They then 
postulate that the general field determines the affinity of the 
drug for the receptor (i.e., its ability to enter into drug- 
receptor complex formation) while certain specific interactions 
within the general field determine the intrinsic activity or 
ability of the drug to evoke a biological response. Regions of 
high or low electron density in the drug molecule will contribute 
to the electrostatic components of the force field, while stereo­
chemical factors will contribute to Van der Waal’s bonding.
A more detailed picture of the acetylcholine receptor 
involved /
involved in neuromuscular transmission has been given by Waser 
(i960) who postulates that the reoeptor site might be a pore in the 
post-synaptic membrane which had an anionic wall and within the 
pore itself, an esteratic site, to which the ester groups of acetyl­
choline become attached* On these assumptions the neuromuscular 
blocking action of non-depolarizing relaxants such as tubocurarine 
could be visualized as due to a covering of the pores of the end- 
plate region by their large bulky molecules* That is, tubocurarine 
or gallamine may act by inhibiting the access of acetyloholine to 
the receptors and thus, by preventing the flow of ions through the 
membrane pores, prevent depolarization of the post-synaptio 
membrane* On the other hand, depolarizing drugs such as deoa- 
methonium and suxamethonium may attach themselves to the anionic 
sites and so bridge the pore at different chords* The molecules 
may not cover the whole circular area of the opening of the pore, 
but may increase depolarization by causing mechanical deformation* 
Ions are assumed to pass through the pore on both sides of the long 
thin molecules, especially when the circular shape of the pore is 
deformed by the strain exerted upon it.
Some years before Waser (i960) presented his theory of the 
nature of the cholinergic receptor and from this attempted to explain 
the mode of action of depolarizing and non-depolarizing muscle 
relaxants, /
relaxants, Mullins (1956) had suggested a structure for the cell 
membrane on the basis of which the action of narcotics could be 
explained. If Mullins1 view is accepted, then it is possible that 
the thin elongated molecules of decamethonium, instead of bridging 
the pore, enter the channels directly through the pores on the cell 
membrane. These molecules by their presence may cause mechanical 
folding or dislocation of the channels which consequently causes 
an increase in the size of the pores on the cell's surface.
Sodium, which can ordinarily only get Into the few pores which are 
enlarged by the thermal agitation of the maoromolecular cylinders, 
is now able to find a large number of pores and channels large 
enough for its entry. This process is presumed to cause an 
increase in the permeability of the cell membrane to sodium and 
potassium ions. If these assumptions are true, then molecules 
of intermediate stereochemical properties may by their partial 
entry into the channels, cause a disturbance of a similar nature 
in the normal distribution and permeability of the cell membrane 
to oations.
It is possible that the entry of narcotic molecules into the 
pores formed on the cell surface causes a physical derangement of 
these channels (similar in manner to those described for depolar­
izing agents) and so results in an increased influx of sodium 
together /
together with a correspondingly increased release of potassium ions. 
Although ether is known to potentiate the musole relaxant 
aotions of tuboourarine, it has also been shown that ether causes 
an increase in the level of the potassium ions in the circulating 
blood (Kiersz, 1948)* Potassium chloride on the other hand, is 
known to cause antagonism to the neuromuscular blocking actions of 
tubocurarin© (Wilson and Wright, 1936; Altamirano and Huidobro,
1948; and £i, Jacobs, Aviado and Schmidt, 1952)* The same has 
been found true for sodium (Fatt and Katz, 1952b), The role of 
sodium and potassium ions is vitally linked with the process of 
neuromuscular transmission and the normal excitation of the cell 
(Fatt and Katz, 1952b),
The present studies were undertaken with the object of 
approaching the nature of the muscle relaxant aotion of ether and 
other volatile anaesthetics.
Investigations have been carried out upon the movements of 
sodium-24 and potassium-42 ions under the influence of ether, 
chloroform, halothane and methyl-n-propyl ether (neothyl). The 
isolated frog sartorius and rectus abdominis muscles and Isolated 
strips of rat diaphragm have been used.
The effects of ether, tuboourarine and neostigmine on the 
movements of sodium—24 and potassium—42 from the rat phrenic nerve— 
diaphragm /
diaphragm preparation during muscular activity were also studied* 
The effects of ether on the in vivo serum potassium level of 
the oat were also investigated and compared with those of tubo­
curarine, adrenaline and neostigmine* A simultaneous study of 
the effect of these drugs on the responses of the gastrocnemius 
muscle of the oat to Indirect stimulation was also made*
The results are described in the following chapters*
A. Materials ...................  Page 3^3
Experimental and Methods ......... Pages 3^ 4- to 3&1.
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C H A P T E R  II 
A. MATERT ATiK
The drugs used in the investigation which is described in this 
section of the thesis, together with their shortened names, are as 
follows:
(1
(2
(3
(4
(5
(6
(7
(8
(9
Acetylcholine chloride, is described as acetylcholine.
Adrenaline bitartrate, is described as adrenaline.
Decamethonium iodide, is described as decamethonium.
Neostigmine methyl sulphate, is described as neostigmine.
(+)-Tubocurarine chloride, is described as tubocurarine.
Atropine sulphate, is described as atropine.
Diethyl ether (Anaesthetic Ether, B.P.), is described as ether. 
Methyl-n-propyl ether (Neothyl,Macfarlan) is described as Neothyl. 
Chloroform (Chloroform, B.P.), is described as chloroform.
(10) Halothane (Pluothane, I.C.I.), is described as halothsne.
Radioactive materials were obtained from the Radiochemical Centre 
Amersham, England.
Potassium-42 was obtained as a sterilised isotonic solution of 
42-KC1 and had an activity of approximately 0.10 to 0.12 me. per ml. 
at the time of dispensing.
Sodium-24 was obtained as a sterilised isotonic solution of 
24-NaCl and had an activity of approximately 1.00 me. per ml. at the 
time of dispensing.
Solutions of volatile anaesthetics were prepared by shaking 10 
ml* of the anaesthetic liquid with 90 ml* of the appropriate saline 
solution in a separating funnel of 500 ml* capacity for a period of 
15 minutes at room temperature* After shaking, the solutions were 
left for a period of 15 minutes so as to form two liquid layers*
The anaesthetic-saturated saline solution was then drained from the 
lower outlet of the separating funnel for use in the experiment*
These solutions were prepared freshly prior to each experiment.
tten ether, neothyl, chloroform or halothane solution is referred 
to, this indicates the use of a solution of the anaesthetic in the 
appropriate saline solution*
The composition and methods of preparation of the physiological 
saline solutions used in this investigation are to be found in the 
Appendix I, page 452* The statistical method employed to calculate
i
the experimental observations is described in Appendix I, page4,5V
B* EXPERIMENTAL*
To investigate the effects of the volatile anaesthetics on ion 
fluxes, the following preparations were used:-
1* Isolated frog sartorius muscle*
2. Isolated strips of rat diaphragm.
3* The rat phrenic nerve-diaphragm preparation.
A* The cat gastrocnemius muscle-sciatic nerve preparation.
5» Isolated frog rectus abdominis muscle.
The /
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The investigations carried out using these preparations are 
described below,
1, Isolated frog sartorius muscle.
Investigation of the effect of ether, neothyl, chloroform and 
halothane upon (a) the uptake of potassium-42, (b) the efflux of 
potassium-42, and (c) the uptake of sodium-24 by frog sartorius muscle,
2, Isolated strips of rat diaphragm.
Investigation of the effect of ether, neothyl, chloroform and 
halothane upon (a) the uptake of potassium-42, (b) the efflux of 
potassium-42, and (c) the uptake of sodium-24 by isolated strips of rat 
diaphragm,
3, The rat phrenic nerve-diaphragm preparation.
Investigation of the effect of ether, and tuboourarine upon the
magnitude of the muscle twitch produced by direct or indirect stimula­
tion of the rat diaphragm, and upon potassium-42 efflux,
4, The cat gastrocnemius muscle-sciatic nerve preparation. 
Investigation of the effect of ether upon muscular contractions
induced by indirect stimulation via the soiatio nerve and also upon 
the level of potassium-42 in the blood serum,
5* Isolated frog rectus abdominis musole.
Investigation of the effect of ether, neothyl, chloroform and 
halothane upon acetylcholine-induced contractions of the isolated frog 
reotus abdominis muscle,
1(a) /
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1* Isolated frog sartorius muscle,
(a) Uptake of potassium-42.
Method, The method used was based on that described by Lister and 
Lewis (1939)* Spring frogs (Rana temporaria) unselected as to age or 
sex and weighing from 25 to 50 g. were stunned by a sharp blow on the 
base of the head, decapitated and pithed* The skin covering both thighs 
and the pelvic region was reflected to expose the attachments of both 
ends of the two sartorius muscles. Each muscle was carefully dissected 
free, extreme care being taken to prevent damage to the muscle fibres. 
The distal tendons were sectioned and the muscles freed by cutting 
through the pelvic attachments. The muscles were blotted dry and each 
rapidly weighed on a torsion balance. With careful dissection, paired 
muscles could be obtained differing in weight from one another by less 
than 1 mg. By means of two stainless steel hooks the muscles were then 
suspended in two centrifuge tubes each containing 10 ml. of frog 
Ringer's solution at room temperature.
In this solution, part of the stable potassium chloride was re­
placed by the radio-active salt. The control muscle was suspended in 
10 ml. of radio-active frog Ringer's solution which had previously been 
gassed for a period of 30 minutes with a mixture of 93 per cent oxygen 
and 3 per cent carbon dioxide* The other member of the pair was sus­
pended in an identical solution which contained the drug. The muscles 
were exposed to drug or control solution for 30 minutes, after which 
they /
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they were removed from the radio-active solution, each side of the 
muscle washed for 5 seconds by means of a stream of non-radioactive 
frog Ringer's solution and blotted dry to remove adhering moisture.
The muscle was then placed in a test tube as shown in Fig. Ill (page 
368 ) and counted in a thallium-activated, sodium iodide, scintillation 
crystal (Ecko type N.597) connected through a photomultiplier unit to 
an automatic scaler (Ecko type N.530D).
The muscles were usually exposed to the radio-active Ringer's sol­
ution for a period of from one and one half to two hours, and the radio­
activity of both the test and control muscles was measured at 30 minute 
intervals. Corrections for decay were not made as in every experiment 
a control muscle was compared with the test under identical conditions. 
After correcting for background, the counts were expressed as counts 
per minute.
(b) Potassium-42 efflux.
Method. Spring frogs (Rana temporaria) unselected as to age or sex 
and weighing from 25 to 50 g. were used* For the estimation of 
potassium-42 efflux, 0.5 nl* of isotonic 42-KC1 solution which at the 
time of dispensing contained 0.10 to 0.12 me. per ml. was injected 
into the dorsal lymph sac. After a period of two hours, which was 
allowed for equilibration to take place, the frog was pithed and the 
paired sartorius or rectus abdominis muscles moved, washed for five 
seconds with a stream of non-radioactive Ringer's solution, blotted dry 
and weighed. Two series, each containing nine 10 ml. centrifuge tubes 
were /
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Diagram of the apparatus for suspending 
a muscle for the study of the uptake 
or release of radioactive ions*
were set up in parallel. Each tube contained 10 ml. of non-radio­
active frog Ringer's solution at room temperature which had been 
previously well gassed with a mixture of 93 P©r cent oxygen and 5 per 
cent carbon dioxide; one series of tubes was used for the control 
muscle and the other for the test muscle. Each member of the pair of 
sartorius muscles was suspended from one end by means of a steel hook 
made from an entomological pin and stretched by a weight made out of 
a No. 20 hypodermic needle which was attached to the lower end (Eig.
Ill, page 368). The paired muscles were suspended, one in the first 
member of the control series of tubes and the other in the corresponding 
Wbe in the test series. After a period of 10 minutes in the first 
pair of tubes, the muscles were transferred to the second pair. The 
fluid which remained in the previous tube was counted, using a G-eiger- 
Muller liquid counter (type M6) linked to an automatic scaler (Ecko 
type N.330D). In the test series, the drug was present in the fourth 
tube and in each case there was a ten minute period of contact between 
muscle and solution. After immersing it in the ninth tube of the 
series, the muscle was digested in 2 ml. of concentrated nitric acid, 
the volume adjusted with Ringer's solution to 10 ml. and the radio­
activity counted in the manner described above.
(c) Uptake of sodium-24.
Method. The procedure adopted for the investigation of the effect of 
volatile anaesthetics upon the uptake of sodium—24 by isolated frog 
sartorius /
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sartorius musole was similar to that described on page $66* Muscles 
were suspended in centrifuge tubes containing 10 ml* of frog Ringer rs 
solution in which part of the stable sodium chloride was replaced by 
24-NaCl.
2. Isolated strips of rat diaphragm
(a) Uptake of potassium-42*
Method* Albino rats of either sex, weighing from 200 to 230 g*,were 
stunned by a blow on the head* The throat was then cut and the animal 
allowed to bleed out* The diaphragm was dissected out and the 
tendinous parts cut away* Taking two strips from each side, four 
rectangular strips of about equal weight were prepared from each 
diaphragm* One member of each pair of strips was used as a control 
and the other for the test* The experiment was carried out in a 
manner similar to that described on page Krebs'-Ringer's solution
(Appendix I, page 452) was used as the bathing fluid.
(b) Potassium-42 efflux*
Method* Albino rats of either sex, weighing from 200 to 230 g*, were 
injected intraperitoneally with 0*3 ml. of isotonic solution of 42-KC1. 
which at the time of dispensing contained 0*10 to 0*12 mo* per ml*
After an equilibration period of 2 hours, the rats were killed and 
the diaphragm dissected out* The rest of the procedure was similar 
to that adopted for studying the release of potassium-42 from the 
isolated /
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Experimental physiology, 5th Edition, page 327 
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phrenic nerve diaphragm preparation.
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isolated sartorius muscle of the frog and described on page 3 7^.
(c) Uptake of sodium-24.
Method* The procedure adopted for investigation of the effect of 
volatile anaesthetics upon the uptake of sodium-24 by isolated strips 
of rat diaphragm was similar to that described on page 366 • Muscle 
strips were suspended in centrifuge tubes containing 10 ml* of Krebs'- 
Ringer rs solution in which part of the stable sodium chloride was 
replaced by 24-NaCl*
3. The isolated rat phrenic nerve-diaphragm preparation
Method* The method adopted to reoord the contractions of the isolated 
rat phrenic nerve-diaphragm preparation was based on that of Bulbring 
(1946)* The electrode described by Bell (1952) (Pig* 112, page371 ) was 
used so that the muscle could be stimulated both directly and indirectly* 
Adult rats of either sex were used* 0*25 ml* of 42-KC1 was 
injected int r ape rit one ally and the animal left for a period of two 
hours for equilibration to take place* The rat was then killed by a 
blow on the head, the throat cut, and the blood allowed to drain out*
The animal was now placed on its baok and pinned upon a dissecting 
board* The skin over the thoracic wall was removed on both sides, 
the abdomen opened and a small incision made through the diaphragm 
from the abdominal aspect, at the point of its attachment to the ribs 
and close to one side of the sternum. One blade of a pair of 
soissors /
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scissors was inserted through the incision and the ribs divided close 
to the sternum. This procedure was repeated on the other side of the 
sternum. The sternum was then dissected from the mediastinal tissue 
and removed. Starting between the fifth and sixth ribs, an incision 
was made across the ribs on the right side parallel to the diaphragm­
atic attachment. All the ribs above this incision were removed. A 
second transverse incision was made along a curved line Just below the 
attachment of the diaphragm to the thoracic wall. The right phrenic 
nerve was identified as it entered the diaphragm. It was moved 
gently to the medial side and the lobes of the right lung cut away
near the hilum and removed. The thoracio cage was washed with fyrode's
solution containing double the usual amount of glucose and the right 
phrenic nerve carefully dissected free from the mediastinal tissues. 
When the nerve had been freed as high in the neck as possible, a 
ligature was tied around it and the nerve severed above the ligature.
A length of about 4 to 5 om. of nerve was usually obtained. Two 
ligatures were now inserted through the costal segment which was 
attached to the diaphragm and lengths of threads were left with the 
ligatures. The ligatures were from 2 cm. to 2.3 cm. apart, with the 
point of entxy of the phrenic nerve lying midway between them. They 
were pulled gently to stx*etch the diaphragm and to observe the
direction in which the muscle fibres ran. Two cuts were made through
the ribs and diaphragm, parallel to the muscle fibres and commencing 
Just /
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Diagram of the apparatus used for recording 
contractions of the rat diaphragm produced 
either by direct or indirect stimulation of 
the muscle using Bell’s electrode*
just outside the costal ligatures, so as to converge on the central 
tendinous part of the diaphragm. The muscle-nerve preparation was 
then taken out of the animal and placed in a petri dish filled with 
Tyrode's solution. A similar preparation was also obtained from the 
left side of the animal. The right side preparation is, however, said 
to give better contractions, although the nerve is more difficult to 
dissect out than that on the left side where it is not so closely 
bound to the mediastinum.
The muscle-nerve preparation was then fixed on to the electrode 
assembly. The two ligatures which had been passed through the costal 
margin were tied firmly to the horizontal arm of the diaphragm support 
and a platinum wire tied to the tendinous part of the diaphragm. The 
other end of the wire was fixed to a light isotonic heart lever which 
recorded the contractions on a moving smoked paper surface. The 
phrenic nerve was passed into the groove described previously so that 
it lay across the two wires of the electrode. To keep the nerve firmly 
in place, the end of the phrenic nerve was fixed between the electrode 
holder and the diaphragm support. The whole assembly was immersed in 
a 100 ml. organ bath (Pig. 113, page 374) filled with Tyrode1 s solution 
containing double the usual amount of glucose. The solution in the 
organ bath was gassed with 95 per cent oxygen and 5 per cent carbon 
dioxide through a gas distributing tube fitted to the bottom of the 
organ bath. Due to the high volatility of the anaesthetic agents 
used, /
used, the experiments were carried out at room temperature* Anaes­
thetic agents, dissolved in Tyrodefs solution, were added directly to 
the bath by means of a graduated pipette*
The preparation was stimulated from two Bobbie Mclnnes stimulators 
- one for indirect stimulation of the diaphragm via the phrenic nerve 
and the other for direct stimulation of the muscle* Por indirect 
stimulation, the frequency was 6 to 8 stimuli per minute, the voltage 
8 to 10, pulse width 0*3 to 1 m.sec. Por direct stimulation, the 
frequency was 6 to 8, voltage 23 to 50 and pulse width 2 m.sec. In 
any one experiment, the frequency, voltage and pulse width both for 
direct and indirect stimulation were kept constant.
The effects of the solution of ether (2 to 10 ml*) upon the 
twitch height of the rat diaphragm preparation in response to both 
direct and indirect stimulation were observed. The effects of the 
solution of ether (2 to 10 ml.) and of tuboourarine (l to 3 Ug* P«r 
ml.) on the potassium-42 efflux from the rat diaphragm were also 
studied*
To estimate the levels of potassium-42 in the bath fluid before 
and after the addition of the solutions of ether and tuboourarine, two 
2 ml* samples of fluid were taken at 10-minute intervals from the bath 
by means of a graduated pipette* The sample of bathing solution was 
then adjusted to 10 ml. with non-radioaotive Tyrode's solution and the 
radioactivity of the sample measured by means of a Geiger Muller 
liquid /
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liquid counter (type M.6) linked to an automatic scaler (Ekco type 
N 53OD).
4* Experiments on the gastrocnemius musole-soiatio 
nerve preparation of the anaesthetised cat#
Method# Cats of either sex, weighing from 1*75 to 2 kg# were used.
Each animal was given an intraperitoneal injection of 4 ml* of 42-KG1 
solution which at the time of dispensing contained from 0.10 to 0#12 
me# per ml. A period of four hours was allowed for equilibraiiOJl.%
An intraperitoneal injection of 1 mg. per kg. of atropine was given to 
the oat so as to reduce the bronchial secretions due to the irritant 
action of ether vapour. The cats were anaesthetised by means of an 
intraperitoneal injection of sodium pentobarbitone. A dose of 60 mg. 
per kg# was usually adequate for the induction of surgical anaesthesia# 
The external jugular vein and the trachea of the anaesthetised cat 
were cannulated in a manner similar to that described on page 27 
of this thesis. The left leg was now prepared for indirect stimulation 
of the gastrocnemius muscle via the sciatic nerve. The gastrocnemius 
muscle was partially dissected from the surrounding tissues and the 
Achilles tendon severed at a point near to its insertion into the 
calcaneus • A strong linen thread was tied around the free end of the 
tendon, the leg was then held with its long axis perpendicular to the 
operating table and fixed rigidly in position by means of two clamps - 
one /
378.
Fis^rut
Diagram of the oat gastrocnemius muscle-3ciatic 
nerve preparation of the anaesthetized cat
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one at the knee joint and the other at the ankle (Fig. 114, page 378).
The thread .tied to the Achilles tendon was led over pulleys and attached 
to a myograph lever, the writing point of which was adjusted so as to 
record the contractions of the muscle upon a moving smoked surface. By 
means of an incision made through the skin covering the lateral aspect 
of the thigh, the sciatic nerve was exposed between the hamstring 
muscles. It was then crushed proximally between the jaws of a pair of 
artexy forceps and a pair of shielded platinum electrodes placed around 
the nerve distal to this point. When this dissection was completed, 
the iliac vein of the contralateral leg was cannulated through the 
femoral vein using a fine polythene cannula. This was connected to a 
1 ml. graduated tuberculin syringe which was used for the collection of 
samples of venous blood. The cat was given an intravenous injection 
of 1,000 units of heparin through one of the external jugular veins.
Two 1 ml. samples of blood were collected at 5 minute intervals into 
heparinised centrifuge tubes, shaken gently and then centrifuged at 
1,500 revolutions per minute for a period of 10 minutes. The cat was 
allowed to inhale ether vapour through an ether bottle for a period of 
from 5 to 10 minutes. Duplicate blood samples were again collected at 
5 minute intervals. Collection was continued in this way following 
the end of the period of ether inhalation until the potassium level in 
the serum returned to control levels or to values near these.
0.25 ml. of the plasma was adjusted to 10 ml. with normal saline 
and /
and the radioactivity measured using a Geiger Muller liquid counter 
(type M.6) linked to an automatic scaler (Ekco, type N 530D).
The effects of adrenaline (50 to 100 pg. per kg*), neostigmine 
(0.25 mg. per kg.) and tubocurarine (100 to 200 pg. per kg,) on ether- 
induced neuromuscular block and blood serum potassium—42 levels were 
studied.
The sciatic nerve was stimulated by means of a Dobbie Mclnnes 
square wave stimulator, using single shocks at a frequency of 4 to 8 
per minute, at 10 to 20 volts, the pulse width being 2.0 to 3*0 m.sec. 
In any one experiment frequency, voltage and pulse width were kept 
constant, but in some experiments the muscle was also tetanized 
indirectly by using a frequency of 1,500 impulses per minute. The 
tension placed upon the muscle varied between 0.2 and 0.3 kg. In any 
one experiment the tension was kept constant. The tension produced by 
the contraction of the muscle in response to electrical stimulation 
varied from experiment to experiment but usually remained constant 
between 0.6 and 0.8 kg. The drugs administered were in the form of 
their solutions in normal saline. Injections were given into the 
rubber connection between the jugular vein cannula and the burette, and 
the drug solutions were then washed in by means of 2 ml. of saline.
5. Isolated frog rectus abdominis muscle.
Method. The method adopted was similar to that described previously 
(page /
(page 47 ).
Contractions of the isolated reotus abdominis muscle of the frog 
in response to acetylcholine (0*1 to 0*5 pg* per ml*) were recorded in 
a conventional manner* Solutions of ether (2 to 10 ml*) in frog 
Ringer's solution were then added directly to the bath* The ether 
solution was allowed to remain in the bath for a period of from 2 to 5 
minutes and after washing out, acetylcholine (0*1 to 0*5 pg* per ml*) 
added end the response recorded* This dose of acetylcholine was 
repeated at intervals of 3 minutes until the response returned to the 
control level* The effect of ether on the tubocurarine-induced (2 to 
10 pg* per ml*) reduction of the response to acetylcholine was also 
investigated* A simultaneous estimation of potassium-42 levels in 
the bath solution was also made* The Ringer's solution in the bath 
was counted at the end of each reading and the effect of the stimulant 
drugs upon ion fluxes noted*
3$L.
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RESULTS.
The effects of volatile anaesthetics upon (a) the uptake of 
potassium-42, (b) the efflux of potassium-^42 and (0) the uptake of 
sodium-24 by the isolated frog sartorius muscle and by isolated 
strips of rat diaphragm.
(a) Influence of ether upon the uptake of potassium-42 by the 
isolated frog sartorius muscle and by isolated strips 
of rat diaphragm.
Solution of ether (2 to 10 ml.) produced a significant decrease 
(P < 0.001) in the uptake of potassium-42 by the isolated frog sar­
torius muscle (Fig. 115b, page 383 and Table 15, page 412) and by 
isolated strips of rat diaphragm (Fig. 116b, page 384 and Table 15, 
page 412). The control muscle showed an increase in the uptake of 
potassium-42 when compared with the drug-treated muscle.
Neothyl
Solutions of neothyl (2 to 10 ml.) produced a significant 
decrease (P<_ 0.001) in the uptake of potassium-42 by the isolated 
frog sartorius muscle (Fig. 117a, page 385 and Table 19, page 416) 
and by isolated strips of rat diaphragm.
Halothane
Solution of halothane (2 to 10 ml.) produced a significant decrease 
(P < 0.001) /
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(P 0.001) in the uptake of potassium-42 by the isolated frog 
sartorius muscle (Pig. 118, page 387 ana Table 17, page 414) and 
by isolated strips of rat diaphragm.
Chloroform
Solution of chloroform (2 to 10 ml.) produced a significant 
decrease (P<C 0.001) in the uptake of potassium-42 by the isolated 
frog sartorius muscle (Pig. 119a, page 388 and Table 19, page 416) 
and by isolated strips of rat diaphragm.
(b) Influence of ether upon the efflux of potassium-42 from
isolated frog sartorius musole and strips of rat diaphragm.
Solution of ether (3 to 10 ml.) produced a marked increase in 
the release of potassium-42 from the isolated frog sartorius muscle 
(Pig. 120, page 389 and Table 20, page 417) and. from isolated strips 
of rat diaphragm (Table 21, page 418).
Neothyl
Solution of neothyl (2 to 5 ml.) produced a marked increase in 
the release of potas3ium-42 from the isolated frog sartorius musole 
(Pig. 121, page 390) and from isolated strips of rat diaphragm.
Halothane
Solution of halothane (2 to 5 ml.) produced a marked increase in 
the release of potassium-42 from the isolated frog sartorius musole 
(Fig. /
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Fig* 120,
Effect of 5 *&1# and of 10 ml* of ether solution on the release of 
potassium-2+2 from the isolated frog sartorius muscle* The vertical 
arrows indicate the point of exposure of the test muscle to the drug- 
containing solution*
The broken line indicates control muscle and the unbroken line the 
test muscle*
390
Time in minutes
Fig* 121
Effect of 5 ml* of neothyl solution upon the release of potassium-42 
from the isolated frog sartorius musole* The vertical arrow indicates 
the point of exposure of the test muscle to the drug-containing 
solution*
The broken line indicates the control muscle and the unbroken line 
the test muscle*
(Fig. 122, page 392 and Table 22, page 419) and from isolated strips 
of rat diaphragm. .
Chloroform
Solution of chloroform (2 to 10 ml.) produced a marked increase 
in the release of potassium-42 from the isolated frog sartorius 
muscle (Fig. 123, page 394) and from isolated strips of rat diaphragm.
(c) influence of ether upon the uptake of sodium-24 by isolated
frog sartorius muscle and by strips of rat diaphragm.
Solutions of ether (2 to 10 ml.) produced a significant increase 
(P^L 0.001) in the uptake of sodium-2 4 by the isolated frog sartorius 
muscle (Fig. 115a, page 3^3 and Table 16, page 413) and by isolated 
strips of rat diaphragm (Fig. U 6a, page 3^4 and Table 16, page 413)* 
The control muscle did not show an increase in the uptake of sodium- 
24 when compared with the drug-treated muscle. «
Neothyl
Solution of neothyl (2 to 10 ml.) produced a significant increase 
(p 0.001) in the uptake of sodium-2 4 by the isolated frog sartorius 
muscle (Fig. 117b, page 3^5 and Table 18, page 415) and by isolated 
strips of rat diaphragm.
Halothane
Solutions of halothane (2 to 10 ml.) produced a significant 
increase (P 0.001) in the uptake of sodium-24 by the isolated frog 
sartorius muscle (Table 23, page 420) and by isolated strips of rat
diaphragm. /
diaphragm*
Chloroform
Solutions of chloroform (2 to 10 ml«) produced a significant 
increase (P = 0*05 >  0*02) in the uptake of sodium-24 by the 
isolated frog sartorius muscle (Pig* 119b, page 338 and Table 18, 
page 415) and by isolated strips of rat diaphragm*
The rat phrenic nerve-diaphragm preparation
The effect of ether and tubocurarine upon the magnitude of the 
muscle twitch produced by the direct and indirect stimulation of the 
rat diaphragm and upon potassium-42 efflux*
Solution of ether (5 to 10 ml*) when added to the bath, reduced 
the magnitude of the response to indirect stimulation via the phrenic 
nerve (Pig* 124, page 395)* In the same concentration, ether 
increased the tubocurarine-induced (l to 2 pg* per ml*) inhibition 
of the response to indirect stimulation (Pig* 124, page 395)* A 
marked increase in the efflux of potassium-42 was also noted during 
the presence of ether solution in the bath* On the other hand, tubo­
curarine, although it caused a reduction in the magnitude of the con­
tractions which was similar to that caused by ether, produced no 
demonstrable effect on the efflux of potassium-42 (Pig* 125, page 396).
Ether solution (10 to 30 ml.) produced complete inhibition of the 
muscular / .
393.
Time in minutes
Fig. 122.
Effect of 5 ®1* of halothane solution on the release of potassium-42 
from the isolated frog sartorius muscle. The vertical arrow indicates 
the point of exposure of the test muscle to the drug-containing 
solution.
The broken line indicates the control muscle and the unbroken line the 
test muscle.
394-
Fig- 123. .
Effect of 5 nl. of chloroform solution on the release of potassium-42 
from the isolated frog sartorius muscle. The vertical arrow indicates 
the point of exposure of the test muscle to the drug-containing 
solution.
The broken line indicates the control muscle and the unbroken line the 
test muscle.
Fig* 124.
The isolated rat phrenic nerve diaphragm preparation.
Indirect stimulation via the phrenic nerve.
Contractions downwards*
At TC, 1 pg. per ml. of tubocurarine.
At E, 5 ml* of ether solution*
At E + TC, 5 ml. of ether solution and 1 pg. per ml. 
of tubocurarine.
Time interval (lower trace) = 30 seconds.
396.
ffig. 125.
Effects of (2 pg. per ml.) tuboourarine (at To) and 5 sal* of ether 
solution (at E) in 50 ml# Tyrodefs solution upon the efflux of 
potassium-42 from the rat phrenic nerve-diaphragm preparation. 
Vertical arrows indicate the point of exposure of the preparation 
to the drug-containing solution.
muscular contractions induoed by indirect stimulation, whereas the 
responses of the diaphragm to direct stimulation were not affected 
(Fig. 126, page 398)* .
 ^ Decamethonium (10 to 20 jig. per ml.) produced a decrease in the 
magnitude of the contractions of the diaphragm to indirect stimu­
lation and at the same dose level it potentiated the effect of ether 
upon the response of the muscle to indirect stimulation (Fig. 127a,
page 399).
The depressant effects of ether solution (2 to 10 ml.) on the 
muscular contractions were also antagonized by the addition of neo­
stigmine (2 to 10 jag. per ml.) (Fig. 127b, page 399)*
The cat gastrocnemius muscle-sciatic nerve preparation
Effect of ether upon the muscular contractions induced by 
indirect stimulation via the sciatic nerve and also upon the level 
of potassium-42 in the .blood serum of the cat.
Inhalation of ether for a period of 5 to 10 minutes by the . 
pentobarbitone-anaesthetized cat, produced an inhibition of the con­
tractions due to indirect stimulation (Fig. 128, page 4-00). A 
simultaneous increase in the level of potassium-42 in the blood serum 
was also observed. Tubocurarine (0.2 to 0.5 P®r kg.) produced a 
similar decrease of the twitch height but did not alter the serum 
potassium-42 level (Fig. 125* page 401)*
Adrenaline /
398.
Fig. 126.
The isolated rat phrenic nerve diaphragm preparation. Contractions
downwards•
Tracing a. Effect of 2 yg. Per tuboourarine upon the responses 
of the rat diaphragm to indirect stimulation (unlabelled 
contractions) and to direct stimulation at D.
Tracing b. Effect of 30 ml. of ether solution upon responses of 
the rat diaphragm to indirect stimulation (unlabelled 
contractions) and to direct stimulation at D.
Time interval (lower trace) = 30 seconds.
Fig. 127.
0
* The isolated rat phrenic nerve-diaphragm preparation. Indirect
stimulation via the phrenic nerve. Contractions downwards.
Tracing a. At C1Q, 10 jig. per ml. of decamethonium.
At E + 5 nil. of ether solution and 10 jig.
of decamethonium.
At E, 5 ml* of ether solution.
Tracing b. At E, 30 ml. of ether solution.
At N, 10 yLg. per ml. neostigmine.
Time interval (lower trace) = 30 seconds.
(I Ifllllfll U I I U U U
Fig. 128.
Cat gastrocnemius muscle-sciatic nerve preparation. 
Pentobarbitone anaesthesia (60 mg. per kg.).
Indirect stimulation via the sciatic nerve.
Contractions downwards.
E, the cat was allowed to inhale ether for 5 minutes. Con 
• tractions recovered to about 70 per cent of control levels 
after 30 minutes.
Time interval, (lower trace) = 30 seconds
401.
Time in minutes
*29-
Effect of ether (B) and tuboourarine (Tc) upon the potassium-42 levels 
of the blood serum of the cat.
All drugs given intravenously*
At E, the cat was allowed to inhale ether for 5 minutes*
At -To, 100 pg. per kg. of tuboourarine was given intravenously.
Vertical arrows indicate the points where ether and tuboourarine were 
given to the cat.
Adrenaline (20 to 50 pg* per kg.) when administered intravenously, 
antagonized the inhibition of the muscular contractions following 
inhalation of ether-for from 5 to 10 minutes or the intravenous 
administration of tubocurarine (0*2 to 0.5 mg. per kg.) (Pig. 130, 
page 403)* Administration of adrenaline (20 to 50 pg* per kg.) was 
always accompanied by a marked increase in the serum potassium-42 
level as compared with the control. This effect is shown in Fig.
131, page 404*
Neostigmine (0.25 mg* per kg.) antagonized the depressant effects 
of ether upon the muscular contractions. This effect was also 
accompanied by a marked increase in the serum potassium-42 level of 
the cat (Fig. 132, page 405 and Fig* 1335 page 406)*
Isolated frog rectus abdominis muscle.
(a) The direct effect of ether, neothyl, chloroform and halo­
thane upon the isolated frog rectus abdominis muscle*
(b) The effect of ether, neothyl, chloroform and halothane 
upon the acetylcholine-induced contractions of the muscle.
Solution of ether (2 to 10 ml.) produced a contraotural response 
of the isolated frog rectus abdominis muscle which was accompanied by 
a marked increase in the release of potassium-42* The response of 
the muscle to ether solution was always followed by an inhibition of 
the responses to a subsequent dose of acetylcholine (0.1 to 1 pg* per
ml. /
402*
Cat gastrocnemius muscle-sciatic nerve preparation. Pentobarbitone 
anaesthesia (60 mg. per kg.). Indirect stimulation via sciatic nerve 
Contractions downwards. Drugs given intravenously. '
Tracing a. 
Tracing b.
At Tc, 200 pg. per kg. of tuboourarine.
At A, 50 pg. per kg. of adrenaline.
At E, The cat was allowed to inhale ether for 5* minutes
At A, 50 pg. per kg. of adrenaline.
Time interval (lower trace) = 30 seconds.
404.
Fig. 131.
Effect of ether (E), tubocurarine (Tc) and adrenaline (Ad) upon the 
potassium-42 levels of the blood serum of the cat*
All drugs given intravenously*
At E, the cat was allowed to inhale ether for 5 minutes*
At Ad, 50 pg* per kg* of adrenaline*
At Tc, 0*2 mg* per kg* of tubocurarine*
Vertical arrows indicate the points where ether, adrenaline and tubo­
curarine were given to the cat*
Cat gastrocnemius muscle-sciatic nerve preparation. 4 ml* of 
potassium-42 solution given 2 hours prior to the experiment. 
Pentobarbitone anaesthesia (60 mg. per kg.).
Indirect stimulation via the sciatic nerve.
Contractions downwards.
All drugs given intravenously.
At E, the oat was allowed to inhale ether for 5 minutes.
At N, 0.25 per kg. of neostigmine.
*111110 interval (lower trace) = 30 seconds.
40 6
Viz. 133.
Effect of ether (E), adrenaline (Ad), tubocurarine (To) and neo­
stigmine (N) upon the potassium levels of the blood serum of the cat.
All drugs given intravenously.
At E, the oat was allowed to inhale ether for 5 minutes.
At Ad, 30 jug. per kg. of adrenaline.
At Tc, 100 jug. per kg. of tubocurarine.
At N, 0.23 mg. per kg. of neostigmine.
Vertical arrows indicate the point where ether, tubocurarine, adrenaline 
and neostigmine were given.
ml.). When the muscle was exposed repeatedly to ether solution, 
the contractions failed to return to control levels (Pig. 134, 
page 408). Soaking the muscle in Ringer’s solution containing 
three times as much potassium as noraal Ringer’s solution for a 
period of half an hour did not bring the acetylcholine-induced 
responses of the isolated muscle back to control levels. This may 
indicate that an irreversible change had taken place in the muscle 
cell. Ether solution (2 to 10 ml.) potentiated the action of 
tubocurarine (0.3 to 0.6 pg. per ml.) on the response of the frog 
rectus abdominis muscle (Pig. 136, page 409)* At the same dose 
level tubocurarine had no effect upon potassium-42 efflux.
Neothyl solution (2 to 10 ml.) had similar depressant effects 
on the acetylcholine-induced contractions of the isolated frog 
rectus abdominis muscle (Pig. 137, page 410). It also had a direct 
stimulant effect on the muscle which was accompanied by an increase 
in the release of potassium-42.
t
Halothane (2 to 5 b1.) (Pig. 138, page 411) and'chloroform 
(2 to 5 nil.) also had similar actions on the isolated frog rectus 
abdominis muscle but the doses required were less than those of 
ether and neothyl.
Effect of 5 ml. (at a) and 10 ml. (at b) of 
ether solution (E) on the isolated frog 
rectus abdominis muscle and on the acetyl­
choline-induced contractions.
All other contractions are due to 0.3 
per ml. of acetylcholine (A).
Time interval (lower trace) = 30 seconds.
Fig. 134.
Effect of tubocurarine (TC) and ether solution (E) on the isolated 
frog rectus abdominis muscle and on the acetylcholine-induced con­
tractions •
iAll other contractions are due to 0.5 ug. per ml. of acetylcholine.
Tracing a. At TC, 0.6 pg. per ml. of tubocurarine.
Tracing b. At E + TC, 5 nil. of ether solution and 0.3 ps* Per ml.
of tubocurarine.
Tracing o. At E + TC, 5 nil. of ether solution and 0.6 pg. per ml. 
of tubocurarine.
Time interval (lower trace) = 30 seconds.
Effect of 5 ml. (at a) and 10 ml. (at b) of neothyl 
solution (N) on the isolated frog rectus abdominis 
muscle and on the acetylcholine-induced contractions. 
All other contractions are due to 0.5 pg» P©r 
of acetylcholine (A).
Time interval (lower trace) = 30 seconds.
Fig. 137.
411
• Fig. 138,
Effect of 1 ml* (at a), 2 ml. (at b) and 3 ®1» (at c) of halothane 
solution (h ) on the isolated frog reotus abdominis muscle and on the 
acetylcholine-induced contractions.
All contractions are due to 2 yg. per ml. of acetylcholine.
Time interval (lower trace) = 30 seconds.
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DISCUSSION
The experimental evidence suggests, that in various concen­
trations, ether is capable of producing an increase in the permea­
bility of the cell membrane to inorganic ions.
There was observed a marked increase in the release of potassium 
ions, associated with a significant increase in the uptake of sodium 
ions and a corresponding decrease in the uptake of potassium ions, by 
the isolated frog sartorius muscle and isolated strips of rat diaphragm.
In similar concentrations, ether was shown in separate experi­
ments to potentiate the effect of tubocurarine upon the acetylcholine- 
induced contractions of the isolated frog rectus abdominis muscle.
In the same preparation, ether, chloroform, halothane and neothyl 
were found to be capable of producing a muscle contracture - followed 
by a reversible depression of the muscular activity. This was 
associated with an increased release of potassium ions. This effect 
is identical to the action of depolarizing agents observed by Ahmed 
and Lewis (1962) using decamethonium and suxamethonium.
It was also observed^that concentrations of ether which were 
sufficient to cause inhibition of neuromuscular transmission in the 
rat phrenic nerve-diaphragm preparation and in the cat gastrocnemius 
muscle- /
2*21.
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muscle-sciatic nerve preparation were capable of oansing an increase 
in the release of potassium ions. When used upon the same prepar­
ation tubocurarine, although it caused a potentiation of the neuro­
muscular blook induced by ether, had no observable effect on the flux 
of ions.
Adrenaline and neostigmine were found to antagonize the effects 
of ether on the response to indirect stimulation of the cat gastroc­
nemius muscle-sciatic nerve preparation. Adrenaline produced an 
increase in the serum potassium-42 levels of the cat. This observ­
ation was in agreement with the earlier findings of D*Silva (1933) 
and Cicardo and Ashman (1938)* A marked increase in the serum 
potassium-42 level of the cat was also observed with neostigmine.
When the results obtained from the present investigations are 
considered from the point of view of Overtonfs lipoid cell membrane 
theoiy it seems possible that ether and other volatile anaesthetics 
(by virtue of their high solubilizing action on fats) are acting on 
the cell membrane in such a manner as to alter its permeability to 
inorganic ions. This physical action may depress the activity of 
the cell which is reflected in the appearance of an injury potential. 
It was observed by Galeotti and Di Cristina (1910) that the local 
application of ether to an isolated muscle surface produced a spot 
which became electrically negative when compared to the rest of the 
muscle and this effect was not completely reversible. He suggested 
that /
that this phenomenon was similar to irreversibly damaging the muscle 
by cutting it. It may also be assumed that it is associated with an 
increased release of potassium and an increased uptake of sodium ions. 
If this assumption is true, then the question arises as to the manner 
in which the ability of the muscle cell to respond to electrical or 
chemical stimuli returns to normal. According to Mullins (1956) a 
local transformation of one part of the cell membrane cannot readily 
be compensated for without creating fbrther disturbances of the cell 
membrane. This may indicate that some other mechanism of action is 
involved which brings about a momentary change in the uptake end 
release of sodium and potassium ions, i.e. the type of effect 
produced by depolarizing drugs. This fact is supported by the 
observations of Ahmed and Lewis (1962) that depolarizing agents suoh 
as suxamethonium and decamethonium caused an increase in the uptake 
of sodium and calcium ions and increased the release of potassium 
ions. In contrast to this observation, competitive neuromuscular 
blocking agents, i.e. tubocurarine and gallamine, were found to 
exert no influence on ion fluxes.
The experimental evidence presented in Chapter III, indicates 
that the mechanisms of the muscle relaxant actions of the volatile 
anaesthetics and tubocurarine differ. It seems that ether may 
cause depolarization of the motor end-plate in the first phase of 
its action, possibly due to the presence of a high local concen­
tration /
concentration of potassium and that this effect may he followed by a 
non-depolarizing action (Foldes, Wnuck, Hodges, Thesleff and de Beer, 
1957).
The question arises as to why an increase in the concentration of 
potassium ions in the medium, which ordinarily causes antagonism to 
the effects of tubocurarine, (Paton, 1956) does not antagonize the 
effect of tubocurarine in this preparation. It is possible that 
this is due to the very large concentration of potassium ions in the 
bathing solution which produces a secondary inhibitory effect on the 
excitability of the cell (Penn, 1940).
It was also observed that the concentrations of ether in Tyrode's 
solution which were capable of producing complete inhibition of the 
responses to indirect stimulation, did not alter the response of the 
diaphragm muscle to direot stimulation. This confirms the obser­
vations of Secher (I951d) that although ether in concentrations which 
are capable of depressing neuromuscular transmission, does not alter 
the activity of the muscle cell itself, yet it can cause an increase 
in the permeability of the cell membrane to ions. It is well known 
that neuromuscular transmission is affected more rapidly than the 
muscle cell itself (Nachmansohn, 1959 a and b).
The aotion of ether clearly differs from that of tubocurarine and 
is more like that of the depolarizing agents such as suxamethonium and 
decamethonium. This fact is further supported by the observations of 
Y/atland /
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Watland, Long, Pittinger and Cullen (1957) who suggested that the 
initial stimulant effect of chloroform on the responses of the gastroc­
nemius muscle to indirect stimulation was due to a depolarising action,
Jenden, Kami jo and Taylor (1951 and 1954) suggested that depol­
arizing agents can produce a two phase block of neuromuscular trans­
mission, Prom in vitro studies using the isolated rabbit lumbrical 
muscle preparation, they indicated that phase one block set in rapidly, 
was of short duration, and had the characteristics described by Paton 
and Zaimis (1949) > Bums, Paton and Vienna Dias (1949) and Paton and 
Zaimis (1952) for decamethonium-induced block in the cat muscle-nerve 
preparation. The neuromuscular block in the phase one could be 
antagonized by tuboourarine but was not affected by potassium or anti­
cholinesterases. This phase one block was followed by an increase in 
the neuromuscular block which now resembled that of a non-depolarizing 
block and this was antagonized by anticholinesterases and potassium 
ions. This effect persisted as long as the preparation was kept in 
contact with the depolarizing relaxant. It was also observed by 
Brennan (1956) that, although depolarizing and non-depolarizing drufes 
should antagonize the neuromuscular actions of one another, the neuro­
muscular block Induced by small doses of gallamine was intensified by 
prior use of suxamethonium. Similar effects were reported in man by 
Hodges and Poldes (1956), who observed that when administered for 
a /
a prolonged period, suxamethonium potentiated the neuromuscular block 
induced by tubocurarine.
In the present study using the rat phrenic nerve-muscle prepar­
ation, it was observed that ether potentiated the reduction in the 
magnitude of the responses to indirect stimulation induced by deca­
methonium. It was also observed, that the inhibition of responses 
to indirect stimulation by ether was antagonized by neostigmine. It 
has previously been reported, that tubocurarine is capable of antagon­
izing a depolarizing block produced by decamethonium both in laboratory 
animals (Foldes, 1954; Burns and Pat on, 1951; Jenden, Kamijo and 
Taylor, 1951 and 1954; and Thesleff, 1955) and in man (Macfarlane, 
Unna, Pelikan, Cazort, Sadove and Nelson, 1950).
Although Paton and Zaimis (1952) have suggested that non­
depolarizing agents are antagonized by depolarizing agent3, this does 
not seem invariably to be true. When, for example, a depolarizing 
relaxant is administered after a non-depolarizing agent (Hutter and 
Pasooe, 1951) 9 the administration of decamethonium does not antagonize 
the effect of a subsequent dose of tubocurarine (Paton and Zaimis, 
1949)* On the other hand, there is evidence (Brennan, 1956; Hodges 
and Foldes, 1956; Foldes, Wnuck, Hodges, Thesleff and de Beer,
1957) that prolonged administration of depolarizing drugs such 
as decamethonium, instead of antagonizing the effect of tubo- 
<curarine, may potentiate it. Zaimis (1953)9 Jenden and his assoc­
iates /
associates (1951 s^d 1954) s*id Foldes and his co-workers (1957)* 
using the sciatic nerve-muscle preparation of the dog, cat or rabbit, 
have demonstrated that the end-plate became less sensitive to the 
effects of decamethonium and suxamethonium when these were administered 
over a prolonged period. Neostigmine was found to be capable cf 
antagonizing their effects. Foldes and his associates (1957) 
observed that when the isolated sartorius muscle-nerve preparation 
of the frog was kept in prolonged contact (13 minutes) with depolar­
izing agents, there was potentiation of the tubocurarine-induced 
inhibition. These authors postulated that when the end-plate was 
exposed to depolarizing drugs for a oertain length of time, it 
developed a resistance to them. The same observation was made by 
Thesleff (1955)* When the isolated nerve-muscle preparation of the 
frog was kept in a bath containing acetylcholine, the initially 
depolarized end-plate became repolarized after a certain period.
The same was found true when suxamethonium and decamethonium were 
used.
The release of potassium-42 in the circulating blood of the cat 
observed following the use of ether is in agreement with results of 
Kiersz (1948). It has been said to be due to the reflex release of 
adrenaline from the suprarenal glands (Elliott, 1912) or sympathetic 
stimulation (Bhatia and Burn, 1933)* The fact that adrenaline 
causes an increase in the potassium ion concentration of the cat 
blood /
428.
blood was first observed by D'Silva (1933). Adrenaline, on the other 
hand, antagonizes the effect of the neuromuscular block produced both 
by tuboourarine and by ether.
During a neuromuscular block due to inhalation of ether vapour, 
there was an associated increase in the blood potassium level. When, 
however, adrenaline was given, the blood potassium rose further but 
the block diminished. This may mean that the release of potassium 
ions seen during neuromuscular block is not due to the release of 
endogenous adrenaline but some other mechanism. It is possible that 
the source of blood potassium is merely from the erythrocytes and not 
from the muscle cells (Davson, 194b). It may be due to a mechanism 
of depolarization resembling that of decamethonium. This fact is 
supported by the evidence that in the isolated frog sartorius muscle 
and isolated strips of rat diaphragm an increased release of potassium 
ions was observed, when these tissues were exposed to ether.
Although ether exhibits muscle relaxant actions which resemble 
those of tuboourarine, it seems to have a mechanism of action different 
from that of tuboourarine. It is tempting to aceept the theory of, 
Foldes and his associates (1937) that basioally there is no difference 
between the mechanism of action of depolarizing and non-depolarizing 
agents. Both compete with aoetylcholine for the cholinergic receptors 
of the end-plate membrane. After their successful competition with 
acetylcholine, the sequence of events seems to be first determined by 
the /
the chemical characteristics of the relaxant and second by the 
properties of the end-plate (as a marked variation is seen in 
different species). Those relaxants which chemically resemble 
acetylcholine, especially in relation to the size of the oationio 
head (Bovet, 1951) have a tendency to produce initial depolarization. 
The degree and duration of depolarization depends upon the sensitivity 
of the end-plate and the type of depolarizing agent used. If the 
sensitivity of the end-plate is low as seen in the monkey, depolar­
ization block can not be produced (Zaimis, 1953)*
From a consideration of the results of experiments recorded in 
this part of the thesis it seems that ether and other volatile 
anaesthetics tested, increase the permeability of the oell membrane 
to sodium and potassium ions in a manner similar to that of depolar­
izing agents.
This assumption is favoured by the evidence presented by Mullins 
(1956) and Waser (I960). It is likely that ether depresses neuro­
muscular transmission by depolarizing the motor end-plate membrane.
It is felt that the peripheral actions of ether in increasing a non­
depolarizing block, are due to the mechanism suggested above.
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SUMMARY OF PART 2.
In the introduction, a survey has been made upon the work of 
earlier investigators upon the muscle relaxant actions of volatile 
anaesthetics. A discussion of the role of inorganic ions in the 
mechanism of neuromuscular transmission is included together with a 
consideration on theories of the nature of the oell membrane and the 
cholinergic receptor.
In Chapter H ,  the experimental techniques used to investigate 
the mode of muscle relaxant action of ether and some other volatile 
anaesthetics are described.
In Chapter III, the results of the investigations described in 
Chapter II, are presented. Ether, halothane, chloroform and neothyl 
in various concentrations were found significantly to increase the 
uptake of sodium-24 end the efflux of potassium-42 by the isolated 
frog sartorius muscle and by isolated strips of rat diaphragm. In 
other series of experiments ether, halothane, chloroform and neothyl 
were found to inhibit the aoetyloholine-induoed contractions of the 
isolated frog rectus abdominis muscle. This inhibitor effect was 
preceded by a reversible contracture and an increase in the efflux 
of potassium ions. Ether was capable of potentiating the effects 
of /
C H A P T E R  V .
of tubocurarin© on acetylcholine-induced contractions of the isolated 
frog rectus abdominis muscle.
In lower concentrations, ether was found to be oapable of 
depressing the response of the isolated rat phrenic nerve-diaphragm 
preparation to indirect stimulation, whereas larger concentrations 
were required to cause a similar effect on the response of the rat 
diaphragm to direct stimulation. The inhibition of neuromuscular 
transmission in this preparation was associated with an increase in 
the efflux of potassium-42.
When pentobarbitone-anaesthetised cats were allowed to inhale 
ether for 5 to 10 minutes, an increase was observed in the level of 
potassium-42 in the venous blood. This effeot was associated with 
a simultaneous inhibition of the response of the gastrocnemius muscle 
to indirect stimulation. Tuboourarine, although it caused an 
inhibition of the response of the gastrocnemius muscle to indirect 
stimulation, did not oause any observable change in the serum 
potassium-42 levels.
Neostigmine and adrenaline were found to cause an increase in 
the serum potassium level and also to antagonise the effects of ether 
on the responses of the isolated rat diaphragm and cat gastrocnemius 
musole to indirect stimulation.
In Chapter IV, the significance of the increased permeability of 
the oell membrane to sodium and potassium ions in the muscle relaxant 
action /
aotion of ether is discussed.
It is concluded that the muscle relaxant actions of ether and 
other volatile anaesthetics are probably due to a mechanism which 
resembles that of depolarizing agents.
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